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Abstract 
To date, most health services worldwide have been organized to treat acute episodes, whereas 
chronic conditions consume as much as 80% of national healthcare‟s budgets due to a suboptimal 
management of chronicity. In parallel, the proliferation of health-related devices able to share clinical 
information over communication networks has unleashed new horizons in the clinical practice. This 
new scenario of electronic healthcare leads to reconsider traditional clinical practices toward more 
accurate diagnoses and a more efficient redistribution of resources, both material and human. 
Therefore, in order to adapt the existing health services in a coherent, comprehensive, and reusable 
manner, a number of needs arise that must be efficiently solved, which are described as follows. 
First, theoretically, e-health standards arena must guarantee standardization at different levels of 
interoperability to achieve a faithful exchange of health information. And yet, there is no unified 
solution for interoperability, indeed, even the e-health standards available nowadays are not directly 
interoperable with each other. To bridge this gap, this Thesis proposes a comprehensive methodology 
for formalizing clinical information in accordance with technical, syntactic, semantic, 
process/organizational, and presentation layers of interoperability, that will guide experts on clinical 
domain to actively engage in modelling their own clinical processes into model-driven information 
systems.  
Second, given the heterogeneity of the information systems that must interoperate in a conventional 
health service, there is a need of integrating new technologies and new devices into the legacy 
information systems. In this context, this Thesis identifies the different information systems involved on 
the management of patient-centred clinical processes, to propose an architecture that connects them 
all into an open health computing platform. 
Third, although the advantages of cutting-edge e-health standards – which differentiate data 
structures and domain-related knowledge when modelling clinical information – are well-known, there 
is still a clear need to make contributions to the existing corpus of electronic models, given the current 
scarcity of knowledge artefacts available so far. Such contributions would help in widening the range 
of healthcare scenarios to which the dual-model approach could be applied. Therefore, this Thesis 
formalizes a number of electronic models for real healthcare scenarios. More specifically, models are 
provided for three eye conditions considered strategic for the management of chronicity in 
ophthalmology, since they correspond to the most frequent causes of avoidable blindness in Europe 
and their associated clinical processes threaten to overload the waiting lists of health services, due to 
the scarcity of specialists available to handle the revisions within recommended intervals: Diabetic 
Retinopathy (DR), Age-related Macular Degeneration (AMD), and Chronic Glaucoma (CG). 
Consequently, this Thesis proposes the modelling of the clinical processes associated to these three 
conditions, based on the methodology and in compliance with the open health computing platform 
proposed before. Although in principle the models provided are created for Health Service of Navarre 
(Servicio Navarro de Salud - Osasunbidea [SNS-O]), this Thesis pursues the reusability of the 
electronic resources that comprise these models. 
In summary, this Thesis proves that a definition of a comprehensive methodology for formalizing 
clinical practice into information systems, the design of a model-driven, standard-based, open e-
health platform and the creation of semantically enabled electronic models improves the management 
of electronic information in healthcare, the interoperability as well as the reutilization of the resources. 
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Resumen 
En general, los servicios de salud se diseñan para tratar episodios agudos, mientras que las 
enfermedades crónicas consumen cerca del 80% del presupuesto de los servicios nacionales de salud 
debido a una gestión subóptima de la cronicidad. En paralelo, la proliferación de dispositivos en el 
ámbito clínico con la capacidad de intercambiar información a través de redes de comunicación ha 
abierto nuevos horizontes en la práctica clínica. Este nuevo escenario de salud electrónica nos lleva a 
reconsiderar la práctica clínica tradicional en pro de la precisión diagnóstica y una redistribución más 
eficiente de los recursos disponibles, ya sean materiales o humanos. De modo que, con el fin de 
adaptar los servicios de salud ya existentes de forma coherente, integral y reutilizable, surgen una 
serie de necesidades a considerar, tal y como se describe a continuación. 
En primer lugar, para lograr un intercambio fiable de la información clínica, las normas de salud 
electrónica deben garantizar la estandarización a diferentes niveles de interoperabilidad. Y sin 
embargo, de momento no hay una solución integral para alcanzar dicha interoperabilidad. De 
hecho, incluso los diferentes estándares de salud electrónica disponibles hoy día no son directamente 
interoperables entre sí. Para suplir dicha carencia, esta tesis proporciona una metodología integral 
para formalizar la información clínica de acuerdo a los niveles de interoperabilidad técnica, 
sintáctica, semántica, de proceso/organizativa y de presentación. Esta metodología guiará a los 
expertos del dominio clínico a participar activamente en el modelado de procesos clínicos para que 
sean integrados en sistemas de información clínicos.  
En segundo lugar, dada la heterogeneidad de los sistemas de información que deben interoperar en 
un servicio de salud convencional, existe la necesidad de integrar nuevas tecnologías y nuevos 
dispositivos en los sistemas de información ya existentes. En este contexto, esta tesis identifica los 
diferentes sistemas de información que participan en la gestión de los procesos clínicos centrados en 
el paciente y propone una arquitectura que conecta dichos sistemas en una plataforma abierta de 
salud electrónica. 
En tercer lugar, es cierto que las ventajas de los estándares actuales en salud electrónica (los cuales 
diferencian entre la estructura de los datos y el conocimiento del dominio a la hora de modelar la 
información clínica) son patentes. Sin embargo, en vista de la escasez de artefactos de conocimiento 
disponibles hasta la fecha, se percibe una clara necesidad de contribuir al corpus de modelos 
electrónicos existente. Tal contribución ayudaría a ampliar el abanico de escenarios clínicos en los 
cuales se puede aplicar el enfoque del modelo dual. Por consiguiente, en el marco de esta tesis se 
formalizan una serie de modelos electrónicos que se corresponden con escenarios clínicos reales. 
Más específicamente, se proporcionan modelos para tres afecciones oculares estratégicas en la 
gestión de la cronicidad en oftalmología: retinopatía diabética, degeneración macular asociada a la 
edad y glaucoma crónico. Éstas se corresponden con las causas más frecuentes de ceguera evitable 
en Europa y sus procesos clínicos asociados amenazan con sobrecargar las listas de espera de los 
servicios de salud debido a la escasez de especialistas disponibles para hacer el seguimiento de los 
pacientes dentro de los intervalos recomendados. En consecuencia, esta tesis propone el modelado 
de los procesos clínicos asociados a estas tres afecciones, basándose en la metodología y de 
acuerdo a la plataforma abierta de salud electrónica anteriormente propuestas. Aunque los modelos 
resultantes se crean para el Servicio Navarro de Salud - Osasunbidea (SNS-O), esta tesis fomenta la 
reutilización de los recursos electrónicos que los componen. 
En definitiva, esta tesis demuestra que la definición de una metodología integral para formalizar la 
práctica clínica dentro de los sistemas de información, el diseño de una plataforma abierta basada 
en modelos y estándares de salud electrónica y la creación de modelos electrónicos estructurados 
semánticamente mejora la gestión de la información electrónica, la interoperabilidad, así como la 
reutilización de los recursos en el ámbito de la salud. 
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Chapter 1: 
Introduction 
This Chapter provides general background of the work discussed along this PhD dissertation. 
First, the current sociotechnical scenario in healthcare is introduced, discussing the advent of 
digital Information and Communication Technologies (ICTs) into clinical environments and 
how adoption of e-health standards entails a great potential in terms of interoperability 
among healthcare-related information systems and technologies. Second, the importance of 
the standardization of Electronic Health Records (EHR) systems is highlighted, given the need 
for an integrated management of patients‟ clinical information, and bearing in mind the 
emerging trend in e-health toward development of semantic-enabled vendor-independent 
health computing platforms. Third, the situation on the Health Service of Navarre (Servicio 
Navarro de Salud - Osasunbidea [SNS-O]) is presented with regard to recent 
implementations concerning e-health. Fourth, the Chapter focuses on the context of our 
research group in the field of e-health projects which gave rise to this Thesis. Fifth, a set of 
hypotheses are proposed, and the general and detailed objectives are defined, primarily to 
optimize the management of chronic diseases in the ophthalmology department of the 
SNS-O through implementation of new e-health services. Finally, the outline of this Thesis is 
defined. 
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1.1 CURRENT SOCIOTECHNICAL SCENARIO IN HEALTHCARE 
Over the past 15 years, the Information and Communication Technologies (ICTs) revolution has 
driven global development in an unprecedented way. In 2016, the International Telecommunication 
Union determined that 7 billion people (95% of the world‟s population) live within an area covered by 
a mobile-cellular network, and 3.5 billion people (nearly 47% of population) are using the internet 
[1]. Given the information society in which we live, the increasing success of Web 2.0 and social-
media has empowered citizens in the management of their own health information [2].  
In medicine, this new “sociotechnical” environment has been reflected in well informed citizens asking 
for an active participation on the clinical decisions and procedures concerning their healthcare [3]. 
This fact has shifted the doctor-patient relationship as we knew it: in contrast with the unquestionable 
authority that doctors had in the past, patients today have access to diverse information sources which 
can differ with doctor‟s guidelines.  
In fact, usually there is not only one way to manage a specific medical issue. And therefore, numerous 
care alternatives must be considered so as to find the one which best suits the context found for each 
healthcare scenario. So accordingly, clinicians must assist patients to make sense of a confusing 
cornucopia of information and advice available due to the information age [4].  
Modern society expects the highest level of quality in their healthcare, so clinical processes must 
incorporate leading edge technology and the latest advances in clinical practice. Yet, the problem is 
that the investment of healthcare organizations is limited, especially since the global economic crisis 
started in 2008, which forced to reduce the financial resources earmarked for healthcare in many 
countries. And meanwhile, the population ageing occurring in developed countries entails a growth in 
prevalence of age-related diseases, especially chronic conditions, which in turn, results in an 
increasing healthcare expenditure [5].  
1.1.1 MANAGEMENT OF CHRONICITY 
Nowadays, most health services in the world have hitherto been organized to treat acute episodes, 
whereas chronic conditions consume as much as 80% of national healthcare‟s budgets due to a 
suboptimal management of chronicity [6]. The reason for this is that chronic conditions present special 
features not addressed by the clinical practices focused on treatment of acute episodes: first of all, the 
advance of many chronic conditions is gradual and often presents no symptoms until the patient 
presents advanced stages of the disease, so in many cases patients are treated too late with the 
consequent increase in healthcare costs and the irreversible consequences for health. In addition, the 
healthcare resources necessary to cope with chronic conditions grow exponentially as their level of 
severity increases. Second, as chronic diseases eventually may lead to multimorbidity, most of 
healthcare expenses are concentrated in the last period of patient's life. Thus, few patients with 
complex healthcare needs consume a high percentage of health resources [5, 7]. Finally, we must not 
forget the impact that chronic conditions cause on patient's quality of life. In addition, to cover the 
emerging needs of patients affected by chronic conditions will incur in indirect costs for the society. 
For instance, in the case of ophthalmology, the population in working age affected with blindness or 
severe visual impairment will require special support for their reintegration into the labour market, 
hence the importance of an early diagnosis. 
At this point, a paradigm shift is needed, otherwise the costs arising from chronic conditions will 
continue increasing unless health services adapt their care strategies from reactive to preventive. The 
good news is that new models of chronic care provision, which monitor periodically risk patients and 
adjusts the treatment to the specific needs of each patient, can optimize considerably the health 
expenditure. Hence, specific preventive strategies such as screening and follow-up services must be 
launched so as to take care of patients before acute episodes occur.  
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However, unlike treating acute episodes, these strategies must guarantee the continuity of care for 
chronic patients. This means that health services must consider new issues linked to the long-term care 
not covered so far. For instance, with regard to citizens' mobility needs nowadays, patients might live 
in a different city in which they work, or they could suffer episodes of recurring illness during vacation. 
In such cases, healthcare providers should be able to attend patients wherever they are. 
1.1.2 ELECTRONIC HEALTHCARE OR E-HEALTH 
At this point, the electronic healthcare, also known as e-health, takes on special relevance. The 
proliferation of ICTs and health devices connectable to data networks facilitates the exchange of 
relevant diagnostic information among health facilities. In this regard, the amalgam of papers and 
diagnostic tests in physical format has led to Electronic Medical Records (EMR). Therefore, while 
traditionally, patients living in regions with inadequate health services required to be physically present 
at health facilities properly equipped or else accept substandard care services, conversely, e-health 
provides analogous services in which clinicians can access medical records remotely [8]. Through e-
health, distance and time are becoming trivial, so the healthcare facilities in which the care of patients 
is carried out turns irrelevant. Thus, healthcare providers can decentralize care services, and still offer 
patient-centred clinical processes [9].  
This new context of electronic healthcare leads to reconsider traditional clinical practices toward more 
accurate diagnoses and a more efficient redistribution of resources, both material and human. 
Accordingly, many e-health services emerged, generally to cover the shortcomings of traditional care 
procedures. However, due to the lack of standardization of clinical information, most of these 
proposals would be limited to very specific local healthcare scenarios. And meanwhile, many clinical 
processes hitherto applied are becoming obsolete given the potential of ICTs, and yet these will 
remain in force while a seamless integration of e-health is not achieved. Actually, that is one of the 
main challenges of e-health nowadays. 
Although novel therapeutic strategies/mechanisms keep in constant evolution toward efficient 
healthcare strategies, most health services do not reconsider traditional clinical procedures because of 
the intense efforts required to remodel their static and vendor-specific electronic health information 
systems [10]. Moreover, even if the system is finally modified, the healthcare providers are error 
prone, so they must overcome a training process until they get familiar with the new software 
tools [11].  
Obviously, there is a gap when putting these proposals into practice due to lack of normalization 
when applying them, because healthcare facilities need for additional effort to adapt new strategies to 
the requirements and resources of the specific healthcare scenarios. At best, the technological 
ecosystem on which e-health services are implemented nowadays entails heterogeneous information 
systems compliant to multitudinous health information standards which even are not interoperable 
with each other [12]. According to this, the common breeding ground for new e-health proposals are 
either research projects specifically designed for the diagnostic devices and information systems 
available on the health service, or turnkey services installed by a given manufacturer which provides 
all infrastructure necessary.  
Either way, any novel contribution upon medical practice must contemplate the enormous base of 
technologies, information systems, and medical devices, often based upon proprietary specifications, 
installed in the health service concerned. Therefore, the future of healthcare will be determined by a 
holistic management for the arising new electronic clinical information.  
In this sense, the normalization of information and communications in medicine are considered 
strategic, as they facilitate the development of new e-health services that coordinate devices from 
different manufacturers. Those e-health services, in turn, will provide software tools that, relying on 
objective parameters, would facilitate an efficient management of healthcare resources [13, 14]. 
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1.2 STANDARDIZATION OF EHR SYSTEMS 
To share clinical information among health facilities, EHR systems are a cornerstone of any e-health 
service. Likewise, those systems have demonstrated to be a powerful tool to organize healthcare, 
especially when it comes to clinical processes centred on patients [15].  
Nevertheless, the healthcare industry has an enormous installed base of legacy systems based on 
proprietary technologies, so the lack of normalization of EHRs makes it difficult, if not impossible, to 
exchange information. To address this, some EHRs have adopted interoperability standards that define 
common data architectures to reach an agreement during message exchange among heterogeneous 
systems [14, 16, 17]. In this context, the standards development organizations – such as the 
International Standards Organization (ISO), the European Committee for Standardization (Comité 
Européen de Normalisation [CEN]), Health Level 7 (HL7), the Institute of Electrical and Electronics 
Engineers (IEEE), or the European Telecommunication Standards Institute (ETSI) – are key in the 
normalization of the clinical information. 
In this regard, irrespective of the standards chosen, ETSI distinguishes four categories of 
interoperability which must be covered to achieve an efficient understanding during information 
interchange among EHR systems: technical, syntactic, semantic, and clinical process [18]. Nowadays, 
beyond simply ensuring a faithful data interchange among different EHRs (technical and syntactic 
interoperability), the challenge now lies in finding an efficient way to preserve the clinical meaning of 
that information (semantic interoperability) and maintain the integrity of workflow among all health 
institutions involved in a specific clinical process (clinical process interoperability) [19, 20]. Therefore, 
the study of the current ecosystem of standards and specifications for EHR systems which cover the 
aforementioned levels of interoperability would be the starting point of this Thesis. 
By focusing on semantic and clinical process interoperability, the EHRs involved in the communication 
must share the same knowledge base from clinical domain, where every clinical concept and 
procedure would be defined. At this point, some standardization organizations made attempts to 
formalize the whole healthcare domain into pervasive reference models, but the size and complexity of 
medicine hindered the proliferation of this approach.   
In principle, EHR systems are meant to record patient's health information longitudinally to its life [21]. 
And as such, they must guarantee the continuity of patient's care beyond health institutions. For that 
reason, EHRs must be flexible enough to handle complex and constantly changing social information 
and clinical workflows, forever.  
However, most EHR systems used so far in healthcare are not adequately prepared to keep pace with 
the rapidly changing body of knowledge plus the non-deterministic nature of medicine. First, there is 
an important interdisciplinary gap in reaching an agreement among software developers and 
clinicians, when knowledge from clinical domain must be transcribed into electronic health 
information systems. Second, EHRs must handle a huge variety of medical records, given the broad 
and complex knowledge domain of medicine. Further, each EHR system should be adapted bearing in 
mind the specific requirements reliant on the local context of final users. Thus, clinical specialities with 
very specific requirements, such as ophthalmology, are not covered by pervasive information systems 
[22]. Hence the consequent developmental costs resulting from an endless redesign of this magnitude 
would become unaffordable for any health service. And consequently, health services must deal with 
outdated legacy systems, based on proprietary technologies, which can hardly be dismantled since 
they contain sensitive information about patients' health. 
This is mainly because, given the classical software engineering, up to 90% of the cost related to the 
life of software developed for healthcare could correspond to the maintenance phase [10, 23]. 
Therefore, this background has led to a search for more adaptive strategies for modelling the clinical 
knowledge inside information systems [24].  
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1.2.1 MULTI-LEVEL APPROACH ON MODELLING THE CLINICAL KNOWLEDGE 
The advent of health information standards based on dual-model layered architectures, such as the 
EN/ISO 13606 or openEHR, has simplified all of those factors, i.e., agreement among clinicians and 
software developers, continuous need to adapt the information system, and system customization to 
specific healthcare scenarios. These new information standards have simplified the management of 
the clinical knowledge inside the EHR [17, 25].  
This architecture defines two conceptual levels: on the one hand, a reference model that standardizes 
the way the information is handled inside the software, and, on the other hand, an archetype model 
that gathers knowledge about the clinical process to be managed. The former defines the structure 
and semantics of information in terms of information models, which are handled inside the software to 
register the clinical data in a normalized form. By contrast, the latter is constituted by archetypes and 
templates which define formally the clinical knowledge to be registered about a clinical domain. 
Experts in the clinical domain customize the information in their own EHR systems, whereas software 
developers work independently toward better tools to achieve interoperability among information 
systems [14, 26, 27].   
Traditionally, all casuistry is planned before implementation, whereas two-level modelling can face the 
changes to the model on the fly [28], which is why this strategy has significantly improved the 
maintainability regarding time, cost, and simplicity of the software [24]. In essence, this architecture 
combines formal clinical modelling, terminology and a services infrastructure, thus providing a basis 
for implementation of semantic-enabled vendor-independent health computing platforms [29]. 
1.2.2 MODEL-DRIVEN OPEN PLATFORM ARCHITECTURE 
With consideration of all the above, it is expected that EHR systems will evolve from monolithic 
information islands toward open health computing platforms in which even legacy systems are 
integrated into a distributed but interoperable collection of information systems. This would ensure, on 
the one hand, the collaboration among different healthcare providers, whilst health services retain 
control and ownership of the data in the long term; and on the other hand, the progressive 
incorporation of software tools responding to the specific needs of each health service at any given 
time, maintaining the interoperation with institutions that manage different configurations.  
However, nowadays, proposals toward development of open health computing platform architectures 
are actually hindered by the scantiness of electronic models corresponding to healthcare scenarios 
already covered by the foregoing health information standards. In that respect, building new 
knowledge models is not the major concern. Clinical knowledge is already accessible in diverse 
information sources, whether explicit or implicit, resulting from previous efforts in developing novel 
clinical practices, building medical guidelines, specifying technical standards in the clinical setting, 
and gathering experiences of numerous domain experts. The real issue becomes how to gather, 
organize, and incorporate methodologically such knowledge to produce high-quality up-to-date 
electronic models. Therefore, at this point it is imperative to work forward on better modelling software 
tools and define guidelines that would encourage domain experts to participate actively in formalizing 
clinical processes into electronic platforms. 
1.3 STATE OF THE ART ON THE SNS-O 
From previous experiences conducted in the SNS-O, we learnt that innovative healthcare procedures 
involving e-health are easily adopted locally, but when the service has to be extended to new 
healthcare scenarios, it is necessary to deal with different information systems, clinical guidelines, and 
healthcare resources [30-32]. In this regard, unless a clear strategy is defined to normalize the 
medical records, and the way these are exchanged among health facilities, the resulting e-health 
projects will depend to a large extent on the healthcare scenario for which they were originally 
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implemented. Thus, in the event that the underlying healthcare scenario evolves, the respective e-
health projects would be at risk of becoming obsolete accordingly. For this reason, the lifespan of e-
health projects is very short, hence their implementation ends up being very costly for the health 
service. 
Moreover, because of lack of consensus among standard-setting institutions, and without strong 
government or cross-border institutional regulations, it is usual to suffer data loss and duplication of 
diagnostic tests among different organizations. Which is, in fact, unacceptable to achieve high-
performance healthcare models, since this increases the cost, whilst it does not revert to any 
improvement for the service [14]. 
Presently, on the service of ophthalmology of the SNS-O, there is an opportunity to leverage ICTs to 
redistribute more efficiently the workload derived from the chronic diseases consuming most time from 
specialists. Within this health service, very interesting proposals have been made during the last years, 
with regard to management of the chronic diseases corresponding to the most frequent causes of 
avoidable blindness in Europe, namely, Diabetic Retinopathy (DR) [30, 31], Age-related Macular 
Degeneration (AMD) [32], and Chronic Glaucoma (CG) [33]. Thus, by formalizing these healthcare 
scenarios in compliance with multi-level modelling standards, and the ensuing management using 
semantically enabled model-driven health computing platforms, should therefore serve to better adjust 
the responsibilities and assign the workload according to specific training and capabilities of the care 
providers available in the health service. Hence, given the scarcity of specialists in ophthalmology, this 
initiative should alleviate the overall waiting lists in the service. 
Further, if the resulting electronic models are provided in open-access repositories, any health service 
interested in adopting the same clinical processes could easily reproduce or adapt this strategy to its 
needs. 
1.4 BACKGROUND OF THE RESEARCH 
This section contains a brief description of the research projects of our research group, as the work 
developed at those projects is the kernel of this Thesis. Each project presented different objectives, all 
of them aimed at improving specific aspects of the health service. As the projects were implemented in 
real healthcare scenarios, new possibilities were identified in terms of the use of ICTs. Thus, the 
experience we acquired in each project was progressively incorporated to new proposals, constituting 
the starting point for the present proposal of this PhD dissertation.  
Our first research project proposed the implementation of a screening service of DR using non-
mydriatic funduscopy in a primary care setting:  
2008-2009: “REDIAP Project: Diabetic Retinopathy in a Primary Care Setting”. Collaborative project among 
the ophthalmology department of the Hospital of Navarre (HN), the Public University of Navarre (UPNA) and 
the Primary Health Care department of the Health Service of Navarre (SNS-O), and funded by the health 
department of the Government of Navarre. 
To that end, a software tool was designed using funduscopic images labelled beforehand by 
ophthalmologists, firstly to support the training of General Practitioners (GPs) on the analysis of non-
mydriatic retinographies, and secondly to evaluate the agreement between GPs and ophthalmologists 
in DR screening [34]. Thus, it was proved that specifically trained GPs can reliably identify signs of DR 
by reviewing non-mydriatic retinal photographs. Therefore, ever since practitioners joined the DR 
screening, only patients presenting symptoms of DR were referred to ophthalmologists, thus alleviating 
the waiting lists of specialists in retina [30, 35].  
The new DR screening service was successfully implemented in the SNS-O. Indeed, that year it was 
considered the best research project in Navarre in the area of health system management and it was 
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awarded with the “Mikel Larumbe Zazu” grant by the health department of the Government of 
Navarre. However, all diagnostic test acquisitions and clinical data had to be exploited manually, 
hence monitoring the outcomes from the screening service was slow and laborious. This stems from 
the fact that the diagnostic devices available used proprietary implementations to model clinical 
information. In consequence, it was not possible to interconnect devices from different manufacturers. 
Moreover, the worklist was managed using referral notes in paper, so the flexibility of the DR 
screening service was conditioned by outdated administrative procedures. 
Our next research project proposed a normalized management for exchange of diagnostic images in 
ophthalmology regardless of device manufacturers: 
2009-2010: “OPHTIMA: Ophthalmologic Image Management”. Funded by the innovation, business and 
employment department of the Government of Navarre.  
The ophthalmic devices had to be adapted so as to provide clinicians a comprehensive access to 
imaging studies. Therefore, ubiquitous access to diverse diagnostic tests would improve accurateness 
of diagnoses, and agility in clinical practice [31, 36]. 
Digital Imaging and Communications in Medicine (DICOM) standard was established to achieve 
interoperability among the heterogeneous diagnostic imaging devices involved in ophthalmology. In 
this sense, installation of a Picture Archiving and Communication System (PACS) was proposed to 
handle all medical imaging studies acquired by ophthalmic devices. Nonetheless, clinical information 
relating to diagnostic tests not based on medical imaging and medical reports from clinicians were 
beyond the scope of the DICOM standard.  
Our third research project leveraged the work on standardisation for DR, and extended the use of 
ICTs to other healthcare scenarios within ophthalmology: 
2010-2011: "Evaluation of an e-ophthalmology system for monitoring wet AMD". A two year-long project 
that involved HN and UPNA, was coordinated by the Miguel Servet foundation, and funded by the health 
department of the GN.  
The use of e-health strategies was studied to manage the monitoring of patients with wet AMD. This 
proposal would allow clinicians to adapt the treatment of wet AMD according to the progression of 
symptoms identified on images assessed remotely to diagnostic devices [37].  
However, before implementation of the e-health approach, the remote assessment proposed must be 
validated with respect to traditional face-to-face consultations. To that end, both procedures 
functioned in parallel during an evaluation period, and meanwhile, diagnostic decisions resulting 
from both approaches were registered in a web platform specifically set up for the project. After using 
the platform to analyse the results, we determined that e-health proposal might be a useful alternative 
for the follow-up of wet AMD [38].  
However, creating a framework from scratch to handle the results of this specific project of research 
involved a huge effort on coding. Moreover, the clinical process should be adapted as clinical 
knowledge evolves, but applying modifications into this platform was too slow due to the lack of 
standardization of the information registered. Therefore, it was not worth adapting this platform to 
include new requisites or to be reused in future studies. 
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Our last project proposed modelling the clinical process designed to monitor wet AMD in compliance 
with openEHR norm: 
2012-2014: “Evaluation of an e-ophthalmology model for monitoring exudative AMD” code PI11/02797. 
Funded within the “Fondo de Investigación Sanitaria” (FIS) by the Spanish Ministry of Economy and 
Competitiveness, this project involved the Hospitalary Complex of Navarre (CHN), the Bellvitge University 
Hospital (HUB) and the UPNA. 
The model-driven standardized information system used would be more adaptive than the non-
standardized proprietary systems used in previous projects. Besides, the results of the clinical process 
could be managed by any EHR system compliant to that modelling standard. Thus, using this strategy, 
the clinical knowledge modelled would be reusable for different healthcare scenarios. 
One could say that this PhD dissertation stems from this last project, although the scope of this thesis 
work goes beyond that. As we will see later, modelling will be extended to include three clinical 
processes we considered strategic based on the experience acquired in the domain of ophthalmology. 
To that end, the ICT infrastructure deployed for the aforementioned projects must be adapted to the 
new scenario. Finally, based on the two-level modelling seen so far, a semantically enabled model-
driven health computing platform will be proposed to manage patient-centred clinical processes. 
1.5 HYPOTHESIS AND OBJECTIVES 
The first major aim of this Thesis, is to research into, and make contributions toward interoperability 
among information systems applied to e-health. And, secondly, this work seeks to gather the 
experience that our research group acquired during the last decade in the clinical domain of 
ophthalmology, and transcribe it into computerized models. In this way, other researchers would be 
able to progress from that point onward. 
Thus, bearing in mind the two pillars of this Thesis, the focal aim is on the one hand to investigate 
major e-health standards so as to find solutions toward interoperability among information systems 
used in ophthalmic environments; and, on the other hand, to make contributions on development and 
normalization of efficient e-health services in ophthalmology. This approach suggests the following 
foremost underlying hypotheses:  
− A clearly defined methodology to build semantically computable electronic models would
prompt domain experts to contribute to formalize the management of specific clinical
processes.
− The definition of an open health computing platform in ophthalmology would, on the one
hand, empower healthcare facilities on a flexible choice of Application Programming
Interfaces (APIs) and services, incorporated incrementally according to the needs of the health
service at any given time, and on the other hand sustain the usefulness of the electronic
medical records over the long-term, by guaranteeing backward compatibility with legacy
systems.
− Building electronic models (including archetypes, templates, terminology subsets, guideline
rules, and User Interface (UI) forms) for the main chronic diseases threatening to overload the
waiting lists of ophthalmology services would enhance the management of patients through
complex healthcare procedures, and by extension, would save time and costs for all parties
involved: patients, clinicians, and health services.
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Thus, the major aim of the Thesis, together with the abovementioned hypotheses, leads us to the 
overall objectives: 
1. To deeply study the ecosystem of standards and specifications pervasive in e-health, 
remarking initiatives focused on interoperability among EHR systems, e.g. openEHR, EN/ISO 
13606, DICOM, HL7 (HL7v2, HL7v3, HL7 Clinical Document Architecture or CDA, and 
more recently HL7 FHIR), and standard medical terminologies (Logical Observation Identifiers 
Names and Codes – LOINC, Systematic Nomenclature of Medicine - Clinical Terms – 
SNOMED-CT, International Statistical Classification of Diseases and Related Health Problems 
– ICD-x or International Classification of Primary Care – ICPC). 
2. To design a methodology that would guide domain experts to actively engage in modelling 
their own electronic models compliant to model-driven e-health standards. 
3. To propose an open architecture for building health computing platforms based on the e-
health standards mentioned above, so as to coordinate heterogeneous information systems 
toward a comprehensive management of patient-centred clinical processes and guaranteeing 
the continuity of care of patients. 
4. To contribute to the design of new e-health services in the SNS-O that would optimize clinical 
practice in chronic diseases threatening to overload the waiting lists of the ophthalmology 
department (DR, wet AMD, and CG). 
5. To formalize into electronic models the clinical processes devised in the previous point, i.e. a 
DR screening service, a service monitoring the intravitreal antivascular endothelial growth 
factor (anti-VEGF) therapy used to treat wet AMD, and a follow-up service for CG. 
6. To collaborate closely with standard-setting institutions and to use open platforms to share 
the experience gained during this Thesis. 
7. To prepare the ophthalmology department to implement e-health proposals: standardization 
of the diagnostic tests and information systems involved in the clinical processes proposed 
above. 
At a deeper level, the following objectives regarding contributions to the DR screening service 
deserved mention: 
− To consolidate a standardized, future-proof solution to manage the clinical information 
handled in the DR screening service, given the continuous evolution of the clinical 
knowledge. 
− To build an electronic model for the DR screening service which proved to be a success in the 
SNS-O, so as to facilitate implementation for this clinical process in other healthcare facilities 
and organizations. 
Regarding the service monitoring the intravitreal anti-VEGF therapy used to treat wet AMD: 
− To provide a solution to adjust the therapeutic strategy, as well as the health resources 
allocated to each patient depending on the state of the disease presented at any time.  
− To design a high resolution consultation model that would address the revision and treatment 
of patients diagnosed with wet AMD throughout a single outpatient visit in order to alleviate 
the waiting lists of the service. 
Finally, regarding the follow-up service for CG: 
− To design a health computing system to analyse all diagnostic studies transversal to the 
disease of each patient, thus facilitating the implementation of software tools able to identify 
any sign of evolution in CG. 
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1.6 THESIS OUTLINE 
The rest of this Thesis has been organized as follows: background on the main topics addressed 
further on along this Thesis is presented in Chapter 2. To this end, first, the clinical domain is 
addressed, with a special focus on management of chronic diseases in ophthalmology; second, 
background upon e-health standards and EHR architectures is provided; third, the strategies found in 
literature which address the design and implementation of electronic models are discussed; fourth, the 
state of the art of open health computing platform architectures is described; fifth, the management of 
clinical information within the SNS-O is depicted, emphasizing the needs identified for such 
healthcare service; and finally, an overall analysis of the knowledge artefacts modelled so far in the 
clinical domain of ophthalmology is provided as a starting point for the electronic models proposed 
along this Thesis. 
Next, the guidelines toward integration of e-health systems into pervasive clinical practices are 
outlined in Chapter 3. To start with, a methodology is proposed to guide domain experts to 
participate actively in building their own electronic models compliant to model-driven e-health 
standards. Then, an architecture is provided to build an open health computing platform that would 
integrate the installed base of heterogeneous information systems of an entire health service, in order 
to implement the electronic models resulting from that methodology applied to a seamless 
management of patient-centred clinical processes.   
Then, given the open health computing platform and the modelling guidelines mentioned above, 
specific electronic models are presented along Chapter 4 as proof of concept. These models 
correspond to specific healthcare scenarios identified in the SNS-O, with regard to the management 
of chronic ophthalmologic diseases responsible for the most frequent causes of avoidable blindness in 
Europe. Accordingly, electronic models for a remote screening for DR, a high resolution consultation 
to monitor the treatment in AMD, and a follow-up service for patients diagnosed with CG who are 
medically stable are provided in this chapter. 
Along Chapter 5, the topics covered along the Thesis are discussed: on the one hand, the 
implications of applying the methodology, and the architecture proposed in Chapter 3 are outlined. 
On the other hand, the conclusions reached from modelling the three clinical processes proposed in 
Chapter 4 are discussed. 
Subsequently, in Chapter 6 the objectives achieved along this PhD dissertation are summarised and, 
suggestions for future research lines are described briefly.  
To conclude, two additional appendixes have been added at the end of the present Thesis: one for 
listing all elements involved in the electronic models defined along this Thesis, and other for setting 
out the outcomes of a use case for one of the electronic models provided. 
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Chapter 2: 
Background 
This chapter introduces the main topics addressed along this PhD dissertation, i.e. 
ophthalmology and interoperability on e-health. To start with, the three major 
ophthalmologic diseases are studied as concerns the most frequent causes of avoidable 
blindness and visual impairment in Europe. Second, this chapter provides an in-depth 
analysis of the current management strategies for electronic information in healthcare. In this 
regard, different levels of interoperability have been identified to guarantee a faithful 
communication among heterogeneous information systems. Thus, given the aforementioned 
interoperability levels, primary standards bodies doing specific work in e-health standards 
and specifications applicable to EHR systems are presented. Third, the state of the art related 
to the design and implementation of electronic models that could cover the aforementioned 
interoperability levels is reviewed. Fourth, the open health computing architectures are 
presented as a solution to face the main challenges nowadays with regard to management 
of clinical information and interoperability in e-health. Fifth, in contrast to that architecture, 
the chapter focuses on the specific scenario found in the SNS-O, in terms of the base of 
information systems installed for the management of clinical information. To conclude the 
present chapter, the knowledge artefacts compliant to dual-model layered architecture, and 
specifically modelled for the clinical domain of ophthalmology are identified. This would 
establish a starting point for the subsequent electronic models. 
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2.1 THREE MAJOR CHRONIC DISEASES IN OPHTHALMOLOGY  
AMD (26%), glaucoma (20.5%) and DR (8.9%) are the most frequent causes of avoidable blindness in 
Europe. Although there are even more frequent ophthalmic conditions, such as cataract, because of 
the chronicity of the aforementioned diseases, they cause severe and irreversible loss of vision when 
patients are not early treated [39, 40]. The visual loss resulting from these affections will accompany 
patients throughout their lives, whereby the prevalence of visual impairment increases with patients' 
ageing.  
To avoid that scenario, the management of such chronic conditions should entail the continued care 
of patients. However, given the traditional clinical procedures, there are not enough specialists in 
health services to handle the increasing workload arising from periodic revisions necessary to 
guarantee a suitable management of chronicity in ophthalmology. What‟s more, due to the increasing 
life expectancy in developed countries, the occurrence of blindness or visual impairment will become 
even more common the coming years [41].  
For this reason, research into efficient management for DR, AMD, and CG is becoming critical in the 
area of ophthalmology. Thus, in line with that research, this section introduces briefly the aetiology as 
well as generalized strategies used worldwide to manage each of these chronic affections. 
2.1.1 DIABETIC RETINOPATHY (DR) 
Diabetic retinopathy is one of the most feared complications of diabetes mellitus, and an important 
cause of visual loss worldwide among middle-aged and therefore economically active people [42]. 
The International Diabetes Federation estimated the worldwide prevalence of diabetes in 8.8% (415 
million) of adults aged 20-79 in 2015. And according to the projections for 2040, this figure is 
expected to increase to 10.4% (642 million) of adults worldwide [43]. From these figures, 
approximately one-third of people with diabetes develop nowadays some degree of diabetes-related 
eye damage. Thus, as the global prevalence of diabetes increases, so will the population affected with 
vision-threatening DR, namely, severe Non-Proliferative DR (NPDR), Proliferative DR (PDR) and 
Diabetic Macular Edema (DME) [44].  
Classification system 
When it comes to establish normalized diagnoses and consequent therapeutic procedures concerning 
DR and DME, the Early Treatment Diabetic Retinopathy Study (ETDRS) severity scale became the gold 
standard for many years. However, the precise description of symptoms, and the definition of more 
severity levels than necessary made this scale too complex to be used in daily clinical practice. 
Consequently, the American Academy of Ophthalmology (AAO) proposed the “international clinical 
Diabetic Retinopathy and Diabetic Macular Edema disease severity scales”, which simplified the 
ETDRS severity scale toward a more generalized clinical applicability [45, 46]. 
Based on scientific evidence, this new classification distinguished different levels depending on clinical 
findings easily recognized upon eye fundus. As a result, five severity stages were identified for DR as 
described by Wilkinson CP, Ferris FL III, et al [45]:   
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− No apparent DR (ETDRS levels 10, 14, 15): No abnormalities. 
− Mild NPDR (ETDRS level 20): Microaneurysms only. 
− Moderate NPDR (ETDRS levels 35, 43, 47): More than just microaneurysms but less than 
severe NPDR (less than 4:2:1 rule described below). 
− Severe NPDR (ETDRS levels 53A-E): Any of the following (4:2:1 rule) and no signs of 
proliferative retinopathy:  
 Extensive (>20) intraretinal haemorrhages in each of 4 quadrants. 
 Definite venous beading in 2 or more quadrants. 
 Prominent Intra-Retinal Microvascular Abnormalities (IRMA) in 1 or more quadrants. 
− PDR (Preliminary PDR: ETDRS levels 61 & 65, High-risk PDR: ETDRS levels 71 & 75, Very 
severe or advanced PDR: ETDRS levels 81 & 85): One or more of the following:  
 Neovascularization. 
 Vitreous/preretinal haemorrhage. 
Any stage of NPDR can lead to DME, which can cause rapid vision loss to patients. For this reason, it 
is important for ophthalmologists to classify the severity of DME along with the diagnosis of DR. To 
that end, first, it is checked whether Macular Edema (ME) is present or not and, if so, the severity is 
classified as mild, moderate, or severe, according to its location relative to the macula. Indeed, DME 
involving the centre of the macula implies major consequences concerning visual loss compared to 
the same findings but distant from the macula.  
Accordingly, Wilkinson CP et al. identified four severity stages to classify DME [45]: 
− DME apparently absent: No apparent retinal thickening or hard exudates in posterior pole. 
− Mild DME: Some retinal thickening or hard exudates in posterior pole but distant from the 
centre of the macula. Not clinically significant ME. 
− Moderate DME: Retinal thickening or hard exudates approaching but not involving the centre 
of the macula. Clinically significant ME. 
− Severe DME: Retinal thickening or hard exudates involving the centre of the macula. 
Clinically significant ME. 
Given the severity scales above, it should be noted that patients can still be assessed using different 
levels of precision, depending on the purpose of the study. For example, whereas differentiating 
patients presenting signs of DR from those with no evidence of DR (ETDRS value ≤20) is sufficient for 
screening purposes, the assessment of ophthalmologists for patients with confirmed DR must be more 
fine-grained, including levels of severity either for DR and DME. In this sense, the American 
Telemedicine Association recognizes four categories of validation for DR e-health programs, all of 
them based on the severity scales seen above [47]. 
Strategy for diagnosis and follow-up 
DR progresses over a long period before it becomes symptomatic, so early detection and prompt 
treatment enables preventing up to 98% of diabetes-related visual impairment [48]. According to this, 
most authorities recommend that retinal examinations for patients with type 1 or type 2 diabetes 
should be repeated at least annually to avoid irreversible damage at eye fundus: patients with type 1 
diabetes should undergo fundus examination 5 years after their diagnosis and then annually, whereas 
patients with type 2 diabetes should be examined as soon as diabetes is diagnosed and then annually. 
Only if no sign or evidence of retinopathy is found for one or more annual eye exams, exams every 2 
years may be considered [49].  
Consequently, due to the high prevalence of the disease and the scarcity of ophthalmologists, many 
patients do not benefit from an eye examination within the recommended periods. In that respect, 
today, there is an ongoing debate regarding the choice of the best protocol to conduct a screening to 
detect DR. First of all, which care professionals should be involved in the DR screening is a subject of 
- 14 - 
 
discussion: ophthalmologists, optometrists, GPs, screening technicians, or clinical photographers [42]. 
Second, in case of DR classifications not made by ophthalmologists, there are variations concerning 
the training method chosen for the personnel, or how the resulting clinical decisions are validated 
(whether or not evaluated by peer-review) [50].  
Third, a screening method must be chosen: direct ophthalmoscopy, dilated slit lamp bio-microscopy 
with a hand-held lens, mydriatic or non-mydriatic retinal photography, or retinal video recording [42]. 
Beyond these methods, the International Council of Ophthalmology also considers including the 
Visual Acuity (VA) exam and a thorough diabetes history to assure appropriate referral [51]. 
Given the foregoing methods, Non-Mydriatic Retinography (NMR) has become a widely accepted 
alternative to identify signs of DR, since it has similar reliability to the classical methods of ocular 
examination [52-54], but at a greater cost-effectiveness [55]. Moreover, it requires less time for each 
patient, it can be applied to populations at a distance from the specialist, and it does not require 
pupillary dilation. In other words, this diagnostic method complies with all requirements for 
development of e-health programs that would alleviate the burden of DR screening. 
With regard to NMR, different authors propose variations in number and size (angle of view) of the 
ETDRS fields acquired for each eye [56]. Moreover, although pupillary dilation is rarely necessary, this 
possibility may be considered for specific cases [50]. 
Therapeutic recommendation 
Management of patients varies depending on the severity of the DR, hence the importance of 
preventive screening to avoid irreversible damage on eye fundus. In that respect, intraocular steroids 
and anti-VEGF agents have the greatest potential in treatment of DME and proliferative disease. 
Likewise, grid laser photocoagulation is recommended in the setting of clinically significant ME when 
macular ischemia is absent. Conversely, Pan-Retinal Photocoagulation (PRP) and vitrectomy are 
indicated to treat patients presenting advanced stages of DR [57]. 
Thus, considering scatter PRP laser, focal and/or grid laser photocoagulation, intravitreal anti-VEGF 
therapy, intravitreal corticosteroids, and vitrectomy surgery as main procedures to treat DR, the AAO 
defined a set of therapeutic recommendations depending on the diagnoses established. Therefore, the 
aforementioned recommendations made by the AAO are summarized in Table 1, in connection with 
the stages used to classify severity of DR and DME [58]. 
2.1.2 AGE-RELATED MACULAR DEGENERATION (AMD) 
Age-related macular degeneration is a degenerative process of the central retina that develops in 
elderly people. The macula covers the central area of the retina which actually is responsible for 
detecting high-acuity details of central vision. Therefore, when it gets damaged, the VA decreases 
drastically, especially in central areas of the Visual Field (VF). 
The visual impairment due to AMD has devastating effects on the quality of life of patients. 
Consequently, daily activities such as reading, driving, watching television, recognizing faces or doing 
housework become great challenges for them [59, 60]. The severity of those consequences sets the 
AMD as the leading cause of blindness in people over 65 years. Indeed, its prevalence in people over 
40 years in the United States is 6.5%, and more than one out of every 10 Americans over 80 has 
advanced symptoms of AMD at least in one eye [61]. Studies in other developed countries concluded 
that the increase of AMD depends on the age of patients [62]. Consequently, as AMD is a process 
strongly associated with age, the prevalence of AMD would increase in the coming years 
proportionally with the ageing population. 
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Table 1: Management recommendations defined by the AAO for patients with diabetes. 
Severity of 
Retinopathy 
Presence of ME Scatter PRP laser 
Focal and/or grid laser 
photocoagulation 
Intravitreal anti-
VEGF therapy 
No apparent DR No No No No 
Mild NPDR 
No  No No No 
Non-clinically significant ME No No No 
Clinically significant ME No Sometimes Sometimes 
Moderate NPDR 
No  No No No 
Non-clinically significant ME No No No 
Clinically significant ME No Sometimes Sometimes 
Severe NPDR 
No  Sometimes No No 
Non-clinically significant ME Sometimes No No 
Clinically significant ME Sometimes Sometimes Sometimes 
PDR 
No  Recommended No Considered 
Non-clinically significant ME Recommended Sometimes Usually 
Clinically significant ME Recommended Sometimes Usually 
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Classification system  
AMD is divided into two subtypes: atrophic (dry) and exudative (wet) [63]. The former is more frequent 
and it has not treatment yet, but its consequences are less visually debilitating for patients, whereas the 
latter occurs less frequently and is treatable, but its consequences are more severe for the vision. It is 
worth mentioning that the prevalence of wet AMD represents 10-15% of all cases of AMD, but 
accounts 90% of severe visual loss due to AMD [64].  
One of the main classification systems for AMD was proposed by the Age-Related Eye Disease Study 
Group (AREDS) to define different categories according to progression of the disease [65, 66]. These 
categories established for AMD are further described in Table 2: 
Table 2: Classification of the severity of AMD according to the AREDS scale. 
AREDS Category Severity of AMD Description 
Category 1 No AMD No or a few small (<63 micrometres in diameter) drusen. 
Category 2 Early AMD 
Many small drusen, a few intermediate-sized drusen (63-
124 micrometres in diameter), or pigmentary changes on 
the macula. 
Category 3 Intermediate AMD 
Many intermediate drusen or at least one large drusen 
(≥125 micrometres), or geographic atrophy not involving 
the centre of fovea. 
Category 4 
Advanced or late 
AMD 
Dry: Drusen and geographic atrophy involving the foveal 
centre. 
Wet: Choroidal neovascularisation or evidence for 
neovascular maculopathy. 
Strategy for diagnosis and follow-up 
The visual loss due to wet AMD progresses rapidly compared to dry AMD. As per wet AMD, a study of 
the natural progression showed that during 28 days elapsed between initial diagnosis and treatment, 
44% of patients investigated had some degree of visual loss, and 16% lost more than 3 lines of 
distance VA [64]. Meanwhile, the appearance of geographic atrophy ranges from 2.5 to 5.9 years 
depending on the type of lesion [67]. Thus, to minimize the risk of visual loss, wet AMD has to be 
continuously monitored in short periods of time. Furthermore, the treatment is significantly more 
effective when applied at first stages of the disease, since the VA deterioration caused by delaying the 
therapy can become irreversible [68]. Nevertheless, the symptoms are imperceptible in the initial 
stages of AMD, so the population at risk, which usually consists on elderly patients, should be 
included into follow-up circuits guaranteeing the detection of the disease. Concerning those follow-up 
processes, the study of different viewpoints of the macula is required. Consequently, the tests of NMR, 
combined with either the diagnostic tests of fluorescein angiography or Optical Coherence 
Tomography (OCT) are involved in monitoring the progression of wet AMD [69]. 
Therapeutic recommendation 
Once the diagnosis of wet AMD has been confirmed, the progression of subretinal neovascularization 
which characterizes this condition can be retarded by repeated injections of anti-VEGF agents into the 
vitreous cavity [70]. Originally, all patients were treated equally by applying them monthly intravitreal 
injections. Actually, great results were achieved in terms of VA, but at the expense of a huge number 
of monitoring visits and invasive therapeutic procedures [71-73]. Therefore, considering that not all 
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patients respond similarly to the same treatment, as we shall see later, more personalized treatment 
approaches are suggested in literature.  
In that respect, in order to reduce the number of unnecessary treatments and clinical encounters, 
some authors recommend, after the three first monthly injections, including an evaluation for further 
treatment as part of the therapy. Consequently, the treatment could be adapted for patients not 
responding to the injections, and so the anti-VEGF agents are used only when they are effective [69, 
74, 75]. In the same way, by reducing unnecessary interventions, the adverse complications resulting 
from intravitreal injections are minimized too.  
Infectious endophthalmitis is regarded to be the most adverse postoperative complication of anti-
VEGF intraocular injections, due to its vision-threatening potential [76]. Thus, when the intervention is 
considered necessary, it must undergo in compliance with procedure guidelines specially designed to 
guarantee the safety of patients. In this sense, the choices made according to the location where the 
procedure takes place, the strategy for ventilation, the sterilization of surgical equipment and barriers 
used to prevent the infection, the method employed to apply anesthesia, the preparation of 
antiseptics, the use of post-injection antibiotics, and the anti-VEGF agents used are critical to reduce 
the risk of infection to the greatest extent possible [77, 78].  
Taking into consideration the pharmaceutical agents used for intravitreal injection, ranibizumab 
(Lucentis®, Genentech/Roche, Inc., South San Francisco, CA) is the most cost-effective among 
treatments for neovascular AMD approved by the United States Food and Drug Administration agency 
[79]. However, bevacizumab (Avastin®, Genentech/Roche, Inc., South San Francisco, CA) has to be 
considered as an alternative to ranibizumab, since both are anti-VEGF compounds whose 
effectiveness has been proved for AMD before ranibizumab was licensed [80]. Indeed, the use of 
bevacizumab was approved in the USA in 2005 and in Europe in 2006 as a systemic anticancer 
therapy, but it is still being debated whether it is safe enough for intravitreal injections. In that respect, 
compared to bevacizumab, ranibizumab presents decreased risks of ocular inflammation and venous 
thrombotic events [81]. Even so, latest publications and guidelines support the safety of using 
bevacizumab within AMD, since the effectiveness is similar to ranibizumab but at lower cost [70, 81, 
82]. Aflibercept (Eylea®, Regeneron Pharmaceuticals Inc., Tarrytown, NY) is proposed as salvage 
therapy when the patient does not respond to ranibizumab and bevacizumab [83, 84]. Other 
medications such as pegaptanib sodium (Macugen®, Eyetech, Inc., Cedar Knolls, NJ), or alternative 
treatments such as antioxidant and vitamin supplement intake, Photodynamic Therapy (PDT), and 
thermal laser photocoagulation surgery are used when patients do not respond to those primary 
therapies [84, 85]. 
2.1.3 CHRONIC GLAUCOMA (CG) 
Chronic glaucoma is an optic neuropathy associated with a progressive loss of the VF that often but 
not necessarily is associated with high intraocular pressure (IOP). As a consequence of the 
progression of glaucoma, patients may present acquired atrophy of the optic nerve and loss of retinal 
ganglion cells and their axons [86]. Consequently, the progressive damage on Retinal Nerve Fiber 
Layer (RNFL) may become clinically manifest in nerve fiber layer thinning (Figure 1), increased 
cupping of the Optic Nerve Head (ONH) (Figure 2), and glaucomatous VF loss (Figure 3), or any 
combination of these: 
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Figure 1: OCT measurement of the RNFL thickness measured around the ONH. 
First of all, the black line in Figure 1 indicates the RNFL thickness measured for a specific patient, 
while the dark green line draws the average value obtained statistically from healthy subjects 
consistent with that patient‟s age. Thus, the upper chart shows the measurement in a patient with no 
signs of thickness reduction. On the contrary, the second measurement presents a marked reduction 
of the RNFL thickness. In this case, the line corresponding to the patient measurement goes into red 
zone, which means that the thickness is clearly under the average value. 
 
Figure 2: Different degrees of optic disc cupping. 
Second, three eye fundus photographs centred on the ONH appear in Figure 2 to show different 
degrees of optic disc cupping. The fundus image on the left presents an optic disc with no cupping. 
The one in the middle, is affected by an intermediate cupping, whereas the one on the right 
corresponds to an optic disc with complete cupping. 
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Figure 3: Comparison of a VFs of a patient with no signs of glaucomatous damage (image on 
the left), and a patient presenting advanced glaucomatous damage (image on the right). 
Finally, the dark spots visible on the VF at the right of Figure 3 represent areas of irreversible VF loss 
characteristic of glaucomatous damage. 
These manifestations of progressive damage make chronic glaucoma an important cause of 
irreversible visual loss which generates an important demand for ophthalmologic consultations. 
Indeed, the prevalence of adults (aged between 40-80 years) worldwide diagnosed with glaucoma in 
2013 was estimated in 3.54% (64.26 million people), from which open-angle glaucoma accounts for 
86.16% of all glaucoma cases. In this regard, even though most cases present open-angle glaucoma, 
angle-closure glaucoma is more aggressive, hence it is responsible for a disproportionate number of 
patients with severe vision loss [87]. Besides, it is expected that the number of people with glaucoma 
worldwide will increase by 74% from 2013 (64.26 million) to 2040 (111.8 million) [88]. This trend is 
mainly due to the increase of life expectancy, so in developing regions such as Asia and Africa, the 
epidemiology of glaucoma will move up more dramatically in the years ahead, compared to the 
leading nations in terms of the ageing of the population (Europe and North America) [88]. 
In view of these figures, and given that affected individuals require lifelong ophthalmic care, CG 
represents an important problem for health authorities due to the increased number of consultations 
required to manage this disease.  
Classification system 
Glaucoma can be classified into two broad categories: open-angle and (acute) angle-closure 
glaucoma, each of which can be categorized as primary and secondary.  
Open-angle glaucoma is usually but not always in the presence of elevated IOP, perhaps in part 
related to increased aqueous production and decreased outflow. The main feature distinguishing 
Primary Angle-Closure Glaucoma (PACG) from Primary Open-Angle Glaucoma (POAG) is that the 
angle, the site of aqueous outflow in the eye, is obstructed by apposition of the iris, resulting in an 
anatomically closed angle (defined if at least 270° of the angle is occluded). 
Both open-angle and angle-closure glaucoma can be primary diseases, whereas secondary glaucoma 
results from trauma, certain medications such as corticosteroids, inflammation, tumour, or conditions 
such as pigment dispersion or pseudoexfoliation [87]. 
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As can be seen in Table 3, many types of glaucoma are distinguished, even if we only consider 
primary types. In fact, there is an ongoing debate on the best classification approach to determine the 
prognosis or optimal management. This stems from the fact that the biological basis of this condition 
is poorly understood and the factors contributing to its progression have not been fully characterized. 
Anyway, once CG has been confirmed and a treatment has been established, the follow-up process 
would be limited to identify whether glaucoma is stable or progressive so as to adapt the treatment 
accordingly [89]. 
Table 3: Classification of primary types of glaucoma for assessment and follow-up protocols. 
Category Description 
Ocular 
Hypertension 
(OHT) 
IOP > 21 mmHg without treatment, whereas the study of VF, optic disc and 
RNFL, family history, and gonioscopy is normal. It can be classified as low-risk 
or high-risk OHT, depending on the severity of risk factors (e.g. IOP, cup/disc 
ration, central corneal thickness). 
POAG Suspect 
Given the study of VF, optic disc and RNFL, at least one is suspicious. Besides, 
IOP can be normal or increased. Thus, risks and benefits of treatment need to 
be weighed against the risk of the development of glaucomatous disc damage. 
POAG (also 
known as chronic 
glaucoma)  
It is defined by elevated outflow resistance in the trabecular meshwork outflow 
pathways. As a result, the patient presents acquired characteristic glaucomatous 
damage on ONH, optic disc haemorrhages, and even RNFL changes. 
Accordingly, glaucomatous defects corresponding to the optic disc damage 
may be present on VF. To rule out any type of PACG, gonioscopy must show an 
open anterior chamber angle. In some cases, the central corneal thickness may 
be thinner than average. 
For diagnostic purposes, POAG can be subdivided into high-pressure (IOP > 
21 mmHg) and normal-pressure (IOP < 21 mmHg) types. Once the diagnosis 
has been confirmed, the follow-up focuses on identifying any sign of 
progression could lead to reconsider the therapeutic strategy. 
PACG Suspect 
Normal IOP, no VF defect, nor glaucomatous optic neuropathy, but two or 
more quadrants of iridotrabecular contact found on gonioscopy. 
PACG (also 
known as acute 
glaucoma) 
PACG is defined by the presence of iridotrabecular contact, hence it is generally 
classified by the type of contact it presents, to wit, acute angle-closure, 
intermittent angle-closure, chronic angle-closure and status post-acute angle-
closure attack. The follow-up service must rule out PACG. 
The follow-up service must rule out any type of PACG. 
Strategy for diagnosis and follow-up 
The detection and follow-up of patients with glaucoma are more complex processes compared to DR 
and AMD. Firstly, identifying symptoms of glaucoma is not obvious in its early stages, when treatment 
can be the most beneficial [40]. Secondly, once diagnosed, the clinical course of glaucoma is usually 
slow, and with the currently available treatments, symptoms of glaucoma progression are not easily 
identifiable.  
No single test has demonstrated an adequate balance of sensitivity, specificity, and positive predictive 
value in this regard, that is why diagnosis and follow-up of glaucoma must combine the assessment of 
various diagnostic techniques simultaneously [33]. Correspondingly, the diagnosis and follow-up of 
glaucoma entails measurement of IOP, inspection using gonioscopy of anterior chamber angle, 
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examination of the optic disc at fundus photographs, determination of the status of the VF through 
campimetry, and monitorization of the loss of RNFL by means of confocal scanning laser 
ophthalmoscopy, OCT, or scanning laser polarimetry [86]. 
Therapeutic recommendation  
Therapy in glaucoma management aims to lower IOP to slow the rate of visual field deterioration. In 
this regard, the upper limit of the IOP estimated to be compatible with a rate of progression 
sufficiently slow to maintain vision-related quality of life in the expected lifetime of a patient is 
established by the target IOP. Given that there is no single IOP level appropriate for every patient, this 
parameter should be re-evaluated regularly and, additionally, when progression of disease is 
identified or when ocular or systemic comorbidities develop. 
Once target IOP is determined, most forms of open-angle glaucoma and many types of chronic 
angle-closure glaucoma are initially treated with topical and occasionally orally administrated agents 
that act either on the reduction of aqueous humour production or enhancement of the aqueous 
outflow or on both. In this regard, there are drugs presenting higher IOP reduction rates than others, 
so the choice of specific medication would depend on the pre-treatment baseline IOP plus the 
patient's tolerance to each drug. If the initial therapy reduces IOP to the target and is well tolerated, 
therapy can be left unchanged, but the patient needs to be monitored with regular checking of 
endpoints. Otherwise, switching to another monotherapy or applying combination therapy (add a 
second drug) would be considered. Alternatively, laser trabeculoplasty would be indicated when IOP is 
not satisfactorily controlled with medications. Laser treatment may also be suitable for patients with 
known intolerance or allergy to topical agents or suspected poor compliance [89]. 
Finally, incisional glaucoma surgery, and cyclodestructive procedures should be considered to slow 
down the progression of the disease whenever medical or laser treatment appear unlikely to maintain 
sight in the glaucomatous eye. Especially for eyes with a very high level of IOP at presentation causing 
an immediate threat to sight [87]. 
2.2 MANAGEMENT OF CLINICAL INFORMATION AND INTEROPERABILITY OF INFORMATION SYSTEMS 
ON E-HEALTH 
As a result of the chronicity of the diseases described in the preceding section, patients affected need 
a continuous management of their condition. To that end, a significant part of patients‟ management 
includes the documentation of clinical information that could help in future medical decisions. Until 
quite recently, the use of medical records in paper limited the availability of patients‟ information 
within a geographic area, and consequently, the responsibility of managing almost the whole clinical 
procedure often would fall on a single clinician. With the advent of electronic management of medical 
records, clinicians gained ubiquitous and instant access to patients‟ clinical information, so many 
health providers were able to coordinate their work toward a specific care plan. 
Although this approach did work at a small scale, each healthcare provider – hospitals, administrative 
entities such as government agencies or insurance companies, pharmaceutical services, or primary 
care physicians or medical specialists – had its own installed base of proprietary systems, 
technologies, and information systems which lacked interoperability with the systems used by other 
providers.  
Therefore, the coordination of healthcare providers equipped with systems made by different 
manufacturers can be accomplished by means of e-health standards. Numerous standardization 
entities work to address this issue, but they are still far from reaching a common solution to achieve 
full interoperability among information systems in healthcare. Instead of that, each standard-setting 
institution provides its own solutions for interoperability, so there is a wide ecosystem of e-health 
standards available nowadays to electronically exchange clinical information among healthcare 
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service providers. In contrast, any of these standards provides comprehensive interoperability, indeed, 
in most cases they are not even interoperable with each other. This stems from the fact that e-health 
standardization must guarantee interoperability at different layers which currently are not covered by a 
unique standard. Thus, the success of interoperability on e-health will be determined by the 
understanding and an effective combination of pervasive standards. 
2.2.1 LAYERS OF INTEROPERABILITY 
As mentioned above, none of the information systems in use nowadays in healthcare implements full 
interoperability. Most of them are compliant on some level, but to achieve an understanding among 
heterogeneous systems, first, the concept itself has to be clarified. There are many views on how to 
define interoperability, for instance, Stroetmann defined interoperability in its most basic form [90]: 
“Interoperability refers to the ability to communicate and exchange data and information such that a common 
understanding of their meaning is possible.” 
We can even narrow down the definition considering interoperability applied into the field of ICTs. 
This concept is not new in computer science, in 1990 the IEEE defined interoperability in that context 
[91]: 
“The ability of telecommunications and digital systems - and the processes they support - to exchange data 
and to enable the sharing of information and knowledge.” 
Although the original idea was clear, during the last years the definitions for interoperability have 
continued to evolve along with development of ICTs and computing [90, 92]: 
“The ability of two or more systems or components to exchange information and to use the information that 
has been exchanged.” – Stroetmann 
“Interoperability’ means the ability of disparate and diverse organizations to interact towards mutually 
beneficial and agreed common goals, involving the sharing of information and knowledge between 
organizations, through the business process they support, by means of data between their respective ICT 
systems.” – European Parliament 
According to these definitions, this concept can be equally valid for information systems in healthcare. 
Many authors were more specific on that direction and described interoperability in healthcare as 
follows [21, 90, 93]: 
“E-Health area interoperability refers to facilitating and safeguarding the exchange, understanding and acting 
on patient and other health information and knowledge among linguistically and culturally disparate medical 
professionals, patients and other actors within and across health systems in a collaborative manner.”                 
– Stroetmann 
“An EHR system consolidates patients’ healthcare data generated from various healthcare systems. Hence, it 
should be capable of integrating data from all such systems. Moreover, it should enable interoperability 
among various healthcare applications and systems that are developed independently.” – Sinha et al. 
“In healthcare, interoperability is the ability of different information technology systems and software 
applications to communicate, exchange data, and use the information that has been exchanged.” – Healthcare 
Information and Management Systems Society 
In short, the level of interoperability implemented would be inversely proportional to the effort it takes 
to use and invoke services among different systems. Thus, to achieve an efficient understanding 
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among healthcare-related information systems, it is necessary to establish common specifications that 
would serve as conformance points to address the exchange of information.  
In this regard, the ETSI distinguishes four layers to structure interoperability for a faithful data 
exchange among information systems: technical interoperability (which supports the physical 
connection among systems), syntactic interoperability (which allows those systems to exchange 
information), semantic interoperability (which provides to those systems the ability to interpret the 
information received, and act accordingly), and process/organizational interoperability (which defines 
the necessary context for organizations to cooperate) [18].  
Besides the aforementioned layers, given the trend of e-health toward an ecosystem, in which 
information from clinical information systems would be accessed from increasingly variety of electronic 
terminals, some authors propose standardising the way the information is presented to end-users [29, 
94, 95]. Along this Thesis, this new layer of interoperability among systems has been named 
“presentation interoperability”.  
The aforementioned layers of interoperability have been briefly described in Table 4, which actually 
has been adapted from the layers of interoperability proposed by Kubicek et al. toward 
“Organizational interoperability in e-government” [92]: 
Table 4: Description of the five layers of interoperability. 
Layer of 
interoperability 
Aim Objects Solutions State of 
knowledge 
Technical 
interoperability 
Technically secure 
data transfer 
Signals 
Protocols of data 
transfer 
Fully developed 
Syntactic 
interoperability 
Processing 
received 
data 
Data 
Standardized data 
exchange formats 
Fully developed, 
still must evolve in 
healthcare 
domain 
Semantic 
interoperability 
Processing and 
interpretation 
of received data 
Information 
Terminologies, 
reference models, 
archetypes, 
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Technical or functional interoperability 
Technical interoperability defines the interfaces, either logical or physical toward harmonization of 
data exchange among systems. Therefore, the technical issues toward linking up information systems, 
the definition of open interfaces, data formats and protocols, including the physical devices necessary 
to guarantee the communication are formalized at this level. Basically, technical interoperability is 
responsible of a faithful delivery of bytes from one system to another. 
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The current state of development of technical interoperability is very advanced compared to the rest of 
the layers, given that this has been extensively implemented in systems other than healthcare. This 
enables establishing advanced pervasive standards which cover all possible scenarios concerning 
data exchange among systems, e.g. IEEE 802.3, IEEE 802.11, Transmission Control Protocol/Internet 
Protocol (TCP/IP), Hyper-Text Transfer Protocol (HTTP), Bluetooth, ZigBee, lower levels of ISO/IEEE 
11073, etc. [19].  
Syntactic interoperability 
Whereas technical interoperability must guarantee the exchange of bytes, the syntactic interoperability 
is responsible for the delivery of documents. It ensures that documents or messages exchanged are 
correctly structured at arrival, so the file formats used and the data types they contain are built in 
compliance with well-defined syntax and encoding specifications. For example, a system could be 
able to make transformations from one file or data format to another depending on the requirements 
of the receiving system, while the coherence and the information contained inside files is preserved 
unaltered. However, systems that uniquely implement this level of interoperability would provide 
messaging services but do not intervene in the content of the files exchanged, and therefore they are 
unable to react accordingly. There would be a need for an additional level of interoperability, to 
enable the interpretation of the information handled by computerized systems. 
This level of interoperability has been developed to a considerable degree too, but still must evolve as 
regards the area of healthcare. At this point, the most widely used specifications which provide for the 
syntactic interoperability in healthcare environments could include: XML, specifications for data types 
such as CEN TS 14796 or ISO 21090, DICOM message specifications, 2.x versions of HL7, 
ISO/IEEE 11073, or even GS1 (for automatic identification and data capture). Reference information 
models from HL7 v3, HL7 FHIR or EN/ISO 13606 standards could also be considered, but these 
would implement semantic interoperability as well [19]. 
Semantic interoperability 
Whereas syntactic interoperability specifies clearly defined classes of data for the information 
delivered, the semantic interoperability concerns the meaning of the information exchanged. Thus, 
systems semantically interoperable must ensure a univocal understanding of data in both sides of the 
communication. In fact, according to IEEE, semantic interoperability responds to the following 
description [91]: 
“Is the ability of two or more systems or elements to exchange information and to use the information that 
has been exchanged.” 
This means that, whenever there is data exchange, the receiving system must be able to interpret the 
information delivered in such a way that that system could react accordingly without external 
intervention of an operator. Thus, considering the current healthcare scenario where clinical processes 
should be centred on patients, and yet clinical information is scattered among heterogeneous 
information systems each covering specific clinical practices, semantic interoperability will contribute 
to organize the amalgam of data generated toward a comprehensive management of healthcare. 
Furthermore, semantic interoperability would facilitate building secondary services upon that 
information, such as ubiquitous access of healthcare providers to the whole of clinical data 
corresponding to specific patient-centred clinical procedures, or data mining services either for 
research or epidemiologic purposes. 
Terminologies, ontologies, and classification systems stand central to achieve semantic 
interoperability. However, these terms can lead to confusion, as different authors used these terms 
differently in scientific literature. For this reason, in this Thesis the glossary of terms proposed by 
SemanticHEALTH European project was taken as a basis so as to clarify this point [96]:  
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 Controlled Vocabulary: A list of specified items to be used for some purpose, usually in an 
information system to reduce ambiguity, misspellings, etc. 
 System of identifiers (“codes”): Controlled vocabularies, and many lexicons, ontologies, and 
thesauri, are usually accompanied by systems of identifiers for their units, e.g., identifiers act as the 
primary unambiguous means of referring to the entities in the system for computational purposes 
with the text form being used for communication with users. Examples are the “Concept Unique 
Identifiers from the Unified Medical Language System (UMLS), SNOMED-CT identifiers, etc. 
 Lexicon: A list of linguistic units that may be attached to a controlled vocabulary or ontology, in a 
specific language or sublanguage, often including linguistic information such as synonyms, preferred 
terms, parts of speech, inflections and other grammatical material. Example: terms and lexical 
material in UMLS identified by Lexical Unique Identifiers. 
 Ontology: A symbolic logical model of some part of the meanings of the notions used in a field, i.e. 
those things which are universally true or true by definition. The key relationship in an ontology is 
“subsumption” or “kind-of”. Every instance of a subkind must be an instance of the kind, without 
exception. Typically ontologies are implemented in logic languages such as Ontylog or OWL or frame 
systems such as Protégé-Frames. Examples: The GALEN Core Model, the stated form of SNOMED-CT. 
 Classification: An organisation of entities into classes for a specific purpose such as international 
reporting or remuneration. Examples ICD and Diagnosis Related Groups. 
 Thesaurus: A system of terms organised for navigation with the primary relationship being “broader 
than”/”narrower than”. Examples MeSH, WordNet.  
 Background knowledge base (or “Knowledge Representation System”): The common knowledge to 
be assumed by the system, including both the ontology – what is universally true – and 
generalisations about what is typically true. 
 Terminology: Any or all of the above in various combinations. Most heath terminologies consist, at a 
minimum, of a controlled vocabulary and a system of identifiers. They may include extended 
lexicons, ontologies, thesauri or background knowledge base. This definition is deliberately broader 
and less specific than that in most of the standard references and intended to approximate common 
usage. 
 Coding system: A terminology with attached identifiers or “codes”. 
Nonetheless, contrary to widespread belief in this regard, semantic interoperability cannot be 
achieved only through the use of normalized terminologies. In fact, terminologies do not contain 
definitions of domain content (e.g. “microbiology result”), but rather facts about the real world (e.g. 
kinds of microbes and the effects of infection in humans). Thus, to faithfully represent semantics of 
clinical domain, terminology services – such as SNOMED-CT [97], ICD-x [98], or LOINC [99] which 
codify the clinical information using normalized clinical terms – must be combined with additional 
information intended to contextualize these terms into specific healthcare scenarios. Normalized 
reference models can be used to that end (EN/ISO 13606:1, HL7 RIM or CDA, etc.), whereas 
mechanisms such as archetypes (EN/ISO 13606:2) or DCM would be used to formalize and to 
exchange the resultant clinical concepts [19].  
Process level or organizational interoperability  
Organizational interoperability refers to when two or more healthcare providers must coordinate their 
clinical procedures and work processes to achieve a seamless collaboration among institutions. To 
that end, the healthcare services and care policies provided by each party must be well-known by the 
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rest of organizations concerned. In this regard, business rules are usually the means of maintaining all 
systems up-to-date on the workflow they have in common [100]. 
Although there is still much work to be done in that respect, there are already some attempts to 
normalize this area: the EN/ISO 12967 HISA (Health informatics – Service architecture) and EN/ISO 
13940 (Health informatics – System of concepts to support continuity of care) standards, for instance 
[101, 102]. In this context, some key concepts have been listed below, as provided by the EN/ISO 
13940 standard. These, in fact, correspond to the conformance points on which different systems 
should reach an agreement for guaranteeing their interoperability at organizational level [101, 103]: 
 Care plan: Dynamic, personalized plan including identified needed healthcare activities, health 
objectives and healthcare goals, relating to one or more specified health issues in a healthcare 
process. 
 Health objective: Desired ultimate achievement of a healthcare process addressing health needs. 
 Healthcare goal: Desired achievement of one or more healthcare activities, considered as an 
intermediate operational step to reach a specific health objective. 
 Clinical guideline: Set of systematically developed statements to assist the decisions made by 
healthcare actors about healthcare activities to be performed with regard to specified health issues. 
 Protocol: Customized clinical guidelines in conformance with the health policies of an organization or 
person participating in healthcare. 
 Clinical pathway: Pathway for the healthcare activities informing the content of core care plans. 
 Workflow: Depiction of the actual sequence of the operations or actions taken in a process. 
 Healthcare process: Set of interrelated or interacting healthcare activities which transform inputs 
into outputs. 
These concepts were found to have many similarities; even they overlap to some degree. In this 
regard, Figure 4 illustrates the overall relationship between the concepts in order to clarify the scope 
of each of them [103]. 
Presentation level interoperability 
Traditionally, the UI is integrated in the source code of applications, so it has to be customized for 
each application according to the requirements of end-users. Thus, whenever the content of the 
application is modified, the UI specifications have to be re-engineered accordingly.  
There is an emerging trend toward connecting health information systems to countless electronic 
terminals, from which the clinical personnel must have access to the same clinical information. Thus, 
the need arises for presenting the information in a consistent manner irrespective of the different 
technologies and APIs implemented. In this regard, the latest proposals on standardization suggest to 
go one step further and normalize how the information is presented to end-users [95].  
On the basis of an information model strongly standardized in compliance with technical, syntactic, 
semantic and even process levels of interoperability, the normalization at presentation level is 
essentially about mapping the information elements into the UI definitions of the target technology. 
Taking this into account, it would be possible to model the UI specifications outside the source code 
of the software. Thus, each clinician could even customize the views depending on its working 
procedures, in a way that this change would take place accordingly to every electronic terminal 
accessible by that individual. 
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Figure 4: Relationship between the key concepts studied to guarantee the organizational 
interoperability conforming to the ISO 13940 standard. 
2.2.2 ELECTRONIC HEALTH RECORDS 
When implementing a standalone e-health system, the different levels of interoperability described 
along previous section must be considered for every component involved in the exchange of health 
information. But, with regard to patient-centred healthcare guaranteeing the continuity of care, e.g., 
for management of chronic conditions, EHR systems are definitely the cornerstone in the management 
of medical records of individuals. 
At present, the ISO/TR 20514:2005 standard defines an EHR as [104]:  
“A repository of information regarding the health of a subject of care in computer processable form, 
stored and transmitted securely, and accessible by multiple authorized users. It has a commonly agreed 
logical information model which is independent of EHR systems.” 
The ISO also states that an EHR should record the complete healthcare information longitudinal to 
patient's life-long medical history, irrespective of the organisations or different kinds of specialists 
involved. Thus, insofar healthcare is increasingly producing and consuming large amounts of 
information from heterogeneous origins, EHR systems must be able to include all these contributions 
to patient's history. Which is why most e-health standards converge into this point, and thus a 
comprehensive strategy is needed to interconnect all sources of clinical information with the EHR 
systems. 
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In this regard, given the architecture of any modern e-health system on which the EHR is the 
centrepiece, we must contemplate the implementation of the standards necessary to support the 
services needing a safe, secure, reliable exchange of information with the rest of system components 
concerned, such as [14]: 
− Demographic information system: Manages the Patient Master Index (PMI), and overall 
demographic data records of the hospital, both for patients and for clinical personnel. Data 
exchanged with the EHR: univocal identifier for patients in different clinical settings. 
− Hospital information system: Manages administrative data of hospitals, including patient‟s 
affiliation, agenda, human resources, and patient admission. Data exchanged with the EHR: 
administrative data such as patient registration and identification, clinic appointments, 
admissions, discharges and transfers (ADT). May also provide commissioning, billing and 
accountancy data. 
− Laboratory information management system: Manages the investigation requests for 
laboratory tests and generates the corresponding reports. Data exchanged with the EHR: 
requests for laboratory tests, and the resulting investigation reports. 
− Medical image management system: Schedules medical imaging tests, and refers the 
corresponding radiology reports back. Data exchanged with the EHR: requests for imaging 
investigations, and the resulting diagnostic reports. 
− Pharmacy administration system: Manages drug prescriptions, supervises the dispensation of 
medications, and monitors the stock in pharmacy at all times. Data exchanged with the EHR: 
prescriptions for medication. 
− Remote Patient Monitoring (RPM) system: Manages the information submitted by personal 
health devices located outside the healthcare facility, and analyses such data to generate 
medical reports from remote monitoring and trend analysis of patient's physiological 
parameters. Data exchanged with the EHR: monitoring reports, and clinically significant 
events. 
− Other EHR systems: Manages medical records associated to a clinical activity addressed in a 
different healthcare facility. Services associated with the EHR: Transfer and merging of EMRs 
between hospitals.  
To achieve a faithful communication with all these e-health components, currently there are several 
international organizations working on standards relating to EHRs:  
− The Technical Committee (TC) 215 of the International Standards Organization: It is the peak 
international standards body for EHR and other e-health standards. Although some standards 
such as ISO 18308 are produced “de novo”, it commonly works on integrate existing 
standards from other national and international standards development organizations so as 
to pool pervasive standards on e-health, e.g. IEEE, CEN, HL7, etc. For this reason, for 
research purposes the source standardization organizations confer greater agility to 
standards, whereas ISO provides greater stability necessary for implementations in healthcare 
industry [105]. 
− The TC 251 of the CEN: It corresponds to the health informatics committee of CEN, which is 
the peak European standards organization that transcends the national standards 
organizations of the 33 member countries it comprises. TC 251 developed the EN/ISO 
13606 standard (currently accepted by ISO) for the communication of the EHR, as well as 
EN/ISO 12967 HISA (Health informatics – Service architecture), that was subsequently 
adopted in 2009 by the International Standards Organization within the ISO 12967 norm 
[106]. 
− Health Level 7 (HL7): Although HL7 standardization focuses primarily on U.S., it nowadays 
comprises over 20 international affiliates. It defined standards for communicating data 
between different systems through messaging (HL7v2.x and HL7 v3 messages) and also a 
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model that defines the structure and semantics of medical documents (HL7 CDA, FHIR) 
[107].  
− Other entities working on EHR standardization: With the archetype specification in common 
with EN/ISO 13606 standard, the “openEHR foundation” published the specifications of a 
complete EHR architecture designed to support distributed, patient-centred, life-long, and 
shared care health records [108]. “Clinical Data Interchange Standards Consortium” is an 
open organization that develops data standards that enable information system 
interoperability to improve medical research and related areas of healthcare [109]. 
“Continua health Alliance” is dedicated to establishing a system of interoperable personal 
connected health solutions with more than 230 member companies around the world [110].  
Messaging standards 
Until recently, the main efforts toward interoperability in healthcare were focused on messaging 
standards developed for normalized information exchange between EHR and non-EHR systems (e.g. 
laboratory, imaging, and pharmacy systems), and between EHR systems which did not share the same 
information model, e.g. HL7 (HL7v2.x and HL7 v3 messages), DICOM (approved as the ISO 12052 
standard), UN/Edifact (approved as the ISO 9735 standard), or even ISO/IEEE 11073 
(medical/health device communication standards). 
However, these messaging standards are limited to well-known healthcare scenarios for both parties 
of communication, since the same message transmitted in different healthcare contexts may acquire 
different meaning. In this regard, normalized profiles are routinely used to specify unambiguously how 
a specific application or project conforms to the messaging standard. Furthermore, in the case of EHR 
extracts, it would be much more efficient to exchange those directly using lower level interoperability 
protocols (Simple Object Access Protocol (SOAP), Remote Procedure Call (RPC), etc.), although 
this is only possible with EHR systems compliant to the same information model and independent of 
the EHR systems architecture. 
Consequently, to move forward on interoperability in e-health, specific standards were developed for 
defining the information models and architecture of EHRs. The standard setting organizations stated 
above proposed different approaches to normalize the clinical information handled by EHRs at the 
semantic level, which in turn would facilitate the development of high-level services able to achieve a 
seamless coordination and cooperation between EHR systems (process level interoperability). 
EHR architectures 
The international standards development organization ISO/TC 215 defined the “Requirements for an 
EHR Architecture”, which have been reflected in the ISO 18308 standard [111]. This standard 
establishes the following requirements to exchange safely the information accommodated within the 
EHR [17]: 
− Content structure model: The requirements for the content structure model that an EHR 
system should conform to are established by the standard. 
− Inclusion of clinical and record processes: An EHR will implement services supporting either 
clinical or record processes. While clinical processes include orders, care plans, clinical 
guidelines, decision support, and so on, record processes include processes for capturing, 
editing, updating, querying, and presentation of data. 
− Content exchange: It should be possible to exchange partial or complete records between 
healthcare systems having different medical record structures, while maintaining integrity and 
context of EHR data. 
− Privacy and security: An EHR should support authentication, data integrity, confidentiality, 
nonrepudiation, and audit trail for the accessed information. 
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− Legal considerations: It is mandatory to record every action (read, write, insert, update, verify, 
transmit) performed by an actor to the EHR to enable auditing and recreation of the EHR at 
any specific point in the past. 
− Ethical, consumer/ cultural aspects: The actors must access and share only the specific parts 
of the EHR records it corresponds, depending on different levels of permissions. 
− Future-proof framework: An EHR should be able to represent new types of data, incorporate 
new record types, and generally be extensible in nature. 
Aligned with these principles, the following standards for interoperable EHR can be found in literature: 
− EN/ISO 13606: It is a five-part standard for EHR communication. The first part provides a 
reference model that defines generic data structures and their relationships to represent any 
kind of information which may be registered as part or totality of an individual‟s EHR. The 
second part proposes an archetype specification, which consists of a generic information 
model to define re-usable models of a domain concept built from the reference model. The 
third part specifies reference archetypes and term lists; the former represent how other 
standards can be expressed with this norm, and the latter the local terminology used by the 
reference model of the standard. In the fourth part the security framework specifies the 
security and access policies for the EHR. And finally, the fifth part defines the minimal 
messaging specification and service interfaces to enable the communication between EHR 
systems [112]. 
− OpenEHR: It is an open standard specification of a technology-independent and patient-
centred EHR architecture consisting of a reference model, an archetype model and a service 
model. It conforms to EN/ISO 13606, given that its reference model is closely related to ISO 
13606-1, and the openEHR archetype model was adopted "as is" within ISO 13606-2. In 
contrast to EN/ISO 13606, openEHR standard is more focused on providing an EHR 
architecture rather than on ensure the data exchange between systems [108]. 
− HL7 CDA: It was the first HL7 standard relating to EHRs. CDA is a schema standard that 
specifies the structure and semantics of the clinical documents to be exchanged between EHR 
systems. For this purpose, CDA represents medical records as XML documents based on the 
normalized information model of HL7v3 RIM. Even if HL7 CDA is not a full EHR specification, 
it covers the issue of defining clinical documents for the purpose of exchange and is 
compatible with the equivalent components in openEHR and EN/ISO 13606 [17]. 
− HL7 EHR-S Functional Model (approved as ISO/HL7 10781): The HL7 EHR-S DSTU project 
is HL7‟s first conscious move into EHR standards development. It describes the various 
functional profiles categorized as Direct Care, Supportive Functions, and Information 
Infrastructure that individually enlist the various functions involved in patient care 
management, Clinical Decision Support (CDS), administration and financial management, 
security, record management, registry, and standard terminology and related services.  
In brief, to achieve semantic interoperability between EHR systems, each of the standards described 
above specifies its own reference model for EHR communication. Then, concepts from clinical domain 
are defined using different clinical models. Examples of such models are openEHR or EN/ISO 13606 
archetypes [113], CDA templates [17], and DCM [16]. And clinical vocabularies, e.g. terminologies, 
ontologies and classification systems, are used to provide precise description about the elements used 
to define the clinical domain. Provided that reference models have been normalized, even though 
differently, harmonization and therefore the exchange of information is possible even between 
different standards. To that end, clinical models must be shared among all parties beforehand, so as 
to achieve semantic interoperability among the EHR systems involved in the communication. Finally, 
the use of clinical vocabularies should foster computerization of medical guidelines, as they contribute 
to connect the abstract clinical models with objects in the real world.  
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At this point, considering the complexity and the continuous evolution of the health domain, the 
flexibility that provides the archetype model of openEHR or EN/ISO 13606 on modelling the domain 
knowledge is very interesting compared to the pre-established clinical models presented by other 
standards. This architecture approach for EHRs is known as dual-model layered architecture since it 
differentiates a reference information model representing technical properties settled for interoperable 
EHRs on the one hand, and the formal clinical modelling represented by archetypes on the other. 
Although it is preferable that the archetype model should be defined under the aegis of the health 
professional colleges in conjunction with standards development organizations (ISO, CEN, or HL7), 
this approach enables clinicians or other domain experts to adapt the EHRs to their domain-specific 
needs, while IT specialists work upon the reference model to ensure interoperability and propose new 
services for EHR systems.  
Consequently, using EHR systems compliant to dual-model layered architecture would facilitate 
organizing the heterogeneous information managed in specific healthcare scenarios, irrespective of 
the diversity of components connected in the e-health system. Likewise, this architecture gives rise to 
the empowerment of EHR users on the clinical information they use. 
2.3 DESIGN AND IMPLEMENTATION OF ELECTRONIC MODELS AND THE INTEGRATION THEREOF INTO 
HEALTH INFORMATION SYSTEMS 
Due to the recent advent of health information systems based on dual-model layered architectures, 
the content model of these systems is still limited compared to previously established e-health 
implementations. Therefore, in order to extend the two-level modelling approach into a broad range 
of healthcare scenarios, experts of the clinical domain should actively engage in modelling their own 
clinical processes. And, to facilitate this process, a clear strategy is needed to produce high-quality 
electronic models. 
In this regard, modelling new healthcare procedures is not the major concern; the clinical knowledge 
is usually already available in many information sources, either explicit or implicit, having been built 
thanks to previous efforts in medical guidelines, clinical practice, healthcare technical standards, and 
the experiences of other domain experts. The real issue is how to gather, order, and incorporate 
methodologically that knowledge into electronic models.  
Different strategies can be found in literature to address the modelling of clinical processes. A good 
starting point could be the analysis of Rosenbrand et al. about the procedure for development of 
evidence-based clinical practice guidelines [114]. This work presents an overview of the history of 
clinical guidelines development. These guidelines aim at analyzing and organizing the clinical practice 
according to validated scientific methodologies. However, this proposal does not explain how to 
transcribe these theoretical guidelines into the electronic models.  
In that respect, considering the amalgam of information systems and e-health standards available, the 
report about semantic interoperability published by the Institute of Health Carlos III [19] introduces us 
on design practices when modelling specific components of electronic models. Likewise, publications 
focused on describing methodologies for development and maintenance of archetypes can be found 
in the literature [115-118]. In practice, examples applying such types of archetype modelling 
methodologies can also be identified for specific healthcare scenarios [119-121]. Some publications 
have gone one step further and have considered the use of standard terminology services to support 
the semantic interoperability among heterogeneous information systems [122-124].  
Based on a semantically enabled definition of clinical information, other studies propose using the 
information registered during clinical encounters to provide computerized decision support to 
clinicians [125-128]. To that end, the rules that trigger a specific action or another depending on pre-
established medical guidelines must be modelled. However, the conditions governing these guideline 
rules depend strongly on the context information registered in the information system. Therefore, these 
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guideline definitions were solutions designed to satisfy the specific requirements of particular 
implementations. Alternatively, Chen et al. presented the Guideline Definition Language (GDL) that 
leverages the archetype model of information systems compliant to the two-level modelling approach 
to normalize the clinical content included within the guideline rules [129]. 
The aforementioned guideline rules were originally devised to trigger CDS services depending on 
specific events observed during clinical practice. But, theoretically, these guidelines rules could also be 
used to manage the workflow of clinical processes. Nonetheless, the workflow modelling strategies 
found in the literature do not contemplate using a formal workflow to coordinate model-driven EHR 
systems [130, 131].  
Aligned with the presentation layer of interoperability, a recent inclusion into the design of electronic 
models is the definition of UI specifications as part of the clinical process. A related article was that in 
which Palau et al. presented the UI forms as a solution to normalize the presentation of healthcare 
information into heterogeneous visualization front-ends [95]. However, there is no consensus on how 
these UI forms should be defined. In fact, although some health information systems implement this 
approach in practice (see EhrScape form definitions on the API explorer) [132], current modelling 
methodologies still do not contemplate UI specifications as part of the modelling guidelines. 
All said, no previous work has created a comprehensive methodology taking into account the different 
layers of interoperability identified in e-health (technical, syntactic, semantic, process/organizational, 
and presentation). Thus, it is required to define a methodology based on the knowledge from the 
state-of-the-art modelling experiences to cover all the necessary steps to build electronic models from 
the clinical concept to the presentation layer. This approach would guide experts on clinical domain to 
build their own clinical processes into model-driven information systems. 
In Subsection 3.1., a novel methodology for defining clinical concepts, archetypes, termsets, 
templates, guideline definition rules, and UI forms within its steps is presented.  
2.4 OPEN HEALTH COMPUTING ARCHITECTURES 
Traditionally, the development of EHR systems responded to the need for gathering the clinical 
information generated by the increasing electronic diagnostic devices in specific clinical areas. Many 
of these systems were built on proprietary technology, so ended up being information silos which use 
was confined to the department of origin [29]. Therefore, when e-health standards provided solutions 
to interconnect heterogeneous information systems, not-standardized legacy systems had to be 
adapted, in order to connect them all by means of a common Clinical Data Repository (CDR). 
However, many features provided by these systems could not be integrated into the main information 
systems, since the development of proprietary systems focused on meeting the requirements of specific 
clinical scenarios.  
Today, there are many initiatives of governments worldwide to integrate the management of clinical 
data beyond health institutions [17]. But, given the predominant strategy of centralizing the clinical 
information into monolithic information systems, the enormous base of hierarchically connected 
proprietary technologies must synchronize the clinical data regularly. Thus, the comprehensive 
management of clinical information would increase in complexity as it integrates more and more 
healthcare organisations and systems.  
To face this issue, open health computing architectures propose building health computing platforms 
presenting a modular design. Each module would comply with a set of specifications agreed by 
manufacturers to connect compatible components. Thus, despite the modules that comprise a health 
computing platform would be commercial solutions supplied by different manufacturers, the customer 
would retain at any time the control and ownership of the data managed within the platform. In other 
words, an architecture based on open standards should prevent technical incompatibilities among 
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purchased components, due for instance to proprietary implementations, which could lead to lock-in 
or unexpected costs in the future. In fact, a proposal in this regard would contribute to face the main 
challenges nowadays in managing clinical information in e-health [29]. 
Moreover, this platform-based e-health ecosystem would unleash the decentralization of healthcare 
into care networks, hence it will provide access to normalized clinical data, regardless the information 
system where it was originally registered. As a result, each health department could implement 
dedicated health information systems compliant to the requirements of specific clinical specialties, and 
yet maintain interoperability with information systems nationwide, even internationally. In this way, a 
health service implementing the open health computing platform approach could incorporate 
progressively clinical models, terminologies, and service infrastructure tailored to the unique needs of 
the service at any given time. Thus, an e-health ecosystem comprised by domain specific information 
systems, e.g. OpenEyes which provides a rich set of tools focused solely on eye care, would be 
feasible [133]. 
In that respect, the advent of dual-model layered architecture has led to the development of 
semantically enabled, open health computing platforms in e-health. On the premise that the 
information inside the EHR has been semantically enabled, a fully-fledged service infrastructure could 
be built upon normalized data, giving rise to endless possibilities in the management of clinical 
information.  
In [134], Frade et al. identify different dual-model-based system implementations (particularly EN/ISO 
13606- or openEHR-based approaches). This paper includes both proposals from R&D institutions 
and companies around the world. For example, Pazos proposes an architecture to build a standard-
based open source EHR platform compliant to openEHR specifications [94]. Furthermore, Maldonado 
et al. focus on an EHR architecture for integrating the dual-model approach into non-standardized 
EHRs in compliance with EN/ISO 13606 (this proposal includes editing domain concepts, mapping 
EHR data to electronic models, and automatically transform source data into archetype instances) 
[135]. Marco-Ruiz et al. used the same approach to normalize into standardized data repositories the 
proprietary data from a Laboratory Information Management System (LIMS) in Norway. 
Implementations like this would foster integration of proprietary EHR systems into open health 
computing platforms [136]. Mandl et al., in turn, puts into practice the health computing platform 
concept, by proposing the SMART platform (Substitutable Medical Applications, Reusable 
Technologies). This platform presents a modular architecture, upon which different applications or 
apps are attached. In this regard, different manufacturers would have a common API at their disposal 
for implementing healthcare applications compatible with the platform. As the platform functionally 
separates the core system from the third party apps, the customers or final users would customize their 
workspace depending on the apps chosen [137]. 
Nonetheless, the architectures surveyed are focused on specific EHR implementations. Given the 
heterogeneity of the information systems that must interoperate in a conventional health service, there 
is a need of guidelines on the basics of building health computing platforms based on open 
standards. Such recommendations would facilitate the manufacturers to develop new e-health 
proposals along this line. In this context, this Thesis will identify the different information systems 
involved on the management of patient-centred clinical processes, to propose an architecture that 
would connect them all into an open health computing platform approach. This topic is approached 
in Subsection 3.2. 
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2.5 MANAGEMENT OF CLINICAL INFORMATION IN THE SNS-O 
Currently, the SNS-O covers 3 health areas divided into 56 basic health zones: 41 health zones on 
the health area of Pamplona, 8 health zones on the health area of Estella, and 7 health zones on the 
health area of Tudela. These health areas are covered by a hospital complex (grouping together 3 
public hospitals from the health area of Pamplona), 2 additional public hospitals, 58 primary care 
centres and 232 local practices [138]. 
To connect all these health facilities, the Government of Navarre deployed a corporate network that 
provides service to the aforementioned points of care (except for 22 local practices located in 
geographic areas of difficult access). An overview of the information systems for the management of 
clinical information within the SNS-O network can be seen in Figure 5. 
2.5.1 IDENTIFICATION OF PATIENTS 
To manage patient admission on all these facilities, the SNS-O issues a health card that enables a 
unique identification of patients. In this way, it is possible to access to the clinical and administrative 
information of a specific patient, although spread throughout the corporate network of the 
Government of Navarre. In the SNS-O there are three stand-alone patient databases using their own 
identification codes to conduct admission depending on where the patient was registered: first, patient 
admission services in hospitals assign a unique identifier for the EHR system of specialized care. 
Second, the primary care centres provide another unique identifier corresponding to the basic health 
zone where the patient want to be attended. Third, the health card office registers patients through 
administrative channels, and generates the Personal Identification Code of Navarre (Código de 
Identificación Personal de Navarra [CIPNA]) for all patients using any service from the SNS-O. The 
latter code prevails over the others, so the patient databases are synchronized accordingly to maintain 
coherence of the information about patients' admission in the SNS-O [139]. 
During 2007, the SNS-O collaborated with the National Health Service (NHS) to synchronize their 
personal health card databases. Consequently, today, information about admissions and discharges 
of patients resident in Navarra are automatically updated in both databases. Thus, patients attended 
in other health services can be uniquely identified along the country using the CIPNA or the personal 
identification code provided by the NHS (CIP-SNS) indistinctly [140]. 
2.5.2 ELECTRONIC HEALTH RECORD 
To manage the clinical information generated along the health service, the SNS-O combines the use 
of two interoperable EHR solutions. At this point, the unique identification of patients facilitated the 
coordination of these EHR systems when it comes to assemble all clinical information pertaining to 
each patient.  
On the one hand, there is an EHR system accessible from every primary care centre in Navarre. In this 
regard, the commercial solution OMI-AP was adapted to manage the clinical practice specific to 
primary care, taking the name of “Atenea” [139]. 
On the other hand, there is another EHR system devised to manage the medical records submitted on 
specialized care. This one was an own development of the Government of Navarre, based on the 
original design of an EHR originally created for the hospital "Reina Sofia" in the city of Tudela, so it 
was adapted and extended to the rest of Navarre. This EHR should cover the needs of every clinical 
specialty on specialized care on the same platform. 
As an exception, in 2007 an EMR system was launched to record solely the nursing care practices that 
take place on specialized care. This software was named “Irati”, and it was designed by nurses from 
the SNS-O in collaboration with teachers in nursing from the UPNA, and implemented by experts in 
development of EHR systems from the Government of Navarre and the SNS-O [140]. 
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Figure 5: Setting of information systems in the SNS-O for the management of clinical information.
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Exceptionally, medical records in paper are also used: on the one hand, the diagnostic devices not yet 
integrated on the EHR system continue producing clinical information in paper form. But generally, 
medical records are still used in paper when it comes to review studies previous to the comprehensive 
implementation of the EHR. Anyway, this is no longer an issue, since they have been scanned and 
uploaded to the EHR. Therefore, currently these medical records can be accessed indistinctly on paper 
or electronically [139]. 
The NHS developed an EHR (HCDSNS) that would access to the summarized patient's clinical record 
from EHR systems implemented on regional health services. The EHR systems from the SNS-O were 
successfully connected to that server, so they would exchange EHR extracts defined by the NHS as 
relevant data sets. This makes it possible reviewing medical reports registered outside Navarre, along 
with those originally belonging to the SNS-O [141]. 
However, although predefined EHR extracts can be exchanged nationwide, inside the SNS-O the 
installed base of EHR systems does not support the data richness actually required by clinicians. Thus, 
specialists have to deploy parallel databases, for example for research purposes. To face this issue, it 
would be necessary to implement software tools compatible with the existing EHR systems, each 
covering the requirements of specific clinical specialties. Nonetheless, to that end, as in the case of 
the EMR “Irati”, it would be necessary to redesign the knowledge base and the service catalogue.  
For the same reason, at present, the software tools for analyzing the clinical information registered in 
EHRs are limited by the lack of standardization of their knowledge model. In this regard, a 
complementary EHR solution implementing dual-model layered architecture would provide flexibility to 
attach new features upon the existing base of medical records. Indeed, this would enable deploying 
an ecosystem of tailor-made applications for each clinical specialty, while maintaining interoperability 
with the original EHR servers of the SNS-O. 
Besides registering clinical information, the EHR systems of SNS-O provide modules to interoperate 
with other information systems available on the health service, such as digital medical imaging, 
electronic referral, or medication prescriptions (Figure 5). 
Digital medical imaging 
The EHR servers incorporate a Radiology Information System (RIS) module which manages the 
requests for specific diagnostic imaging modalities, and refers them as a work list addressed to the 
main PACS server available in the SNS-O. 
The main PACS is in turn connected to departmental PACS servers, so the orders are redirected 
through them toward the appropriate imaging modality. As a result, the work lists are loaded into 
each diagnostic imaging device, where the responsible clinician undertakes the imaging studies as 
requested. Then, once the imaging studies have been completed, they are sent back to the 
corresponding departmental PACS. 
At this point, the studies stored in departmental PACS servers are copied immediately into the main 
PACS, which in turn comprises a backup server located in a different data processing centre. 
Therefore, the SNS-O relies on two layers of backup. Taking advantage of this architecture, to 
improve performance of the searches, clinicians access first to the PACS server of the department 
where they are located, and, if the imaging study requested cannot be found, then the request is 
automatically redirected to the main PACS. 
The implementation of the DICOM network of the SNS-O, and the subsequent integration with the 
EHR servers accelerated considerably the clinical practice, as both request and examination of 
imaging studies can be conducted ubiquitously today. Anyway, DICOM is a standard which 
compliance does not always imply the same level of conformance of the norm. Thus, in the SNS-O 
there are still many imaging modalities and features to be integrated into the DICOM network. 
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Consequently, in many cases, clinicians must go directly to the diagnostic device to retrieve specific 
data from an imaging study [139]. 
Management of care service referrals 
In order to put an end to the use of referral notes in paper, the SNS-O implemented a module for 
electronic referral, aimed at managing the requests for provision of a specified service by means of 
telematics. Besides the request of specific services, the electronic referral would also monitor the status 
of these requests, i.e. it would provide information about the procedures completed, pending and 
remaining at any given time. For example, the request for radiodiagnosis and laboratory tests are 
triggered by electronic referral notes, and the service is completed when the test results are returned. 
To implement such module, first, a common catalogue had to be defined listing all the care services 
provided on the SNS-O. Specifically, the services provided by the following clinical specialties were 
included in that catalogue: allergology, digestive system, cardiology, general surgery, pediatric 
surgery, genetics, haematology and haemotherapy, internal medicine, nuclear medicine, 
pneumology, neurophysiology, gynecology and obstetrics, ophthalmology, radiodiagnosis, 
rehabilitation, sleep unit and urology. Thus, all specialists had to reach an agreement in specifying the 
requirements of each service considered.  
Furthermore, the electronic referral modules of primary care and specialized care EHRs have been 
integrated, so a service request ordered from primary care can schedule an appointment on the 
calendar of services from specialized care [139, 140].  
Electronic prescription 
In 2010, the SNS-O implemented a module integrated in the front-end of the EHR systems to manage 
electronic prescriptions. This module was connected to a pharmacy management system that registers, 
in a central server, every prescription and the consequent dispense of medications associated to 
patients from the SNS-O. At the other end, pharmacies from Navarre installed a different module to 
register which medications were dispensed due to these electronic prescriptions. The whole system 
devised to manage the electronic prescriptions in the SNS-O was named “Lamia”.  
When patients arrive to a pharmacy, they are uniquely identified using the personal health card, so 
that they can receive their corresponding medications. Likewise, healthcare professionals can instantly 
supervise the medication regimen prescribed for each patient, and pharmacists keep track of the 
quantity of subsidized medications delivered. 
The integration of this mise en scène entailed a great challenge, not technically but due to the 
conflicts of interest among personnel from the public health service and pharmacists owning a private 
business that must delimit their competences. Today, this service has replaced the traditional 
prescription in paper [139]. 
2.5.3 OPHTHALMOLOGY IN THE SNS-O 
To date, the ophthalmology service of the SNS-O makes use of the specialized care EHR to register 
the information electronically. However, the information defined within the medical reports is mostly 
text-based and not structured. Consequently, the later exploitation of clinical information is 
unpractical.  
Alternately, in order to partially solve the gaps of the main EHR system, our research group proposed 
several projects to research on specific healthcare procedures taking place in the service [34, 38]. 
However, this research work implied the duplication of information in the main database. Additionally, 
these projects had a limited lifespan and the effort invested was aimed at solving very specific issues, 
which could not be reused. 
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In any case, no previous work has achieved to model the clinical practices in ophthalmology while 
guaranteeing interoperability with the existing EHR. In this regard, in Chapter 4 of this Thesis, the 
integration of the dual-model layered architecture into the SNS-O to semantically enable the clinical 
information contained in the non-standardized EHR is proposed. 
2.6 ELECTRONIC MODELS IN OPHTHALMOLOGY 
As said before, there are two main standards supporting dual-model layered architectures, namely 
EN/ISO 13606 and openEHR. Both of them have repositories for electronic models. The former has 
recently launched the Clinical Information Model Manager (CIMM) [142], but to date, there is only 
one archetype defined (CEN-EN13606-ENTRY.Blood_pressure.v1). Additionally, the HCDSNS 
implemented a number of semantic resources to enable interoperability among the health services 
nationwide.  However, it is a reduced set (10 compositions, 7 sections, 38 entries, 3 clusters, making 
a total of 58 EN/ISO 13606 archetypes) and none of them are related to ophthalmology [141]. The 
latter, openEHR, launched the Clinical Knowledge Manager (CKM), which includes 499 archetypes, 
78 templates and 29 termsets [113]. Among them, the electronic models related to ophthalmology 
are the following: 
− openEHR-EHR-OBSERVATION.visual_acuity.v1 
− openEHR-EHR-OBSERVATION.fundoscopic_examination.v1 
− openEHR-EHR-OBSERVATION.visual_field_measurement.v1 
− openEHR-EHR-OBSERVATION.refraction.v1 
− openEHR-EHR-CLUSTER.refraction_details.v1 
− openEHR-EHR-OBSERVATION.intraocular_pressure.v0 
In addition, the openEHR CKM includes a specific project to author ophthalmology models. However, 
to date, there are no electronic models for the most frequent causes of avoidable blindness and visual 
impairment in developed countries: DR, AMD, and CG.  
Consequently, this Thesis will propose in Chapter 4 the modelling of the clinical processes associated 
to these three conditions, based on the methodology proposed in Section 3.1. 
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Chapter 3: 
Guidelines toward the integration of e-health systems into 
pervasive clinical practices 
 
First of all, this chapter describes a comprehensive methodology to guide experts on clinical 
domain to actively engage in modelling their own clinical processes into model-driven 
information systems. To this end, technical, syntactic, semantic, process/organizational, and 
presentation layers of interoperability were covered by the guidelines devised for clinical 
knowledge modelling.  
In connection with that methodology, the second half of this chapter presents a health 
computing architecture based on open standards and good design practices, for setting up 
the e-health environment necessary to manage the electronic models resulting from the 
above guidelines.  
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3.1 METHODOLOGY PROPOSED TO FORMALIZE CLINICAL PRACTICE INTO INFORMATION SYSTEMS 
The modelling experiences reviewed along section 2.3 were refined and then unified into a 
comprehensive methodology. This methodology therefore goes one step further than merely 
computerizing the domain knowledge using the two-level modelling approach. On top of that, it 
proposes using standardized terminology services, modelling computerized medical guidelines, 
managing workflow pathways of the clinical process, and formalizing the specifications for the UI (how 
that information is presented to users).  
That would guarantee a suitable level of quality for the electronic models designed with the aim of 
ensuring continuity of care in patient-centred clinical processes that require tight coordination among 
multidisciplinary care providers. Considering all this, the modelling strategy proposed is comprised of 
three main phases (Figure 6): 
 
 
Figure 6: Methodology proposed for modelling the clinical knowledge into electronic models. 
3.1.1 DEFINITION OF THE PROJECT 
In this first phase, a work team is convened to analyse available information resources and define 
requirements to redesign a clinical procedure in response to deficiencies detected in daily clinical 
practice for a particular healthcare scenario.  
Detection of a need within a healthcare process (step A.1) 
The process of modelling healthcare guidelines into standardized knowledge repositories begins when 
healthcare providers identify in their daily practice the absence of formally described domain 
knowledge specifications for a particular healthcare scenario. 
Establishment of a work team (step A.2) 
When this occurs, a work team is established to determine the objectives and scope of the project 
initiated. As shown in Figure 7, such work team would be comprised of multidisciplinary experts who 
assume different roles depending on their capabilities. In this way, the work team will be able to cover 
broad viewpoints about the healthcare scenario to be modelled [19]:  
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− Discussion Committee: Healthcare experts are convened to expose the information and 
requirements of the clinical process to be modelled. On the other hand, experts in technical 
domain guide them to efficiently transcribe their knowledge into electronic knowledge 
repositories.  The collaboration of experts from other domains is welcome depending on the 
scope of the project (engineers, statisticians, economists…). 
− Convenor: A convenor is elected for each discussion committee. This role manages and 
registers every decision made by the committee and distributes the workload among the 
participants. In case of collaboration meetings with multiple discussion committees, the 
convenor is also the representative of his/her own discussion committee. 
− Experts in clinical domain: Experts with broad knowledge about the clinical domain under 
study. Thus, they direct the decisions made by the discussion committee and then validate the 
information gathered.  
− Experts in technical domain: Specialists in ICTs, with expertise in standards defining the 
interoperability between the electronic information systems used in healthcare. This role is the 
responsible of guaranteeing the compliance of technical standards when the information 
agreed by the discussion committee is transferred into electronic knowledge repositories.  
− Expert terminologists: They are engaged to supply detailed terminologies and ontologies for 
the artefacts modelled by the discussion committee. 
− Subgroups: When a clinical process involves many healthcare areas, the meetings of the 
work team can become overcrowded, and hence they can lose efficiency. Thus, the experts 
are distributed in smaller groups (preferable multidisciplinary) and then, the aforementioned 
roles are shared for each one of those. Meanwhile, the main discussion committee – 
composed of the convenors from each subgroup – coordinates the overall modelling. 
Thereby, each convenor would share in the main group a summary of the achievements and 
executive decisions made in their corresponding subgroups.   
Once the work team is established, this organizational structure facilitates coordination of project's 
workload among the work team members. At this point, Agile mindset-based project management 
approaches, e.g. SCRUM, could be applied to ensure sustainable development for projects with 
continuously changing requirements [143].  
Background analysis (step A.3) 
Then, the work team proposes a solution for the issue identified during clinical practice, but it must be 
supported by reliable sources of information resulting from a comprehensive review of the state of the 
art. In that respect, three different information sources should be reviewed: 
− Work experience in clinical practice: It is comprised of clinical knowledge obtained from 
evidence based medicine experiences in local scenarios. These experiences are based on the 
service procedures used to date (healthcare protocols and guidelines, medical forms, data 
field) and are the basis of service modelling due to the extensive expertise of the work team.  
− Scientific literature: Peer-reviewed scientific journals, internationally validated clinical 
guidelines, and technical standard specifications shall be periodically reviewed to complete 
and/or update locally used healthcare procedures whenever they become outdated.  
− International clinical knowledge repositories: These offer clinical knowledge which has been 
already electronically modelled. Repositories of archetypes such as the clinical knowledge 
manager (CKM) for openEHRs must be considered, including both published models and 
drafts [113]. Clinical terminologies such as SNOMED-CT, LOINC, or ICD-x provide univocal 
meaning for specific clinical concepts [122]. Other useful sources of information can be 
reference information models from technical standards used in healthcare, e.g., DICOM or 
ISO/IEEE [14, 144]. 
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As a result of reviewing the state of the art, a list of the information sources identified shall be 
documented; all members of the work team can access that information.  
 
Figure 7: Organizational chart of the roles defined within a work team. 
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3.1.2 DESIGN OF THE CLINICAL PROCESS 
At this phase, the methodology proposed must satisfy the requirements of the project described 
previously. The clinical process is defined as a combination of activities, decisions, and conditions that 
constitute the clinical pathways in the healthcare service. Those pathways are completed with the 
clinical concepts identified and then organized hierarchically according to the healthcare scenario 
chosen. 
Definition of the clinical process (step B.1) 
The work team proposes a clinical process in conformance with the specifications defined during the 
previous phase of the modelling. That process constitutes the workflow between the stages 
corresponding to different clinical encounters a patient has to go through to receive continuous 
clinical care. So first of all, the overall clinical process is agreed in a set of healthcare activities, 
conditions and decisions that represent the pathways between clinical stages. In this regard, activity 
diagrams in UML provides a suitable way to represent that workflow according to the definition of 
Martin Fowler [145]: 
“Activity diagrams are a technique to describe procedural logic, business process, and workflow.”  
Moreover, collaborative and on-line diagramming tools are recommended to reduce the number of 
meetings of the work team, since each expert can contribute remotely on the design of the activity 
diagrams [146, 147].  
To conclude this step, the work team defines a project report that specifies every clinical practice 
conducted inside each one of the clinical stages identified on that activity diagram. 
Study of clinical concepts (step B.2) 
The stages identified in the clinical process are reviewed at this point, looking for reusable patterns of 
information that correspond to the clinical concepts to be modelled. And consequently, every clinical 
concept of interest to the clinical service is listed in a table which is added to the project report to keep 
every domain expert up-to-date about which parameters have to be included in the modelling. 
In that respect, given that archetypes are used to register clinical knowledge in a standardized and 
reusable manner, some of those clinical concepts could be already modelled and validated as 
archetypes [26]. In this way, the contributions of previous projects are reusable for subsequent 
modelling. Thus, reuse of appropriate archetypes will avoid modelling every clinical concepts from 
scratch.  
For this reason, the work team must review the archetypes available in the clinical knowledge 
repositories identified during the analysis of resources. Therefore, three situations can be 
distinguished: some archetypes will perfectly fit the concepts consulted, so they will be downloaded 
from the corresponding knowledge repository and used directly in the model; other archetypes will 
require modifications to match the needs of the current model; and other concepts will be new, so 
their archetypes have to be created from scratch.  
Hierarchical organization of knowledge artefacts (step B.3) 
The clinical concepts identified in the last step will be combined to build diverse knowledge artefacts 
hierarchically related to each other. Specifically, the knowledge will be structured within the electronic 
models according to the hierarchy that Skyrme defined in 1999 for modelling knowledge [148] (see 
Figure 8). 
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Figure 8: Knowledge hierarchy proposed by Skyrme compared to archetype-based models. 
According to this, the work team will design a tree-type diagram in which the relationships among 
different knowledge artefacts involved on the computerized management of a specific clinical process 
are defined. Therefore, for each healthcare scenario to be modelled, the knowledge artefacts 
described below will be structured given the following hierarchy (see Figure 9): 
− UI forms: Set of rules that determine how the knowledge artefacts modelled in the content 
model – defined by archetypes, templates, and bindings to standard terminologies – will be 
displayed to clinicians. 
− Workflow: The dynamic side of clinical care; the process that guides patient healthcare 
through the stages of the clinical process [149, 150]. 
− Guideline rules: These rules based on medical evidence or by consensus from domain 
experts, provide notification services to support clinicians toward best healthcare practices. 
Guideline rules also can be used to manage other guidelines, e.g., alerts, unit conversion, 
and automatic filling out of data among archetypes. For now, the only rules defined here are 
those concerning the stages of patient flow through the clinical process [150]. 
− Stages and roles: Each stage is a clinical scene inside the healthcare process handled by 
personnel with specific capabilities (roles). 
− Templates: They constrain the concepts and terminology from the archetypes they contain to 
define a form in which clinicians register the results of clinical encounters [151, 152]. 
− Archetypes: Archetypes are formal definitions of knowledge about a clinical domain. Thus, 
the data handled by an archetype-based EHR would be registered through the following 
categories of archetypes [26, 27]:  
− Compositions or thematic archetypes: They are the smallest units for data exchange 
between information systems. They include all clinical and administrative information of a 
clinical care session. As such, they must include meta-information to contextualize the 
healthcare session regardless of the EHR system. In this sense, when a contribution to a 
specific composition is filled out, it is signed by the responsible professional; hence 
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compositions have the same medico-legal validity as paper clinical documents. The extra 
information in compositions guarantees the ACID characteristics of transactions: 
Atomicity, Consistency, Isolation, Durability, indelibility, modification, and traceability  
[149]. 
− Sections or organizational archetypes: They organize the information inside compositions 
for human readability. They usually are used to arrange archetypes, but they also can 
enclose templates [149]. 
− Entry type or descriptive archetypes: These define the semantics for the information to be 
recorded in the information system. Five subtypes of entry are distinguished depending 
on their function in the iterative clinical problem-solving cycle used in medicine: admin 
entry (for non-clinically relevant administrative information), and four types of care entry 
archetypes (observation, evaluation, instruction, and action) [149, 153]. 
− Groupable archetypes: Clusters and structures are used embedded in different entry type 
archetypes to reuse context information they have in common. 
 
 
Figure 9: Conceptual diagram of the overall hierarchy among the knowledge artefacts 
considered in the proposed modelling. 
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3.1.3 BUILDING THE ELECTRONIC MODEL 
At the third phase, all information necessary to build the electronic model has been already 
documented. Consequently, it is time to formalize the different aspects of healthcare for the clinical 
process designed in the previous phases. This section, therefore, would guide domain experts in 
building the knowledge artefacts considered by the proposed methodology: archetypes, templates, 
terminology bindings, guideline rules, and UI form specifications. 
Creation and update of archetypes (step C.1) 
At this point, the clinical concepts identified in step B.2 are defined into archetypes. Based on 
experience with archetype creation in the literature, the work team uses the following procedure to 
create or update archetypes when necessary [19, 115-117, 153]: 
− Definition of the scope: Archetypes must be created with the aim of promoting their 
reusability. However, the first versions are focused on the definition of the information 
considered essential for the specific use case the archetype is created for. Thus, archetypes 
will adopt broader definitions to the extent that they are versioned for different use cases. 
− Naming archetypes: The name of archetypes describing new concepts must be unique and it 
must follow the naming conventions defined by the standard used.  
− Languages: A primary language is defined, so translations will be based on this unique 
reference.  
− Elicitation of content: The clinical concepts identified in the clinical process (section 3.1.2) 
are dismantled into primary data elements. Then, each one of data elements identified must 
adopt at least one data type to represent the information they contain. Thus, those data types 
must be assigned according to the reference model of the standard chosen to build the 
archetypes. Next, in step C.2, the resulting data elements may be connected to equivalent 
clinical concepts defined by standardized terminologies. 
− Content organization: The structure of archetypes is defined by establishing connections 
among those data elements. Mind-mapping diagrams offer precise representation of those 
relationships, providing a key tool to manage the contributions of different work team 
members [146, 147]. 
− Assignments of constraints to data elements: The properties of existence, cardinality, and 
occurrences must be established for each data element of the archetype [154]. 
− Building archetypes: The clinical concepts already designed at a theoretical level must be 
electronically registered. In case of openEHR, for example, the archetype editor of Ocean 
Informatics is used to develop and parse the code expressed in the Archetype Definition 
Language (ADL) defined by the standard [155]. 
− Publishing and validating the archetypes: Once archetypes have been uploaded into a 
Clinical Knowledge Base (CKB) system, they must follow the authoring process defined by the 
standard. For instance, the archetypes hosted in openEHR‟s CKM, have to overcome different 
states of the archetype development lifecycle. So, this authoring process fosters peer-review 
procedures to guarantee archetypes in line with the evolution of knowledge on the clinical 
domain concerned [117, 156, 157].  
Definition of semantic links to clinical terminologies (step C.2) 
This section was established simultaneously with the creation of archetypes and templates (step C.1). 
First, the semantics of data elements must be established for local use; at the same time, those data 
elements will be bound to their equivalent terms defined univocally in standardized terminology 
services in accordance with the following steps: 
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− Selection of terminologies: As seen in section 2.2.1, different terminologies, nomenclatures 
and coding systems are available for this purpose. Thus, the appropriate terminologies must 
be chosen to cover the knowledge structured within the archetypes to be modelled. In some 
cases we will find concepts covered by several terminologies, although this overlapping is 
solved by binding the same concept to as many terminologies as considered necessary. 
− Semantic description of the structure of knowledge: Then, the terminologies chosen are 
analyzed looking for the concepts that best suit the knowledge elements formalized within the 
archetypes, templates, even guideline definition rules that comprise the model. Therefore, 
each knowledge or data element must include notations and links to international 
terminologies that will describe them unambiguously. 
− Association of data values: In addition to the definition of data elements, those that define 
their content as coded data values or term lists must be referred to standardized 
terminologies as well, to constrain the set of possible values they can adopt [122]. At this 
point, different approaches must be considered to determine the connections among the 
information model and terminology services, depending on the scope expected for the value 
sets: 
− Binding the concepts within the archetypes: Value sets can be directly modelled inside the 
archetypes, and then, bound one by one to equivalent concepts in terminology services. 
This is possible when the value sets handled in the archetypes are small, manageable 
and universally applicable. For example, in ophthalmology the data element “laterality” 
would be always limited to: left eye, right eye, or both eyes. 
− Binding at template level: In some cases, the value sets identified toward pervasive use of 
archetypes can differ from the requirements of specific use case scenarios. Thus, those 
value sets must be constrained at template level, providing that they are small and locally 
applicable and the need for coding is not present. For example for registering new 
compounds used in clinical trials that have not yet been adopted on pervasive clinical 
guidelines 
− Create independent termsets: If the value sets are large or may be modified over time, 
involve different levels of hierarchy among concepts, and their use is widespread in the 
clinical domain, then it may be sensible to define them as normalized termsets to foster 
the semantic interoperability. The definition of termsets is comprised of queries addressed 
to a specific subset of concepts defined in a terminology service. Those are managed as 
a separate resource to archetypes and templates, providing them broad applicability with 
no need of additional modifications. For example, the list of substances used in 
anaesthesia which use is extended in many clinical practices, but still may incorporate 
new compounds and/or doses in the future. Another typical example is the termset that 
defines blood groups: A, B, AB, 0, plus the combinations of these due to Rh positive or 
negative. 
Building templates (step C.3) 
Considering that templates are local representations of the stages of the clinical process, they are 
responsible for composing the archetypes modelled in step C.1 into larger structures analogous to 
medical forms in paper [26]. In light of this, this step of the methodology is focused on modelling 
templates for a specific clinical process, which would register significant information obtained during 
clinical encounters:  
− Identification of templates in the healthcare process: First of all, the clinical process is 
analyzed to determine which templates must be modelled to cover the information 
handled in clinical encounters. In this regard, the workflow of such clinical process 
should be divided into clinical stages corresponding to each clinical encounter planned 
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for patients. Then, at least one template must be modelled for each one of the clinical 
stages identified. Nevertheless, the more clinical concepts are involved in a clinical 
encounter, the more laborious becomes maintaining updated all the archetypes within 
the resulting template. Thus, to avoid building too complex templates, it is recommended 
to distribute the clinical concepts to be managed in a single encounter among small 
templates which would require a simpler maintenance. In addition, the use of smaller 
templates fosters their reusability in similar healthcare scenarios, in contrast with complex 
templates which are more use-case dependent. Section-type archetypes, also known as 
organizational archetypes can be used to that end. Those are capable to enclose 
templates as well as archetypes, so they are really useful to arrange the different 
templates concerning a clinical stage. 
− Determine source archetypes: Templates do not change the structure of archetypes other 
than deleting or mandating certain branches, so it is essential to choose properly the 
archetypes to be included into templates. The choice as well as the hierarchy of the 
elements enclosed in the template should already have been described along the design 
of the clinical process. Therefore, the internal structure of templates will be formalized 
according to the hierarchy defined in step B.3. 
− Applying constraints: Given that archetypes contain generic data elements to support 
their use within broad healthcare scenarios, further constraints must be defined at 
template level to adapt the information managed so as to be applicable in local 
healthcare scenarios [151, 152]. Optional nodes of the archetypes can be included, 
removed or turned into mandatory as required; the language in which the resulting forms 
will be generated is chosen at template level; terminologies associated to elements in the 
archetypes are specified to local usage; terminologies or occurrences already defined in 
archetypes, can be restricted so as to register just the information required in a local 
healthcare scenario; default values can be defined for data elements depending on the 
most used options for a local use case.  
− Publication and authoring process: Finally, all previous specifications are formalized 
using the definition language provided for templates by the standards chosen. In this 
sense, templates can be considered as specialized archetypes, so the languages used to 
define archetypes and templates tend to merge into the same. Furthermore, design tools 
can be used to build archetype-based templates disregarding the definition language 
used. In case of openEHR, the templates can be built using the template designer 
developed by Ocean Informatics, and then are published into the CKM [155]. Once 
templates have been published into a clinical knowledge repository, they will follow the 
same authoring process applied for archetypes [152, 157]. 
Modelling guideline rules and workflow (step C.4)  
The computerized guideline rules, and consequently the workflow are formalized at this point. First of 
all, clinical guidelines and recommendations established along section 3.1.2 – on the basis of local 
resources and settings within a specific healthcare service – must be formalized through computerized 
decision rules.  
Then, further elements must be considered in addition to those guideline rules, to devise a workflow 
model. In fact, while guideline rules are modelled to execute specific events found during clinical 
practice, the workflow model considers the whole events triggered as the context information from a 
specific healthcare scenario. As a result, the workflow model would determine patients‟ pathway 
through the clinical process, based on the overall analysis of the context found at any given time. The 
main concepts that comprise clinical guideline and workflow models are further described below: 
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− Clinical pathway: They will provide, depending on the conditions met during clinical practice, 
a route through clinical process for patients. Those pathways are comprised of the healthcare 
activities, conditions and decisions identified in step B.1. Therefore, at this stage, the 
aforementioned pathways are formalized as business process models, to be processed by the 
corresponding workflow engine. 
− Guideline rules: Among all guideline rules modelled, those determining the transitions 
between the clinical stages will be used to govern the workflow. Hence, the clinical stages 
defined along section 3.1.2 will be considered as the baseline when modelling those rules. 
According to these stages, the guideline rules modelled will specify a set of conditions 
determined by the pathways that trigger different actions or events depending on the context-
data registered during the clinical practice.  
− Conditions: The conditions defined in guideline rules must therefore interact dynamically with 
data registered in clinical records to trigger new activities addressed to specific roles. To that 
end, all entities that have impact on the clinical practice must be accessible to give a context 
to those rules, so the use of medical ontologies should be considered at this point. In this 
regard, the use of GDL language is recommended, as it leverages the knowledge base 
provided by multi-level modelling standards, to determine the context for the rules. In 
addition to the conditions defined in guideline rules, the workflow engine implements its own 
conditions to determine the next healthcare activity to be addressed. Provided an event 
listener detecting all guideline rules fired within the clinical process, the workflow model must 
define the process-level rules, which depending on the events triggered by the 
aforementioned guideline rules would determine the clinical pathway for each patient. 
In this way, the workflow engine will assess the set of queued events resulting from healthcare 
scenarios in which diverse guideline rules coexist and interact with each other. Thus, the 
conditions established at the process-level will resolve, for example, priority between 
conflicting rules, coordination of activities running in parallel, or placing time restrictions 
before specific events are launched. 
− Activities: Traditionally, guideline rules were aimed at producing reminders, alerts, and 
recommendations to guide clinicians to determine the clinical best practice when facing 
specific clinical circumstances. Nevertheless, these rules can be also integrated into 
organizational processes that combine complex activities such as the management of flexible 
clinical workflows. 
In that respect, since guideline rules trigger single actions, the workflow engine must 
coordinate all events fired by the rule engine to determine the transition to the coming 
healthcare activity to be addressed in the clinical process. Thus, at this stage of the 
proceeding, the workflow model must specify the healthcare activities to be addressed, and 
the roles allocated to carry them out when the conditions specified in the previous step are 
fulfilled. 
− Context: Any implementation of clinical guidelines in practical scenarios must be adapted to 
specific context parameters. Thus, considering context information regarding patients, clinical 
staff, resources, and location, in addition to the information strictly related to the clinical 
process would improve the management of priorities among guideline rules within complex 
workflows. In this way, when various care procedures are valid for a patient, the context will 
determine the optimum pathway for the patient depending on the characteristics of service 
available in each time. For example, a workflow including different healthcare facilities with 
different characteristics must exploit the capabilities of the personnel and the equipment 
available in each one of them to address a specific healthcare activity from the clinical 
process. 
− Roles: In this sense, considering that the service proposed is aimed at supporting clinical 
decisions, clinicians will have the last say about the decisions affecting patients. Thus, 
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different permissions must be defined within the workflow model, according to the roles 
associated to each clinical activity and decision involved in the clinical process. 
Consequently, the workflow would be distributed among personnel with specific capabilities 
and skills toward best clinical practice. 
Modelling UI forms (step C.5) 
The design of UI forms will normalize how the information modelled within archetypes and templates 
is displayed to clinicians. Nevertheless, UI forms are in the early stages of development; hence, their 
implementations are still prototypes. Thus, this concept has to be discussed extensively before arriving 
at a de facto standard.  
Thus, considering that UI form specifications may vary depending on the implementation, five generic 
steps were identified to model any UI upon a content model based on archetypes: 
− Concept mapping: Every data field to be displayed within the UI form must be connected to 
the corresponding data elements defined inside archetypes or templates. Thus, the UI 
definition would be built upon a list of paths pointing the concepts defined on the content 
model (archetypes and templates). In this way, on the one hand the form could automatically 
inherit properties and constraints necessary to validate each data element according to the 
specifications set out on the content model. And, on the other hand, the data submitted 
through the UI form will be automatically allocated to the corresponding data elements, thus 
generating a valid contribution of a medical record. 
− Design of the form layout: Next, the whole display area must be divided in zones that would 
be used to distribute the data elements referenced in the UI definition along the screen. This 
would enable clinicians to shape the UI form according to their specific needs. 
− Description of UI views: specialisations applied to elements from the UI form would be 
specified along this step. For example, languages supported, form style settings (text 
alignment, font, size, colour, etc.), or support elements such as explanatory text labels, titles, 
etc. 
− Allocation of UI controllers according to data types: The way the information is displayed and 
handled on the screen is defined by the UI controllers. Thus, depending on the output 
technology chosen, a different set of controllers would be available to generate the UI views 
for the front-end application. So, each data element, including any connection to external 
terminology services if available, must be mapped with a specific UI controller according to 
the data type they contain, i.e., a number, a date, or plain text must be handled differently 
within the form. In this way, a specific data-type would generate a known piece of 
programming code, which, in turn, would be compiled as a data field in the screen of the 
visualization device. 
− Definition of output views: At least, three different views must be created for each UI form 
defined. These would correspond to the basic transactions of medical records: creation, 
visualization, and update of clinical information.  
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3.2 ARCHITECTURE PROPOSAL FOR IMPLEMENTING A MODEL-DRIVEN E-HEALTH PLATFORM 
In this section a health computing architecture is proposed, for setting up the e-health environment 
necessary to manage the electronic models resulting from the methodology depicted in section 3.1. 
Such architecture coordinates distributed but interoperable information systems toward an efficient 
management of patient-centred clinical processes. To that end, all information systems involved in the 
management of a specific clinical process are coordinated through an Enterprise Service Bus (ESB) 
built on a Service-Oriented Architecture (SOA) approach.  
It should be noted that the structure of this computing platform is seamless for end-users; the requests 
to specific services are tunnelled through a centralized gateway by the underlying infrastructure of the 
ESB. Indeed, the major part of the implementation – repositories of information, business logic and 
definition of services – takes place at the back-end of the platform. And meanwhile, end-users 
perceive the services offered by the ESB through a set of interfaces implemented at the front-end. 
These front-end applications are lightweight and flexible compared to the design of the back-end. In 
fact, front-end applications rely on services offered by the back-end, so their functionalities can be 
customized depending on the interfaces they implement to the ESB. Thus, the complexity of the front-
end would be determined by the functionalities provided upon the services called through the ESB. 
Likewise, end-users would use diverse electronic workstations to get access to the services from the 
ESB. In other words, the same front-end can be built indiscriminately as web, desktop or mobile 
application, but nevertheless interoperability with the ESB must be guaranteed regardless the 
technology used. For that reason, communication between the ESB and every front-end must be 
designed in compliance with standardized web service protocols, e.g., SOAP, JavaScript Object 
Notation (JSON) or Representational State Transfer (REST) compliant web services (see Figure 10). 
With consideration of all the above, front-end applications are expected to arise to cover the specific 
requirements of each healthcare scenario. 
At the back-end, this architecture implements communication interfaces to aggregate vendor-
independent information systems to the platform. Then, the ESB implements services that correspond 
to the functionalities provided by every information system connected to the platform. In this way, the 
service requests initiated at front-end applications are redirected seamlessly to the corresponding 
system that offers the requested service. Likewise, all operation concerning connectivity, data 
transformation and routing for these services is managed through the ESB.  
Different modules have been made available for managing the access to the services in the ESB. Each 
of these are responsible for providing a specific range of functionalities to the platform according to 
the types of information systems they connect. Given that the scope of some services is transversal to a 
single information system, these modules can also coordinate the capabilities of multiple systems into 
complex services. Each of these modules specifies a set of standards that the information systems must 
comply with before connecting to the ESB. In this way, the information systems would be 
interchangeable with other systems that implement equivalent services whenever they adhere to the 
conformance points of the module. With regard to the architecture proposed, the modules identified 
in Figure 10, are further described along this section.  
- 52 - 
 
 
Figure 10: Distributed architecture for the services comprised in the health computing platform proposed.
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3.2.1 THE ENTERPRISE SERVICE BUS (ESB)  
The ESB is an integration platform that enables aggregation of heterogeneous information systems, to 
provide standard interfaces to the services they offer. It must provide a gateway between those services 
and any front-end applications too. Considering the requirements of the health computing platform 
proposed, and reviewing similar design patterns in section 2.4, the functionalities described below 
were considered for the ESB (see Figure 10): 
− Connectivity: It must provide connectivity between the ESB and the different endpoints. Thus, 
it must support a variety of communication protocols. 
− Data transformation: It must harmonize all data resulting from different communication 
standards, to allow interoperability between the information systems connected to the ESB. 
This transformation of data and protocols would enable a seamless integration of the 
information systems involved in a service. Thus, the service consumers would access to all 
information they need through interfaces compliant to pervasive web service protocols 
(SOAP, JSON, REST-compliant web services, etc.). Meanwhile, the ESB would deal with the 
middleware necessary, for example, to connect not-standardized interfaces, legacy systems, 
or proprietary solutions to the platform. 
− Service routing: For each service request, the ESB must provide interfaces toward the 
appropriate system which provides that service. Nevertheless, the functionalities available in 
the back-end are hidden to users, so that users are not allowed to call the services directly to 
the source repositories. The ESB provides a normalized showcase of interfaces to those 
services instead. In this way, different versions of the same service can coexist, seamlessly to 
the service consumer. Indeed, when more than one service is available to fulfil a service 
request, the ESB can apply a content based routing to provide the service most suitable for 
the requesting user. 
− Service orchestration: It must be able to coordinate elementary services of various information 
systems and provide composite services to the users.  
− Security: Although the information systems may implement their own security, all services are 
centralized at ESB, so it is appropriate to apply an additional security layer at this point 
(encryption, data validation, antivirus, etc.). Unique authentication and authorization services 
including Single Sign-on such as OpenID Connect should be implemented to get access to 
any service provided by the ESB. In that respect, an authorization server could deliver fine-
grained permissions to access specific resources from systems integrated in the ESB. To that 
end, a Role-Based Access Control services could be used to manage the access permissions 
according to the user's credentials and the scope of the service requested. For instance, an 
authorization framework such as OAuth2 would facilitate identity validation, and hence 
define the permissions issued to the end-users of the platform [158]. 
− System monitoring: It would provide functionalities associated to the overall usage of the 
platform. For example, the workload on specific systems, the use of specific services, or the 
status of information systems can be useful for determine the further steps to be taken on next 
developments. In addition, the authentication logs can be used to determine audits-trails 
based on the access of specific users to each service. 
3.2.2 MULTI-LEVEL MODEL-DRIVEN EHR SYSTEM’S MODULE 
This module is the cornerstone of the health computing platform architecture proposed, as it manages 
the clinical information resulting from the healthcare episodes registered for each patient. It 
distinguishes internal components which contribute together to a faithful registry of the clinical and 
administrative information registered on the system. As the EHR centralizes all healthcare events 
regarding the care history of patients, it provides further communication interfaces to feed the services 
from the rest of modules. Specifically, the EHR system‟s module integrates a demographic information 
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system, a CDR, an EHR indexing system, a CKB, a terminology integration system and a query system 
for data mining within a showcase of coordinated services in common (Figure 11). With regard to the 
resulting diverse knowledge artefacts – archetypes, templates, terminology subsets and queries–, they 
are handled by separated and standalone systems, and thus their use is combined solely at runtime 
[159].  
Moreover, the architecture proposed enables managing data from distributed information repositories 
into a loosely centralized platform. Thus, although registered in different sources of information, the 
complete healthcare information of a patient will be accessible ubiquitously as a unique EHR. In this 
way, if innovative information systems are connected to the platform, they will coexist with older 
technologies, and hence their information will be appended to the existing EHR records.  
In this sense, as this architecture encloses many vendor-neutral systems, each one must provide 
normalized interfaces to enable interoperability when information is exchanged among them with the 
aim of coordinating the logic concerning the implementation of final services. The diverse information 
systems involved in that architecture, the services they provide, and their connections are detailed in 
Figure 11. 
Demographic information system  
It provides unambiguous identification of patients handled by any service connected to the ESB. To 
that end, the demographic service can be implemented either as standalone system, or a “wrapper” 
service for existing systems such as a PMI or clinical repositories with demographic information 
embedded. Considering healthcare environments in which distributed systems contain demographic 
data scattered around different organizations, the demographic information system must be capable 
to update and merge consistently all that information requested on the fly. In this regard, requests to 
other demographic services are handled by the Patient Identifier Cross-reference (PIX) and Patient 
Demographics Query (PDQ) profiles provided by the organization Integrating the Healthcare 
Enterprise (IHE). The former is used to ensure that all systems employing demographic resources will 
associate the personal health data they handle with the right patient. However, when the use of a 
patient identity cross-reference manager may not be required or appropriate, the PDQ profile is likely 
to be most appropriate. This one lets applications to query by patient demographics against 
demographic information systems, obtaining a list where those patients that match the specifications 
of the request are identified [160]. Finally, the information gathered is offered through a demographic 
information model compliant to the openEHR standard, since the flexibility and complexity of 
structures it covers make it possible to manage the information of other demographic solutions such 
as EN/ISO 13606 demographic model [161, 162].  
This setting up enables the rest of the systems to access demographic data as a service integrated in 
the ESB (Figure 11). Thus, patients‟ data privacy is managed individually according to the access 
permissions established for each user. Moreover, the synchronization of demographic information will 
reduce problems resulting from wrong identification of patients, duplicated patient files, and outdated 
or incorrectly registered data. 
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Figure 11: SOA proposed for the multi-level model-driven EHR system’s module. 
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Clinical Data Repository (CDR) 
The patients' clinical data can be scattered in distributed clinical information systems built in 
compliance with different standards. In addition, the clinicians would use different EMR systems as 
front-end which use web services to dispatch the clinical information registered during their clinical 
practice to the ESB.  
Therefore, the EHR architecture includes a primary clinical data repository to centrally manage the 
overall information of the healthcare service, and it also enables the exchange of “EHR extracts” 
among other repositories of clinical data compliant to different standards. Furthermore, the central 
CDR will be the repository in which the medical records are continuously updated according to the 
information periodically dispatched by every EMR station involved within the healthcare service (Figure 
11).   
Considering those requirements, the information model chosen for the EHR implementation is based 
on the openEHR standard. Although, this standard implements "EHR extracts" to exchange medical 
records with EHR systems built in compliance with the same standard, it also provides an integration 
module to harmonize, – by using “integration archetypes” – the information modelled in compliance 
with reference models built on other standards such as EN/ISO 13606, HL7 CDA, or HL7 FHIR [163, 
164]. 
Clinical Knowledge Base (CKB) 
As it has already been explained in the introduction, the EHR system architecture provided registers 
medical records using standards based on two-level modelling (also known as multi-level modelling). 
In that regard, the CKB is a standalone system responsible for the management of the knowledge 
artefacts corresponding to the AM, in compliance with the requirements of the two-level modelling 
approach. This system would be dedicated to host the archetypes and templates that specify the 
clinical concepts to be registered into the CDR.  
The CKB system would implement the Archetype Object Model (AOM) to transform the knowledge 
artefacts into computer-processable objects. And, in turn, those objects would be used by the final 
services accessible through the ESB to structure the information registered into the CDR.  
To that end, archetype and template services have been made available to include new knowledge 
artefacts into the CKB or to modify the existing ones in accordance with the latest clinical procedures 
for best practice care. 
EHR indexing system 
While access to the services from the primary CDR is direct, in some cases, when several healthcare 
facilities participate in the same clinical process, the management of medical records can get 
complicated. Therefore, given a distributed environment where medical records from a given patient 
may be located in multiple information systems, the corresponding EHRs must converge into a unique 
“virtual EHR”. Hence, the EHR indexing system will mediate the synchronization of those distributed 
information systems so as to return up-to-date medical records relating to a specific clinical study. In 
other words, whenever clinical information is distributed among several CDR or demographic 
information systems, the indexing system will provide the services inherent in a virtual EHR. 
Consequently, the requests for clinical information addressed to the overall EHR architecture would be 
automatically redirected to the corresponding information systems. And likewise, for each of those 
requests, all responses sent back from different information systems would be checked jointly into the 
virtual EHR, thereby providing comprehensive and consistent results [164].  
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Terminology integration system  
The purpose of terminology services is to provide for computerized systems an unambiguous 
identification strategy for semantically equivalent concepts when information is exchanged among 
different information systems. Indeed, the classification of the concepts according to normalized 
semantics increases the processing capabilities toward interoperability and harnessing of information 
registered in the EHR. 
To that end, standardized medical terminologies provide codes, classifications, terminologies and 
nomenclatures to be used by concepts defined in the EHR [122]. Furthermore, archetypes, templates 
and computerized guideline rules, can include correspondences to resources from terminology 
services within their definitions of clinical knowledge. 
Considering that the standardized terminology services are provided externally to the ESB, the 
architecture proposed must include an integration system dedicated to manage all terminology-
related services used by the EHR. Therefore, it would manage the terminology artefacts defined 
locally, but it also would provide a centralized access to all resources available remotely in standard 
medical terminologies. 
In this sense, the AM provide two approaches to handle terminologies: “term bindings” and 
“constraint bindings”. The former, formalizes direct correspondences to concepts or terms from 
standard medical terminologies and ontologies for the data elements defined within archetypes, 
templates, or computerized guideline rules. Thus, the terminology integration system must provide a 
query service to different standardized terminology providers. The latter, defines “terminology subsets” 
or “ref sets” modelled on the basis of standard terminologies to constraint the occurrences of entire 
archetype branches. Therefore, pervasive archetypes can be specialised to healthcare scenarios 
applicable in multiple clinical domains by the attachment of different terminology subsets. As those 
subsets are locally modelled to fulfill the requirements of clinicians within a specific clinical procedure, 
the reusability of archetypes increases accordingly [159].  
To that end, the integration system must include a standalone repository for terminology subsets and 
locally agreed terminology artefacts defined for the healthcare scenarios covered by the EHR system. 
In addition, this repository would be connected to the query service which populates the elements in 
the archetypes with the information retrieved from standard medical terminologies and ontologies 
such as LOINC, SNOMED-CT, or ICD-x (see section 2.2.1). Likewise, custom terminologies, subsets 
and mapsets (mappings between different terminologies) would be defined to adapt the standardized 
medical terminologies and ontologies to localized healthcare environments (Figure 11). 
Archetype query system 
The archetypes were originally devised to formally define the content of medical records registered 
using the multi-level model-driven architecture of the EHR system proposed. Nonetheless, they can 
likewise be applied in the opposite direction, i.e. to build the data queries used to retrieve structured 
information from the EHR. These queries modelled upon archetypes, would be equally applicable to 
all EHR systems using the same CKB to register the medical records, regardless of whether the clinical 
information is scattered along distributed CDRs.  
Accordingly, the model-driven EHR architecture requires a dedicated system to manage the query and 
data mining services for every information systems connected to the health computing platform. In this 
way, it would be possible to make use of the massive data also known as “big data” available in 
distributed CDR-s. To that end, the system proposed must include an archetype query engine, 
specialized in processing data queries built in compliance with multi-level modelling standards, e.g. 
the Archetype Query Language in the case of openEHR.  
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As introduced above, the information in the EHR was registered in accordance with the tree-structure 
defined by the archetypes. Thus, the syntax of queries would rely on the use of “archetype paths”. 
Therefore, first, the archetype query system would list the set of paths for each archetype (known as 
“path maps”) contained in the clinical knowledge repository, and it would apply terminology services 
to them, so as to present an archetype query builder in a human readable format. In this way, 
clinicians would design complex queries without need of programming skills, since archetype paths 
are connected to the meaning of the concepts they refer to. Therefore, archetype query building would 
consist in identifying specific concepts within archetypes and choosing the appropriate filters to narrow 
the search. 
Not all queries merit being treated as designed entities, in which case they can be directly executed on 
the archetype query engine. However, many queries will be reused, particularly those designed for use 
in research studies and also decision support systems. Thus, the archetype query system incorporates a 
repository connected to the archetype query engine, engaged to host the most commonly used 
queries, ready to be launched whenever necessary.  
In which case, the query engine analyzes all links provided by the health information indexing service 
that refer to the medical records in the CDR, and filters the results according to the search parameters 
specified in the query. Those links are retrieved at runtime, so the archetype query engine would 
retrieve real-time updated results each time the query is processed (Figure 11). 
3.2.3 UI GENERATION MODULE 
Even the minor changes on the content model from the EHR will be reflected in the UI views of front-
end applications. Thus, the continuous evolution of knowledge on the clinical domain will entail 
regular maintenance for those applications. 
Furthermore, the design of diverse forms of front-end applications is expected to make the most of the 
information registered into EHR systems compliant to multi-level modelling standards. That will 
constitute a healthcare environment comprised of autonomous applications, built on diverse 
technologies and software platforms, whereby each one implements specific functionalities. Thus, 
considering that the UI views must fit the day-to-day work of each user, the maintenance of those 
applications will become a challenge unless automation is established to generate the UI views [10]. 
Nevertheless, a fully automatic UI view generation based solely on the representation of content 
model does not reach the usability required by end-users. Thus, custom requirements from end-users 
must be included somehow in the computerized generation of UI views. 
In this regard, the module illustrated in Figure 12 proposes a model-driven information system to 
computerize the generation of the programming code necessary to establish the presentation layer 
into front-end applications. This module implements a service that delivers UI views for different front-
end applications in conformance with a set of specifications defined within each UI request addressed 
to such service. Likewise, the aforementioned specifications can be formalized into UI forms. Such 
forms specify the arrangement of the elements contained into a specific UI view. Furthermore, there is 
no need of programming skills to build those forms, since the UI generation engine generates the 
code automatically from the specifications of the end-users. So, end-users supported with proper 
software tools should be able to model the UI from front-end applications according to their specific 
requirements. 
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Figure 12: Detail of UI view generation system dependencies. 
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UI form repository 
Once defined, UI forms will be accessible from a dedicated repository, to be reused whenever 
necessary. Therefore, UI requests will refer to specific UI forms available in the repository, to avoid 
having to redesign the UI specifications each time. 
In this way, the UI generation engine will parse the UI forms instantiated in each request and it will 
process the UI definitions they contain. Normalized UI views are then automatically generated to cover 
the operations of creation, visualization, and edition of medical records. The UI form definitions, in 
turn, will instantiate the archetypes and templates that constitute the content model to be displayed on 
screen. In this way, the UI generation engine also features an archetype and template manager to 
integrate AOM objects into the UI views. 
Once all the elements to be displayed on the screen have been identified, the UI generation engine 
will build the programming code to be integrated into the application that initiated the request. 
However, such application has to be capable to interpret correctly the code provided by this service so 
as to generate the respective UI view. To that end, a mapping service will transcribe the UI 
specifications into the corresponding classes and controllers provided by a UI markup language 
compatible with the application receiving the UI code. In this way, whenever the UI generation engine 
processes a specific UI form, equivalent UI views are produced regardless the front-end application 
used, since the resulting code will be adapted depending on the output technology set as target. 
Finally, the UI delivery service uses web service protocols to send the resulting code addressed to the 
application where such UI views will be deployed (Figure 12). 
3.2.4 COMPUTERIZED MEDICAL GUIDELINE MANAGEMENT MODULE 
The systems of this module are responsible for processing the information registered during clinical 
practice to provide the clinicians with the necessary tools to make decisions based on the information 
registered on the EHR. So, first of all, computerized medical guideline management systems must 
implement interfaces to query and retrieve data as it is recorded in the EHR. To that end, the 
aforementioned systems must implement a service continuously listening to the events in the services 
of the EHR concerning clinical data exchange and commit. 
Therefore, whenever a front-end application uses the commit service to submit new contributions to 
the EHR, a guideline rule inference engine would analyze the incoming EHR extracts and process them 
proactively according to the guideline rules contained in the rule repository. Those rules will determine 
a set of conditions which instantiate elements described in specific archetypes or templates. Moreover, 
the elements contained within those archetypes could use terminology services to provide semantics to 
their possible occurrences. So, unlike unstructured medical records, the information retrieved through 
archetypes would be unambiguously analyzed by the rule engine. 
Whenever one of those rules is executed, different events are triggered depending on whether the 
conditions specified within rules are fulfilled or not in the instances analyzed. In this way, the events 
determined by guideline rules will be applied dynamically in accordance with best clinical practices, 
whatever the healthcare scenario found.  
At this point, some of those rules may require additional information from the EHR to access all 
instantiated elements. In such case, the computerized guideline rule engine would leverage the query 
services provided by the EHR to obtain retrospective information. 
In summary, the computerized guideline rule engine will be the core for any computerized medical 
guideline system, but different services are provided depending on the use given to the rules when 
triggered. In this regard, according to the architecture proposed in this PhD dissertation, two main 
groups of systems were differentiated: CDS system and Workflow Management System (WfMS). 
Although the Computerized Physician Order Entry (CPOE) management system acts as a standalone 
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management system and belongs to the “complementary information systems‟ module”, occasionally 
it will be used to coordinate the CDS and WfMS. Especially when the workflow being processed 
depends on actions occurring on complementary information systems (Figure 13). 
Clinical decision support system (CDS) 
Digitalization of clinical practice provided a huge amount of heterogeneous data to be evaluated by 
each clinician. The more context data are handled, the more accurate diagnoses should result from 
clinical practice. However, rather than improve diagnosis, clinicians are more prone to committing 
errors due to the difficulty to consider every clinical guideline applicable to such a complex context. 
In that respect, CDS services define computerized guideline rules based on medical evidence or by 
consensus from domain experts and provide notification services to support clinicians toward best 
healthcare practices. Each CDS service implemented would entail a specific set of rules managed by 
the computerized guideline rule engine.  
Thus, whenever any of those rules is triggered, the CDS services referenced to that rule will activate 
the corresponding events within that service. Then, the CDS services process the information 
contained in those rules and notifies clinicians about the best care procedure in the form of reminders, 
alerts, and recommendations (Figure 13). For example, a CDS service could be designed to alert 
about possible incompatibilities among medications during the treatment of a patient. To that end, 
computerized guideline rules identifying the medication actions carried out throughout the study would 
be checked and then verified against a table of incompatible compounds. Then, before every new 
prescription of medicament, the CDS service would warn clinicians about incompatibilities due to 
previous dispenses. 
Workflow Management System (WfMS) 
Unlike CDS services which implement stateless decisions, the WfMS must determine dynamically the 
pathway for each patient enrolled in a clinical process depending on the context of care at a given 
time.  
To that end, the guideline rule inference engine is used to execute the rules concerning management 
of decision points of the clinical process. Nevertheless, most rules processed by this engine belong to 
CDS services, and those that correspond to the workflow management services are decisive only as 
long as patients are situated in specific decision points of the clinical process.  
For this reason, additional components are required to handle the appropriate guideline rules at any 
given time. In this regard, a process engine will transcribe the workflow models into decision points, 
roles, activities, and rules toward a patient-centred care plan. Then, a process event listener would 
detect any event in the computerized guideline rule engine, whenever it concerns the workflow of 
clinical processes being executed on the process engine. This listener will supply the information 
required to move forward on decision points, so it would manage priorities among rules and 
execution order for conflicting events accordingly (see Figure 13).  
Bearing the above in mind, a patient choreographer service would manage the instances 
corresponding to a specific patient enrolled in the clinical process. In this way, the workflow model 
deployed by the process engine is applied to single patients.  
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Figure 13: Architecture and dependencies among information systems toward the implementation of CDS and workflow services.
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3.2.5 COMPLEMENTARY INFORMATION SYSTEM’S MODULE 
As the EHR is a longitudinal electronic record of patients‟ health information [21], every information 
system that can contribute with significant information about patients' healthcare must be included in 
the SOA approach proposed.  
The information systems described along this section comprise medical image management, RPM, 
clinical laboratory automation and pharmacy administration. Anyway, other systems can be 
incorporated as well to the architecture, as long they provide interfaces compliant to the standards 
implemented within the ESB. These systems work independently from the EHR, and each of them deals 
with very specific requirements which cannot be covered by a unique information system (Figure 14). 
For instance, the medical image management system requires large volumes of storage and high 
bandwidth to send the imaging studies through network, whereas the laboratory automation system 
will require less volume of data on the network, but greater number of simultaneous transactions. 
Given that each of these information systems has been optimized to govern clinical information in very 
specific areas, only clinically significant information would be transferred to the EHR. Nonetheless, 
ubiquitous access to all data records must be guaranteed for the cases in which the medical records 
in the EHR are not conclusive, and hence an in-depth analysis is needed. Thus, the architecture 
proposed must implement interfaces to access the information registered on every complementary 
information system connected to the ESB. With the aim of getting a standard-oriented solution to 
implement the communication scenarios mentioned above, the services offered by the information 
systems connected to the ESB must include messaging interfaces compliant to pervasive 
communication protocols in healthcare (TCP, MLLP, HTTP, and SOAP) for the exchange of messages 
structured in compliance with different normalized syntaxes such as ER7, XML, JSON, HL7 CDA. 
Once each information system connected to the platform uses normalized communication profiles, the 
ESB must administer the corresponding profiles to enable data exchange with each of the 
complementary information systems integrated into the framework. Considering the wide choice of 
standards available to achieve coordination among the diverse information systems involved in the 
healthcare environment, the IHE integration profiles were considered. As IHE promotes the 
coordinated use of established standards, the profiles it provides offer a clear implementation path 
toward a truly efficient interoperability for specific clinical scenarios that involve diverse information 
systems [165]. In this regard, the CPOE management system has been conceived to coordinate the 
different information systems toward the same care plan (see Figure 14). 
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Figure 14: Message exchange required for aggregation of complementary tests to the EHR architecture.
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Computerized Physician Order Entry (CPOE) management system  
The CPOE management systems provide messaging services aimed at handling the overall lifecycle of 
computerized orders/instructions defined by clinicians to request any service external to the EHR. 
Traditionally, the notification of physicians' orders is conducted using referral notes in paper, whereas 
the system described along this section provides equivalent services but using pervasive standards on 
ICTs in healthcare to that end. Therefore, the electronic message exchange from the time a physician 
submits a computerized order, until all activities specified by such order are completed according to 
the standard Instruction State Machine (ISM) will be administered within this module. 
Considering that all communication in the CPOE management system is initiated by electronic referral 
notes, instruction-type archetypes will be used to originate the CPOE messages addressed to remote 
information systems. Accordingly, computerized guideline rules with instances to those archetypes 
must be specified into the CDS system. In this way, those rules will be triggered by the guideline rule 
inference engine whenever a clinician defines a new referral note built on the aforementioned 
instruction-type archetypes.  
For its part, the CPOE management system implements an event listener which focuses on identifying 
those events triggered only by rules associated with referral notes. Thus, every new CPOE request 
recorded into the EHR is processed by this system, which consequently instructs the CPOE manager to 
initiate the computerized orders specified in the referral note. 
As a result, the CPOE manager generates the corresponding messages addressed to remote 
information systems based on the instructions specified in the archetype that activated the rule. To that 
end, the specifications inside a computerized order will be accessed by using the same archetype that 
triggered the CPOE instruction to query the EHR. Consequently, the CPOE manager is responsible for 
classifying the incoming orders depending on the services requested, and then generate the messages 
specifying the activities to be undertaken (see Figure 13). 
Accordingly, the CPOE management system must implement diverse communication profiles 
depending on the specific services that clinicians could require from remote information systems. In 
addition, in the event that a number of complementary information systems must work together, the 
workload of those systems will also be coordinated through the diverse communication profiles 
implemented at the CPOE management system. In these terms, the CPOE communication services will 
be used to deliver the resulting messages to the target information system in compliance with the IHE 
profiles it corresponds for each integration scenario. For instance, the imaging related archetype 
“openEHR-EHR-INSTRUCTION.request-imaging_exam.v1” from the openEHR's CKM [113], would 
generate a HL7 ORM/OMI message requesting imaging study to the RIS in compliance with the 
radiology profiles provided by IHE [166] (see Figure 14). 
The CPOE management system also must handle any result or progression upon the activities 
requested, reported by the remote information systems receiving the CPOE instructions. Specific 
action-type archetypes are used at this point to transcribe the incoming messages into the EHR system. 
Although the management of some clinical reports is traditionally allocated to specific information 
systems, the EHR must be ready also to receive reports built in compliance with different reference 
models. Thus, to maintain the autonomy among information systems, the integration service of the 
EHR is used to distinguish different types of reports received in the service. Then, the information 
contained inside those reports is mapped according to the archetype model formalized in the EHR 
(Figure 14). 
At this point, it should be noted that the CPOE management system must handle in parallel the 
communication profiles involved to complete every activity planned within a specific computerized 
order. Thus, considering that completing those activities will extend in time, the CPOE manager will 
put them in queue as long as the requesting order is still active. In this way, the notification delivery 
- 66 - 
 
addressed to remote information systems will be administered according to the progress and priority 
of queued activities. 
In that respect, the CPOE management system uses a standard ISM which defines normalized states 
and transitions for each one of those activities specified in the instruction. Given that a single 
computerized order produces several activities which can be undertaken in parallel, an aggregate 
state determined as a combination of the states reported by all those activities is used to manage the 
overall lifecycle of single instructions. Thus, according to all possible combination of activities, the 
state for instructions has been simplified into four steps (pre-active, active, inactive, terminated) [149]. 
Monitoring the states of activities related to active instructions or actions can also be used to 
determine the transitions among workflow stages and move forward through decision points defined 
within clinical processes. In fact, the same instruction and action-type archetypes analyzed by the 
CPOE manager can be included in clinical processes handled by the WfMS (Figure 13). 
Laboratory Information Management System (LIMS) 
Basically, the LIMS would implement the ordering, scheduling, processing, and result reporting 
activities proposed in the Laboratory Testing Workflow (LTW) integration profile provided by IHE [165]. 
According to this, the LIMS will receive CPOE requests in the form of HL7 ORM/OML messages 
dispatched from the EHR. Those messages would specify the orders to conduct specific laboratory 
studies. Based on the orders received, the LIMS must schedule the patients whose samples would be 
extracted for analysis. At this point, IHE PIX and PDQ profiles are used to retrieve demographic 
information to link unambiguously the extracted samples with the patient they belong.  
Then, the laboratory automation system would proceed with the analytics requested, and would send 
results obtained to the LIMS.  
Finally, clinically significant observations about the analytics registered into the LIMS would be sent 
back to the EHR using HL7 Unsolicited transmission of an Observation or Result (ORU) or Unsolicited 
Laboratory Observation (OUL) messages. 
Pharmacy information management system 
According to the pharmacy interoperability model defined in the Hospital Medication Workflow 
(HMW) from the IHE pharmacy profiles, all pharmaceutical prescriptions are notified to the pharmacy 
information system of the hospital using HL7 Pharmacy/Treatment Order (OMP) messages. Such 
information system is engaged to administer those prescriptions. To that end, all pharmaceutical 
advices (allergies, equivalent drugs, etc.) and medication dispense (stock, resupply, preparation, etc.) 
must be checked from pharmacy repositories before validating the new dispense [167]. 
When the prescription is confirmed and prepared for the corresponding patient, the information 
system would identify them unambiguously (using IHE PIX, PDQ profiles) and provide them 
personalized information about which medications have to receive in each case. 
Whenever a prescription of medication has been addressed, the pharmacy information system would 
send back HL7 Pharmacy/Treatment Dispense Messages (RDS) informing to the EHR system about 
details concerning the medication dispense carried out. 
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Remote Patient Monitoring (RPM) system  
The implementation of RPM services was determined according to interoperability design guidelines 
for personal health systems proposed by Continua Health Alliance [168]. According to those 
recommendations, the service monitoring a patient begins with an ORM order message sent from the 
EHR system. This would provide the parameters required to set up a monitoring scenario aimed at 
registering specific parameters concerning a patient for a period of time. 
A monitoring service can involve more than one personal health device, each one of which 
periodically registers heterogeneous diagnostic parameters about a patient. Thus, all data contributed 
by each one of those devices would be received, using specialisations of the ISO/IEEE 11073 
communication standard depending on the health device used, into a monitoring manager system. 
That manager in turn would transfer periodically any clinically significant signals and measurements 
from all health devices it handles, to a RPM server for data analysis. In this regard, IHE PCD-01 
transactions of the IHE Device to the Enterprise Communication (DEC) profile in the IHE patient care 
devices technical framework would be used to guarantee a reliable arrival of the information (Figure 
14). 
The monitoring server would register all data received from health devices, and then filter – either 
automatically or as a result of analysis of clinicians – the huge amount of data generated over time to 
recognize clinically significant patterns and findings. In that respect, demographic services would be 
checked (using IHE PIX and PDQ profiles), to identify unambiguously all contributions that correspond 
to the monitoring studies of a patient in particular. In this way, services aimed at data visualization 
would provide to clinicians a framework to analyse jointly all data comprised in specific studies. And 
thereby, the information considered relevant for diagnosis would be registered as reports along with 
corresponding observations of clinicians.  
Finally, according to the IHE Cross-enterprise Document Reliable interchange (XDR) profile, the RPM 
server would send back HL7 CDA compliant Personal Healthcare Monitoring Reports (PHMR) to the 
EHR system which initially requested the monitoring service [160, 168].  
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Medical image management system 
These systems provide a standard-based solution to manage clinical studies that involve medical 
imaging. In this regard, DICOM is the most extended standard for medical image management. 
Therefore, the communication among imaging systems is addressed in compliance with this standard. 
According to this, the architecture of medical image management distinguishes the three components 
below:  
− Imaging modalities: Any device that acquire diagnostic images in compliance with DICOM 
standard is categorized by an imaging modality. Those use DICOM Message Service 
Elements (DIMSE) built upon TCP communication protocol to exchange information with the 
PACS. According to those services, the imaging modalities are able to process worklists 
corresponding to the patients scheduled to conduct imaging studies in that device. In 
addition, once the studies described in the worklist have been acquired, the resulting images 
are sent to the corresponding PACS. 
− Picture Archiving and Communication System (PACS): Basically it is a server allocated to 
store, organize and share the imaging studies provided by all imaging modalities which 
administers. The PACS are moreover connected to the RIS, so they receive orders for 
scheduled imaging studies and demographic information retrieved from information systems 
distributed along the ESB. That information which is then distributed as worklists among the 
corresponding imaging modalities. On the other hand, PACS are also responsible of 
supplying the imaging studies displayed into the DICOM viewers used by the image-reporting 
workstations. The resulting reports, however are managed by the RIS. The PACS implements 
DIMSE upon TCP communication protocol, to coordinate the services it provides with regard 
to the aforementioned components contained in a DICOM network (RIS, DICOM viewer, 
image modalities).  
− Radiology Information System (RIS): It provides services regarding medical imaging studies to 
other information systems connected to the ESB. At this point, IHE SWF (Scheduled Workflow) 
profile can be used to define the communication from when imaging studies are requested to 
when the report is returned to the requestor. In this regard, the RIS is able to handle the 
requests for imaging studies coming from other information systems (HL7 ORM/OMI 
messages), and redirect them to the PACS as DICOM worklists [166]. Once those studies 
have been acquired using the imaging modalities, they are loaded from the PACS to be 
reviewed and reported according to the clinically significant findings observed on the images. 
Then, the reports resulting from the imaging studies are handled by the RIS, so they can be 
sent to the EHR as unsolicited observation messages in compliance with HL7 standard (HL7 
ORU).  
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Chapter 4: 
Contributions to clinical process modeling in ophthalmology  
This chapter gathers some modelling experiences carried out in the SNS-O in compliance 
with the guidelines presented in the last chapter. Specifically, three healthcare scenarios in 
the SNS-O were formalized into electronic models: a remote screening for DR, a high 
resolution consultation to monitor the treatment in AMD, and a follow-up service for patients 
diagnosed with CG. 
In light of the continuous evolution of the clinical knowledge, it is expected that future 
revisions will lead the aforementioned electronic models to evolve accordingly. For this 
reason, it should be noted that the knowledge artefacts mentioned along this Thesis were last 
verified in July 2016. 
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4.1 MODELLING A REMOTE SCREENING SERVICE FOR DR 
4.1.1 DEFINITION OF THE PROJECT 
Previous experiences have proved that specifically trained GPs can screen patients for DR using NMR 
[50, 169]. Specifically trained nurses and imaging technicians also can perform the diagnostic tests 
required in this healthcare process [170]. Whereas traditional consultation considers that the expert 
ophthalmologist is responsible for handling the entire process, this new framework distinguishes 
different active roles in the process of detecting DR [47]: 
− The “test acquisition” role involves the use of medical devices to obtain images and data of 
sufficient quality for diagnosis. Nurses or technicians can reliably perform this task. 
− The “DR screening” role includes observation of diagnostic tests to identify signs of DR and 
determine if the patient being examined has treatable DR. GPs can reliably perform this task. 
− The “medical care supervision” role is that in which retina specialists assume the ultimate 
responsibility in this process by interpreting the signs of DR to classify the disease and choose 
the appropriate treatment. Occasionally, they also supervise the work of other clinicians to 
verify correct functioning of the service. 
A primary consequence of this new assignment of different tasks to specialized personnel based on 
fundus photography is that it is more cost effective compared to traditional methods of DR assessment 
[55, 171-173]. 
However, the implementation of new healthcare proposals is hindered by the intense modelling efforts 
required to update the knowledge base, already registered into static and vendor-specific electronic 
health information systems [10]. This is due to several factors. First, there is an important 
interdisciplinary gap between clinicians and software developers when it comes to define the specific 
healthcare scenarios; and, second, the continuous evolution of medical knowledge. The consequent 
developmental costs resulting from this endless redesign become unaffordable for any healthcare 
service [10]. Further, specifically in ophthalmology, EHRs have special requirements regarding other 
clinical specialties that are not considered by traditional information systems [22]. 
In the light of the above, although this DR screening strategy was successfully implemented into the 
SNS-O [30, 35], the lack of normalization of the information inside the service makes it difficult to 
manage this service in the long term. This setting for the DR screening service is restricted to the 
specific healthcare scenario in the SNS-O to which it was designed for. Thus, any change upon the 
clinical procedure and extending this experience to new healthcare scenarios were not supported. 
Considering the effort invested in the design and coordination of the healthcare resources available, 
the need arises to formalize this screening service so as to make the clinical process independent to 
the setting of local implementations. The methodology proposed in the previous chapter of this Thesis 
was used to that end. Therefore, different healthcare organizations sharing the same model could 
coordinate the clinical activities focused on a specific patient, toward a care plan in common.  
With the aim of developing a model-driven e-health system for the SNS-O that can automatically 
manage the information generated during follow-up of retinopathy for diabetic patients, a study of the 
state of art was performed regarding this evidence-based medicine process. Experts in that clinical 
domain (ophthalmologists, GPs and nurses), as well as statisticians of the SNS-O, in collaboration 
with engineers of the UPNA specialized in ICTs participated in a multidisciplinary discussion 
committee. Once the roles within the work team were established, different knowledge sources were 
reviewed (literature, evidence based experience in SNS-O, healthcare standards/guidelines) to 
establish an up-to-date clinical process to handle a DR screening service [47, 57, 58]. 
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Before implementing that clinical process, the work team interconnected every device involved to 
share the information registered during medical practice, for which the essential tasks were organizing 
and standardizing the ICTs to be used during the service. 
4.1.2 DESIGN OF THE CLINICAL PROCESS 
B.1 Definition of the Clinical Process 
The process regarding DR screening was defined according to the different stages a patient goes 
through in the healthcare service. First, patients in a population at risk for DR are evaluated before 
they begin the follow-up. Then, if convenient, those patients are scheduled for periodic necessary 
diagnostic tests to detect existing DR, ensuring the quality of acquisitions for diagnostic purposes. GPs 
trained to detect symptoms of DR then remotely review images and information acquired during 
evaluations. Retina specialists reassess the cases positive for DR. Depending on disease severity, the 
specialists reach a therapeutic decision and schedule a clinical procedure accordingly. Finally, the 
corresponding treatment is administered depending on each patient‟s specific diagnosis (see Figure 
15).  
Once the work team identified those different stages, they were analyzed in detail: 
− STAGE 1 (Patient admission): A patient can be referred for follow-up of DR since diabetes 
was diagnosed by an endocrinologist or if there is suspicion of DR due to symptoms detected 
while evaluating another eye disease during an ophthalmologic consultation or a routine 
primary care examination. In that sense, the admission stage is used to gather relevant 
patient clinical information. That preliminary information will be useful during follow-up and 
to determine the convenience of including or not including the patient in the screening 
service. 
 
− STAGE 2 (Follow-up schedule): In the event that the DR screening is considered appropriate, 
the follow-up service can initiate. Therefore, the diagnostic tests to detect and classify the 
disease are scheduled. 
 
− STAGE 3 (Diagnostic tests): The diagnostic tests of SNS-O consist of NMR and the 
measurement of IOP. Most healthcare organizations recommend repeating these tests at 
least once annually for patients with diabetes even in those without signs of DR. This prevents 
clinicians from overlooking serious symptoms of disease progression during the intermediary 
period between revisions [57]. 
The development of digital and interoperable diagnostic devices implemented in the SNS-O 
provides ubiquitous access from remote workstations to the results of the diagnostic tests. So, 
the results of these tests can be evaluated remotely [174]. This allows nurses or imaging 
technicians (referred to as “imagers”) to use those devices to perform diagnostic tests, 
whereas traditionally the presence of ophthalmologists was required during consultations 
[175]. At this point, the imagers must guarantee the quality of the acquisitions, so that the 
ophthalmologists can make reliable evaluations of those acquisitions. 
The measurement of corrected IOP involves tonometry and pachymetry. However, the results 
of those tests include a single IOP value, and registering this measurement is sufficient for 
later diagnostic purposes. Initially, the IOP measurement was not a component in the 
screening procedure for DR, but it later was included due to the epidemiologic interest in 
identifying early symptoms of other ophthalmic diseases associated with diabetes. In fact, 
measuring the IOP identifies patients with dangerous IOP levels (≥22 mmHg), the point at 
which patients must be referred directly to the corresponding ophthalmologist, even if other 
tests do not show evidence of disease. 
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Figure 15: Activity diagram showing the workflow DR screening service in the SNS-O.
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However, validation of the funduscopic photographs is more complex since imagers must 
review the quality of each acquisition at the capture stage before referring them for 
assessment. The procedure chosen for that purpose involves classifying fundus images 
according to the overall photographic quality using a scale based on objective findings [172, 
176, 177]. Different proposals have been reported when choosing a scale to measure 
quality; we used a scale ranging from 1–5, in which 1 indicates the worst and 5 indicates the 
best as Lamirel et al. proposed in the FOTO-ED study [176]. For diagnostic purposes, 
images of level 3 or lower that can confuse imagers are discarded. With unreadable images 
(≤2), the patient is referred immediately for a face-to-face ophthalmic consultation. 
When images of the ocular fundus are obtained, the numbers of retinal fields photographed 
vary depending on the purpose of the study. Considering the seven fields defined by the 
ETDRS [56, 58], Vujosevic et al. suggested [178] that a central 45-degree color image is 
sufficient to determine the absence or presence of DR and DME; however, a minimum of 
three fields is needed to classify the disease according to the international classification of DR 
proposed by the AAO [45, 46]. Nevertheless, according to clinical criteria, within the specific 
scenario of the SNS-O, two fields were considered adequate to manage the DR screening: 
one focused on the papilla and one focused on the macula. 
During acquisition, some artefacts can appear due to small pupils, cataracts, or other 
complications resulting from the capture. Therefore, acquisition is repeated when the image 
is inadequate for diagnostic purposes. To avoid extending this procedure unnecessarily, the 
test is limited to three attempts unless a technical issue is identified. From the fourth attempt 
on, the probability of obtaining a high-quality photograph is 20% at most [176]. 
In patients with a small pupil, the imager can request a mydriatic agent to obtain suitable 
retinal images; an ophthalmologist must supervise the drug instillation to reduce the risk of 
angle-closure glaucoma. For this reason, these patients must be referred directly for a face-
to-face ophthalmic consultation. 
Once the necessary images for DR assessment are acquired and validated (quality level 4 or 
5), they are sent to a PACS accessible to image reviewers. These acquisitions are labelled 
with the same study identification number, making it possible for a reviewer to retrieve every 
image corresponding to that specific diagnostic study. 
 
− STAGE 4 (DR screening): Image studies suitable for diagnosis are loaded from the PACS to 
remote workstations where image reviewers search for symptoms of DR.  
Retinopathy can be classified with different levels of precision, although for screening 
purposes it is sufficient to classify patients into two categories: those presenting signs of DR 
and those without signs of DR, to wit, ETDRS severity level ≤20 (seen in section 2.1.1) [47, 
56]. There is a third option in case of uncertain images: the patient is referred to a specialist 
for review. To support this classification, it is recommended that the findings identified during 
the examination of the posterior chamber and the criteria chosen to reach a diagnostic 
decision be described. Given that most patients with diabetes do not present with symptoms 
of DR, this screening will markedly reduce the workload of ophthalmologists, since only 
retinopathies and uncertain studies need more specific assessment [31]. 
 
− STAGE 5 (DR assessment): The images in this stage must show signs of DR except for: false 
positives generated during screening, images that created uncertainty for GPs, or diagnostic 
test acquisitions without sufficient quality for remote screening [31]. 
Thus, ophthalmologists must assess the diagnostic tests available and, where necessary, 
schedule an office assessment to thoroughly study each case and determine the best 
procedure to avoid disease progression. 
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By reviewing the findings and diagnostic criteria registered during screening, the assessment 
can be accelerated. Even so, the final classification of DR must be based on the criteria and 
findings of the ophthalmologists. Before reaching a therapeutic decision, the studies are 
classified using the “International Clinical Diabetic Retinopathy and Macular Edema Disease 
Severity Scale” proposed at the AAO [45, 46]. Therefore, according to the DR types, the 
studies can show proliferative or non-proliferative disease; the latter, depending on symptom 
severity, is classified as mild, moderate, or severe. ME, if present, also can be classified as 
mild, moderate, or severe. Thereafter, different therapies will be chosen according to the 
severity and specific symptoms of DR (Figure 15). 
 
− STAGE 6 (DR treatment): Once the most suitable treatment is determined, the special features 
of the procedure being performed are documented. Intraocular injections, laser therapy, and 
surgery are the procedures considered in this model. Diffuse DME is treated either by 
intravitreal corticoids (e.g. dexamethasone) and/or anti-VEGF agents (ranibizumab, 
aflibercept, or bevacizumab); focal DME is treated by macular laser. In contrast, PDR requires 
PRP or vitrectomy [57]. 
B.2 Study of Clinical Concepts 
As a result of studying the healthcare scenario described in step B.1, a set of clinical concepts were 
identified for structuring the electronic model that would manage the remote screening service for DR.  
Given that archetypes are formal definitions of concepts from a clinical domain, these would be used 
to model the clinical concepts listed at this point in a standardized and reusable manner [26]. 
Therefore, rather than modelling every concept from scratch, first the work team reviewed the 
archetypes available in the openEHR CKM repository [113]. Consequently, equivalent archetypes were 
found for some of the clinical concepts involved in the healthcare scenario. Other archetypes found 
were close to the concepts sought, but they would need to be adapted to meet the requirements of the 
healthcare scenario. Lastly, the rest of clinical concepts for which no equivalent archetypes were found 
would be modelled from scratch. 
All concepts considered relevant for the management of the DR screening have been listed in Table 5. 
These concepts will constitute the basis upon which to further develop the electronic model that would 
manage DR screening service. 
B.3 Hierarchical Organization of Knowledge Artefacts 
The design of archetypes for the healthcare scenario of DR screening did not begin until the work 
team agreed to the overall screening service.  
First of all, the clinical concepts listed in Table 5 were structured according to their occurrence into the 
clinical stages described for that clinical process. Then, based on the hierarchy described in section 
3.1.2, relationships were drawn from each of these concepts toward the rest of knowledge artefacts 
involved in the DR screening service (see Figure 9). 
During this process, the work team used collaborative diagramming and mind-mapping tools to 
facilitate organizing the knowledge from domain experts, resulting into the diagram shown in Figure 
16 [146, 147]. 
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Table 5: Clinical concepts to be modelled as a result of study of each stage in the service of DR 
screening.  
 Identified concept name Equivalent archetype 
Archetype 
class 
Process stages in 
which it is applicable 
1.  Reason for encounter 
- Found on CKM 
- Usable as is 
Evaluation Stage 1 
2.  Clinical synopsis 
- Found on CKM 
- Usable as is 
Evaluation 
Stage 1 
Stage 4 
Stage 5 
3.  Problem/diagnosis 
- Found on CKM 
- Usable as is 
Evaluation 
Stage 1 
Stage 4 
Stage 5 
4.  Diagnostic criteria DR 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Cluster 
Stage 1 
Stage 4 
Stage 5 
5.  Story/history 
- Found on CKM 
- Usable as is 
Observation Stage 1 
6.  Symptom/Sign 
- Found on CKM 
- Usable as is 
Cluster Stage 1 
7.  DR screening convenient 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Evaluation Stage 1 
8.  Care plan (request) 
- Found on CKM 
- Usable as is 
Instruction Stage 2 
9.  Care plan 
- Found on CKM 
- Usable as is 
Action Stage 2 
10.  Referral request 
- Found on CKM 
- Usable as is 
Instruction Stage 2 
11.  
Imaging examination 
request 
- Found on CKM 
- Usable as is 
Instruction Stage 2 
12.  
Acquisition details on 
eye fundus images 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Cluster 
Stage 2 
Stage 3 
13.  Procedure 
- Found on CKM 
- Usable as is 
Action 
Stage 3 
Stage 6 
14.  
Intraocular pressure 
measurement 
- Found on CKM 
- It has to be adapted 
Observation Stage 3 
15.  
Central corneal 
thickness details 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Cluster Stage 3 
16.  Medical device 
- Found on CKM 
- Usable as is 
Cluster Stage 3 
17.  Medical device details 
- Found on CKM 
- Usable as is 
Cluster Stage 3 
18.  Imaging examination 
- Found on CKM 
- Usable as is 
Action Stage 3 
19.  Anatomic location 
- Found on CKM 
- Usable as is 
Cluster Stage 3 
20.  Mydriasis application 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Cluster Stage 3 
21.  Medication amount 
- Found on CKM 
- Usable as is 
Cluster Stage 3 
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 Identified concept name Equivalent archetype 
Archetype 
class 
Process stages in 
which it is applicable 
22.  
Funduscopic 
examination of eyes 
- Found on CKM 
- It has to be adapted 
Observation 
Stage 3 
Stage 4 
Stage 5 
23.  
Diagnostic report 
request 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Instruction 
Stage 3 
Stage 4 
24.  
Classification of 
Diabetic Retinopathy 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Cluster 
Stage 4 
Stage 5 
25.  
Exclusion of a 
problem/diagnosis 
- Found on CKM 
- Usable as is 
Evaluation 
Stage 4 
Stage 5 
26.  Service request 
- Found on CKM 
- Usable as is 
Instruction 
Stage 4 
Stage 5 
27.  Recommendation 
- Found on CKM 
- Usable as is 
Evaluation Stage 5 
28.  Medication order 
- Found on CKM 
- Usable as is 
Instruction Stage 6 
29.  Medication action 
- Found on CKM 
- Usable as is 
Action Stage 6 
30.  
Intravitreal injection 
details 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Cluster Stage 6 
31.  Adverse reaction 
- Found on CKM 
- Usable as is 
Evaluation Stage 6 
32.  Procedure request 
- Found on CKM 
- Usable as is 
Instruction Stage 6 
33.  
Ophthalmic laser 
procedure details 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Cluster Stage 6 
34.  
Ophthalmic surgery 
details for posterior 
segment of eye 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Cluster Stage 6 
 
 
- 77 - 
 
 
Figure 16: Hierarchy among the knowledge artefacts involved in the remote screening service 
for DR.
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4.1.3 BUILDING THE ELECTRONIC MODEL 
Once the DR screening service had been discussed at a theoretical level, the same work team that 
defined this clinical process was convened to transcribe the resulting knowledge into electronic models 
interpretable by health information systems.  
To that end, first, the concepts identified during the design of the clinical process would be integrated 
into archetypes that could be used in any clinical scenario; then, those concepts in the archetypes 
would be linked to standard terminologies. Once the archetypes had been defined, they were 
enclosed and constrained into templates. Indeed, each template must be designed according to the 
specifications of the clinical scenario in which it will be used. Then, the guideline rules aimed at 
managing the service workflow were defined. Finally, UI forms were designed to organize all these 
artefacts into end-users' front-end applications. 
Furthermore, given all the knowledge artefacts involved in this procedure, a model-driven health 
computing platform must be launched to manage them all and test the electronic model into a real 
use case scenario. 
C.1 Creation and Update of Archetypes 
Theoretically, archetypes must be designed to be independent of the usage context. Nevertheless, our 
efforts focused on development of elements responding to the needs of the remote screening service 
for DR. In that respect, diverse archetypes were made available to formalize each of the clinical 
concepts listed in Table 5. Therefore, excluding organizational classes (section and composition), 34 
different archetypes were necessary to cover the clinical concepts involved in the DR screening service 
launched in the SNS-O: 10 archetypes were created from scratch, and 24 were downloaded from the 
openEHR CKM, two of which had to be adapted.  
At this moment the authoring process continues on the CKM. In this regard, our work team was 
convened to actively collaborate in an archetype incubator in which ophthalmologists and healthcare 
modellers distributed around the world contribute with their expertise to continuously improve the 
archetypes from the clinical domain of ophthalmology. Consequently, the proposed new archetypes 
as well as those resulting from modifying the existing ones were uploaded to this repository with the 
purpose of make them available to be reviewed by experts from all over the world. 
Therefore, it is expected for this model to be in constant evolution depending on the progress of the 
methodology for the follow-up of DR. Consequently, extending this clinical process to other healthcare 
facilities and periodic updating of that model will be immediate. And each healthcare organization 
adopting these archetypes also will be interoperable worldwide. 
C.2 Definition of Semantic links to Clinical Terminologies 
Once the clinical concepts had been modelled, terminology definitions were determined for those 
data elements contained in each one of the archetypes. First, considering that most archetypes 
obtained from the CKM were originally defined in English, the new archetypes we proposed were also 
modelled using that language. Once modelled, we translated the archetypes into additional 
languages so as to use them into the SNS-O. In this way, we expect to reach greater participation on 
the part of the modellers during the authoring process which takes place in the CKM. 
Secondly, as many data elements as possible were linked to standard terminology services such as 
SNOMED-CT or ICD-10; even some references to equivalent concepts from technical standards like 
DICOM were included. In this way, these terms maintain the semantic meaning independently from 
the translation, since selected terminology services support multiple languages. 
Some of the data elements identified can adopt different values depending on the context they are 
used. So, instead of modifying the source archetypes, the occurrences of those elements were 
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determined by mapping them to normalized lists of terms at template level. In this regard, some 
normalized lists of terms – known as termsets – were specially designed for the DR screening service.  
Specifically, 16 new termsets were created to bind selectable data elements to standard terminology 
services. Some of them were used to specialize generic archetypes with lists of terms specific to the 
healthcare scenario proposed. Other termsets were reused in different archetypes, making it possible 
to work with the same list of terms in different archetypes (e.g. “Findings on posterior pole of eye” or 
“Subdivision of retina”) (see Table 6). 
C.3 Building Templates 
The archetypes modelled in previous steps were structured into templates, according to the hierarchy 
defined along the design of the clinical process (Figure 16). These templates, therefore, specify which 
data elements must be registered for each clinical stage defined in the DR screening service. Because 
the archetypes contain generic elements to support every use case, their data elements must be 
constrained to the specialized healthcare scenario where they will be used. Therefore, most elements 
were disabled at the template level to register only those data elements required for the DR screening 
service proposed. Any template designer compliant to openEHR ADL could be used to that end [155, 
179]. In our case, ADL 1.4 was chosen to build templates and archetypes, since development tools 
available so far are more mature. 
Templates are very changeable knowledge elements, so larger ones should be adapted to more 
manageable proportions. In this sense, composition-level templates were built from grouping section-
level templates, which embedded the archetypes assigned to section-type archetypes into self-
contained templates. These section-level templates can be reused within different compositions, hence 
in the event of modifying or updating a specific section, the respective compositions would be 
automatically updated instead of repeating the modifications repeatedly. 
As a result of that modelling, 18 new templates were built; 12 of them corresponded to the section-
type templates devised to organize the archetypes involved in each clinical stage. With the goal of not 
duplicating templates, 2 of these templates were reused along the clinical process: on the one hand, 
the template “Image test analysis for DR” was equally applicable to DR screening and assessment 
stages. On the other hand, in the case of “Next step in DR screening service” the same goes for 
requesting a remote screening or an office assessment when the results of IOP and NMR study tests 
are available, to schedule next review in a year, or to plan the appropriate treatment for the patient. 
Therefore, although it first appears on the stage for diagnostic tests in the DR screening service, this 
template was also needed in DR screening and assessment stages.  
The remaining 6 templates were created to manage the compositions containing the aforementioned 
sections. Therefore, clinicians can use the latter to register information about clinical evaluations 
(see Figure 17).  
Although the resulting templates were originally built for the use case scenario presented along this 
section, these were made available on the CKM under a Creative Commons licence. Thus, any 
healthcare modeller can obtain our templates and adapt them to the requirements of specific 
healthcare organizations.  
 
- 80 - 
 
Table 6: Termsets modelled to support the archetypes modelled for the DR screening service.  
 
Termset name Description of termset 
Process stages in 
which it is applicable 
1.  Findings on posterior pole of eye Clinical findings identifiable in posterior pole of eye. 
Stage 1 
Stage 4 
Stage 5 
2.  Subdivision of retina List of zones in eye retina for ophthalmic image positioning. 
Stage 2 
Stage 3 
3.  Corneal thickness measurement devices List of methods to obtain the corneal thickness measurement. Stage 3 
4.  Mydriatic agents 
List of mydriatic agents and their corresponding doses validated for 
ophthalmologic use. 
Stage 3 
5.  Complications on ophthalmic image acquisition 
List of possible complications during ophthalmic imaging studies that may affect 
the quality of acquisitions (based on Table CID 4222 of DICOM standard). 
Stage 3 
6.  Ophthalmic photography devices 
Lists the ophthalmic photography acquisition devices (based on Table CID 4202 
of DICOM standard). 
Stage 3 
7.  Identification of diabetic retinopathy Identification of presence or absence of DR for screening purposes. Stage 4 
8.  Clinical grading for diabetic retinopathy International Clinical Diabetic Retinopathy Disease Severity Scale. Stage 5 
9.  Classification for diabetic macular edema 
Classification levels for the presence of ME as defined by the international scale 
for DR grading. 
Stage 5 
10.  Therapeutic procedures for diabetic retinopathy List of therapies available to treat different stages of DR. Stage 5 
11.  Compounds for intravitreal injection Compounds administered in ophthalmology in the form of intraocular injection. Stage 6 
12.  Compounds for local anaesthesia Compounds available to apply local anaesthesia. Stage 6 
13.  Anti-infective agents List of anti-infective agents available. Stage 6 
14.  Laser procedures in ophthalmology List of laser procedures available for ophthalmic purposes. Stage 6 
15.  Ophthalmic laser devices List of laser devices for ophthalmic use. Stage 6 
16.  Operative procedures on posterior segment of eye List of operative procedures on the posterior segment of eye. Stage 6 
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Figure 17: The structure of templates envisaged to register clinical encounters resulting from 
the remote screening service for DR.
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C.4 Modelling Guideline Rules and Workflow 
Seven rules were configured to handle the decisions about workflow. To define these rules, the GDL 
editor developed by Cambio Healthcare Systems was used because it makes use of the reference and 
archetype models from openEHR [180]. 
The GDL language queries to EHRs the information registered by means of archetypes or templates 
and it applies conditions and consequent actions accordingly, making it possible to trigger 
automatically real-time alerts or events for CDS when data are registered in the EHR. 
In this sense and based on the clinical guidelines defining the workflow for the DR screening service 
proposed, different events were configured such that clinicians receive specific instructions about how 
to refer patients through clinical stages. In any case, clinicians will make the final decision, and they 
are free to handle the service manually if required. The guideline rules identified in Figure 16 to 
manage the workflow of the DR screening service are first described in general terms and then are 
further detailed in Table 7:  
− DR screening convenient: The first encounter is used to check if the patient meets the criteria 
for inclusion in the screening process. This rule activates (or not) the archetypes involved in 
requesting the diagnostic tests necessary to start the follow-up. 
− Diagnostic tests valid for screening: This rule validates the diagnostic tests once acquired, 
and discards any unusual value before proceeding with the screening stage. Then, if 
everything is correct, this rule requests a DR screening report to the corresponding GPs. 
− Office examination required: Conversely, this rule identifies patients with dangerously high 
IOP values (≥22 mmHg) or low-quality fundus images (<4 of 5 levels of quality), and 
therefore arranges directly the patient's assessment at the ophthalmologist's office.  
− Altered retina: Any alteration identified during screening is reported to the corresponding 
ophthalmologist (based on the “Classification of Diabetic Retinopathy” archetype). 
Consequently, this rule requests an assessment report to an ophthalmologist. Likewise, the 
studies that require a second opinion due to the evaluator's uncertainty are referred to 
ophthalmologist's office. 
− Apparently not altered retina: In contrast, patients without DR are referred to the next 
evaluation defined by the follow-up process. Thus, this rule must schedule the diagnostic tests 
defined for the DR screening service. 
− DR treatment required: It is triggered whenever the ophthalmologist recommend a therapeutic 
procedure to avoid disease progression. Consequently, this rule will schedule the procedures 
and medication prescriptions determined by such recommendation. 
− DR treatment not required: In case the ophthalmologist, after the office assessment, does not 
consider it necessary to treat the patient, this rule will refer the patient to the next review 
irrespective of whether or not there are alterations of retina. 
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Table 7: Description of the guideline rules modelled for the remote screening service for DR. 
 Rule name Conditions Actions 
1.  
DR screening 
convenient 
Archetype “DR screening convenient”: 
 Admittance in screening: “Screening compliant” 
Archetype instantiated  “Care plan (request)”: 
 Care plan name: “Remote screening service for DR” 
Archetype instantiated  “Referral request”: 
 Service requested: IOP measurement 
Archetype instantiated “Imaging examination request”: 
 Service requested: NMR 
2.  
Diagnostic tests 
valid for 
assessment 
The preconditions for this rule are a “Pressure” value below 
22mmHg for the archetype “Intraocular pressure 
measurement”, and levels 4 or 5 for the “Quality of 
acquisition” proposed for the archetype “Funduscopic 
examination of eyes”. 
Archetype “Care plan”: 
 Care plan name: “Remote screening service for DR” 
 Pathway: “Care plan completed” 
Both diagnostic tests must be completed to run the corresponding actions. 
Archetype instantiated  “Diagnostic report request”: 
 Service requested: “Remote screening of DR” 
 Reason for request: “Completed the diagnostic tests necessary for 
assessment” 
 
3.  
Office 
examination 
required 
Archetype “Intraocular pressure measurement”: 
 Pressure ≥22 mmHg (Dangerously high intraocular 
pressure) 
Archetype “Funduscopic examination of eyes”: 
 Quality of acquisition: Level 1, level 2, or level 3 (Low eye 
fundus image quality) 
When any of the two conditions (“Dangerously high intraocular pressure” 
or “Low eye fundus image quality”) are met, the request for assessment on 
the ophthalmologist's office would be triggered. 
Archetype instantiated  “Diagnostic report request”: 
 Service requested: “DR assessment at ophthalmologist's office” 
 Reason for request: “Patient presenting dangerously high intraocular 
pressure” or “Quality of eye fundus images inadequate for remote 
diagnosis” depending on the case. 
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 Rule name Conditions Actions 
4.  Altered retina 
Archetype “Classification of Diabetic Retinopathy”: 
 DR identification: “DR identified” or “Ungradable” 
Archetype instantiated  “Diagnostic report request”: 
 Service requested: “DR assessment at ophthalmologist's office” 
 Reason for request: “Clinically relevant ophthalmological disorders 
identified” or “Second opinion needed” depending on the case. 
5.  
Apparently 
not altered 
retina 
Archetype “Classification of diabetic retinopathy”: 
 DR identification: “No apparent DR” 
Archetype instantiated  “Service request”: 
 Service name: “Follow-up schedule for patients with suspected DR” 
 Description: “Follow-up comprised by NMR study and IOP measurement” 
 Service due: 12 months 
6.  
DR treatment 
required 
The conditions established within the rule “Altered retina” 
comprise the precondition for this rule. 
Archetype “Service request”: 
 Service name: “DR treatment” 
Archetype “Recommendation”: 
 Recommendation: “Scatter PRP laser therapy”, 
“Focal and/or grid laser photocoagulation”, 
“Intravitreal injection of corticosteroids”, 
“Intravitreal injection of antiangiogenics”, or 
“Vitrectomy surgery” 
Archetype instantiated  “Medication order”: 
 Medication item: “Corticoids” or “Antiangiogenics” depending on the 
values defined in the archetype “Recommendation”. 
 Route: “Intravitreal injection” 
 Clinical indication: Determined by the values defined in the archetype 
“Classification of Diabetic Retinopathy” for “DR classification” and 
“Macular edema classification”. 
Archetype instantiated  “Procedure request”: 
 Procedure name = “Scatter PRP laser”, “Laser photocoagulation” or 
“Vitrectomy” depending on the values in the archetype “Recommendation”. 
 Objective: “DR treatment” 
 Indication: Determined by the values defined in the archetype 
“Classification of Diabetic Retinopathy” for “DR classification” and 
“Macular edema classification”. 
7.  
DR treatment 
not required 
Archetype “Recommendation”: 
 Recommendation: “Do not treat” 
The ophthalmologist has the last word, hence can determine 
that there is no need for treatment and instantiate the next 
review, as in the rule “Apparently not altered retina”. 
Archetype instantiated  “Service request”: 
 Service name: “Follow-up schedule for patients with suspected DR” 
 Description: “Follow-up comprised by NMR study and IOP measurement” 
 Service due: 12 months 
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C.5 Modelling UI Forms 
When we considered designing UI forms for the DR screening service, we identified different solutions 
to the same end. However, each of the form definitions studied was exclusive to specific e-health 
implementations. The lack of agreement on UI specifications nowadays hinders the development of 
pervasive software tools for UI form modelling, which are in fact essential to implement this strategy. 
Therefore, for as long as no consensus is reached on this matter, we must stick with the UI form 
modelling tools available today.  
On the one hand, the template designer of Ocean Informatics includes a form designer feature, which 
leverages the openEHR templates modelled to build customized UI forms. As an outcome, the 
template designer generates the C# code necessary to compile the resulting UI forms. However, the 
fact that the resulting code is provided in a given programming language limits the potential 
implementations on which these UI forms could be applied. Nonetheless standards-based open health 
computing platforms must interoperate with front-end applications functioning on heterogeneous 
electronic terminals, regardless if they are built upon diverse technologies. 
Alternatively, the open source software tools provided by Cabolabs should be considered in this 
regard. Indeed, such tools have recently incorporated a library which parses the openEHR 
Operational Template (OPT) files and automatically generates the corresponding UI forms built upon 
HTML code. This avoided to define one by one the specific data fields necessary for representing the 
archetype paths defined within the openEHR templates. Moreover, although by default such library 
generates HTML code, given that the UI generation tool is provided in open source, it can be adapted 
to generate the UI views in other programming codes. However, the fully automated generation of 
views lacks of tools for customization of the UI to the needs of final user. 
In this regard, the Marand EhrExplorer provides an excellent form builder which includes a dedicated 
web interface to model UI forms in an agile way. Once modelled, the resulting forms are saved into 
the EhrScape server as three complementary form resources: the form-layout, which arranges the 
information and data fields on the screen. The form-description, which defines how the content of the 
form would be shown (language, data validation, data-types, etc.). And the form-dependencies, which 
determine GDL rules among the data elements within the form. The EhrScape server provides these 
form definition components in JSON format through REST interfaces. Thus, any front-end application 
connected to the EhrScape server can retrieve the form specifications modelled in a language-
independent data format. Then, these form definitions would be transformed by each application into 
UI views on the programming language it corresponds. 
Given the flexibility of this approach, the Marand EhrExplorer was chosen to build the UI forms for the 
DR screening service at issue. Consequently, 6 different UI forms were created to represent each one 
of the stages that comprise the clinical process. To build the UI form definitions, first of all, the 
section-type templates were assigned to different blocks of the layout. Then, separate rows were used 
to arrange the different entry-type archetypes contained in the same block. This provided a basic 
structure to arrange the elements on the templates. Otherwise, the resulting clinical forms would be 
too large and unwieldy to register medical records. On this basis, clinicians applied the modifications 
considered necessary to adapt the UI forms to the needs of the daily clinical practice. 
However, this approach requires access to a valid EhrScape domain. In our case, we used a demo 
domain from “ehrscape.com” as temporary solution to build the UI forms. Even so, the scenario for 
this Thesis ought ideally to be provided with open access. For this reason, looking ahead, we prefer 
the implementation proposed by Cabolabs, as despite the UI form generation tools are still under 
development, includes open source EHR and EMR applications which have unrestricted access in the 
cloud, and, if necessary, can also be implemented in our own servers for research purposes. 
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4.1.4 IMPLEMENTATION OF THE SERVICE 
To integrate the use of the electronic models defined along this chapter into the DR screening service 
from the SNS-O, every information system, diagnostic device, and workstation involved in the clinical 
process must be adapted beforehand so as to guarantee ubiquitous and instant access to the 
information registered. To that end, an analysis of the technical environment was conducted, and a 
standards-based implementation was devised accordingly. 
As mentioned in the definition of the project, this clinical process involves three types of workspaces: 
one for diagnostic test acquisition, one for DR screening, and, one for DR assessment. The first 
contains the tonometry plus pachymetry instruments for IOP measurement, a non-mydriatic retinal 
camera, and a PC workstation to register findings identified during acquisitions. The second 
workspace is located in the workplace of the GPs; there, a PC workstation has access to the PACS 
and EHR to remotely visualize clinical images and register the consequent clinical reports. The third 
workspace is similar to the screening workstation but is in the consulting room of the ophthalmologist 
in the same building where diagnostic tests are performed. Thus, if a patient needs more extensive 
analysis, immediate face-to-face consultations are possible with retina specialists. 
To interconnect those workplaces, two independent but complementary standards were chosen to 
coordinate the information among different devices and locations: on the one hand, the openEHR 
standard would be used to manage the medical records resulting from clinical encounters that occur 
in the DR screening service. On the other hand, DICOM would arrange the acquisition and exchange 
of diagnostic tests involving medical imaging. 
First of all, the non-mydriatic fundus cameras involved in the DR screening service were connected in 
compliance with DICOM standard to the PACS server that manages clinical images from the entire 
health service. This server, in turn, is accessible through the corporative network of the health service 
to the remote workstations where DICOM image viewing tools were installed for assessment purposes 
(Figure 18).   
Concurrently, the openEHR-compliant EHR system should be connected to the PACS server. In this 
way, the CPOE management system from the EHR would schedule the diagnostic tests through the 
PACS, and then, the healthcare provider responsible for each workspace could complement the test 
results with information originated as a result of the healthcare encounter. However, most information 
systems available within current healthcare services do not yet support the openEHR standard.  
Thus, while the diagnostic tests are scheduled through the main EHR server of the healthcare service, 
which actually is already connected to the PACS, an additional EHR would be dedicated to manage 
the DR screening service in compliance with openEHR specifications. When necessary, this server will 
send EHR extracts with relevant healthcare results to the main information system, making that 
information reusable for other clinical processes. These extracts must be compliant to healthcare 
messaging standards, according to the different EHRs involved in the health service (Figure 18).  
As mentioned above, the openEHR-compliant EHR would be specifically tailored to manage the 
information generated during clinical encounters corresponding to the DR screening service. To this 
end, it would implement the archetypes, templates, guideline rules, and UI form specifications 
modelled along this section. Likewise, the workstations allocated at each workspace would include 
customized EMR applications that would report the medical records it corresponds to the EHR system. 
A primary advantage of the EHR based on archetypes is its flexibility, because it can load a model to 
manage the DR screening service and apply changes to it as necessary. There is no need to introduce 
any changes in the main EHR system of the service, even if there are modifications in the clinical 
process. 
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As proof of concept, the EHRServer provided by Cabolabs was designated as EHR system for 
openEHR clinical data storage, whereas the EHRCommitter would serve as front-end to commit the 
medical records to the EHR. Both applications are provided in open source, they are compliant to 
openEHR specifications, and provide secure REST API for data exchange. These features fit the 
modular architecture of open health computing platforms; they establish the knowledge model by 
loading openEHR-compliant OPTs, hence although different front-ends can be appended in the 
future, the health service will always retain control of the data recorded [181, 182]. This 
implementation does not leverage the UI form specifications defined through the Marand EhrExplorer 
tool, but it was sufficient to get started using the electronic models built. Anyway, these UI form 
definitions could be used to build a specific front-end interoperable with the EHRServer of Cabolabs 
when it comes to exchange medical records.  
 
 
Figure 18: Flow of information through the service for DR screening.
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4.2 HIGH RESOLUTION CONSULTATION TO MONITOR THE TREATMENT OF WET AMD  
As seen in section 2.1, the treatment of wet AMD is particularly critical regarding the management of 
chronic conditions in ophthalmology. In fact, this condition may present visual loss from 28 days from 
the time of last assessment [64]. Thus, the consultation required to manage this clinical process must 
coordinate tightly the assessment of progression of the disease, with an immediate provision of the 
most suitable therapeutic interventions to minimize the risk of visual loss in each case. 
In that respect, the integration of ICTs with interoperable diagnostic tests provides a new framework 
toward modelling patient-centred efficient and accurate healthcare processes. To that end, this 
chapter of the PhD dissertation proposes a service designed for periodic and long-term monitoring of 
the treatment of patients diagnosed with wet AMD. 
4.2.1 DEFINITION OF THE PROJECT 
On the basis of the above, patients diagnosed with wet AMD must follow a strict treatment of 
intraocular injections to avoid irreversible progression of the disease (see section 2.1.2). Likewise, in 
view of optimizing the effectiveness of this clinical procedure, the response of the patient to each 
treatment can be analysed so as to adjust the next therapeutic intervention accordingly. 
In the case of the ophthalmology department of the SNS-O, patients included within the treatment 
circuit are regularly examined out for any signs of progression within AMD. Namely, they are 
convened monthly for a monitoring of the treatment that includes the periodic measurement of VA, 
and the examination of the macula using slit lamp biomicroscopy and a non-contact fundus lens, 
combined with OCT. However, due to the complexity of the aforementioned procedure for monitoring 
each response to therapy, as the volume of patients requiring treatment for wet AMD increases the 
healthcare resources available to carry out this clinical process may become insufficient to treat all 
patients within recommended intervals [183].  
Consequently, a multidisciplinary group comprised of ophthalmologists expert in retina (belonging to 
the CHN and the HUB), and specialists in ICT engineering (from the Department of Electrical and 
Electronic Engineering of the UPNA) was convened to work toward efficiency in devising a clinical 
process aimed at providing the appropriate therapy to patients diagnosed with wet AMD. In that 
respect, the work team proposed a high resolution consultation –also known as „one-stop outpatient 
consultation‟– geared to manage the treatment of wet AMD.  
This approach would optimize the waiting time and cost-effectiveness of the clinical process by 
conducting all examinations, diagnostic decisions and consequent therapies along a single outpatient 
visit. Thus, the work team determined the following changes upon traditional proceedings to integrate 
the high resolution consultation strategy into the monitoring of the treatment of wet AMD: 
− Rethink of the treatment: Considering that the clinical knowledge evolves continuously, the 
modelling must consider the emerging new therapeutic strategies: as seen in section 2.1.2, 
traditionally, the treatment by repeated injections of antiangiogenic agents into the vitreous 
cavity was systematically applied to all patients diagnosed with wet AMD. Conversely, the 
guidelines in the ophthalmology department of the SNS-O includes, after each treatment, a 
stage for monitoring the progression of the disease so as to adjust the therapy accordingly. 
Thereby, the number of treatments per patient is limited to the cases in which such treatment 
is effective, hence the suppression of unnecessary interventions leads to alleviate the waiting 
lists.  
With regard to intravitreal injections of VEGF inhibitors, the alternative use of bevacizumab is 
considered since its effectiveness is similar to ranibizumab, or aflibercept but at lower cost 
(see section 2.1.2). This makes the treatment accessible to more patients, considering a 
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limited health budget to meet the demand of a treatment administered regularly and 
restricted by the recommended periods. 
The location of the treatment itself has been reconsidered. Whereas traditionally intraocular 
injections were carried out within an operating room, by setting up a dedicated procedure 
room compliant to guidelines for best practice that guarantee the safety of patients, this 
intervention can take place in the same office where ophthalmologists assess the patients 
[78]. This will accelerate considerably the workflow regarding the time elapsed from the 
examination of patients until their treatment. In addition the waiting list of the operating 
rooms reserved to intravitreal anti-VEGF injections will be alleviated, and thus, those would 
be allocated to other interventions. 
− Redistribution of the workload: The integration of ICTs in healthcare provides to clinicians 
ubiquitous access to the clinical information registered within a clinical process. This new 
scenario facilitates the redistribution of the workload of traditional healthcare processes 
toward services that use the human and technical resources more efficiently. This will facilitate 
dealing with the scarcity of highly qualified professionals in healthcare services. The workload 
can be divided in simpler modules but requiring very specific skills, and then the clinical staff 
available can be trained accordingly so as to cover diverse roles specifically defined to 
manage the clinical process. In that respect, it is noteworthy that similarly to the DR screening 
service modelled, the management of the treatment of wet AMD is limited by the scarcity of 
specialists in retina. Thus, routine tasks that require less specialization such as the acquisition 
of diagnostic tests can be delegated to specifically trained nurses. In this way, the workload of 
ophthalmologists would be alleviated, so they can concentrate their efforts on specialized 
tasks such as analysis of clinical data, determine therapeutic decisions or conduct surgery. 
− Allocation of specialized workspaces: According to the high resolution consultation, every 
clinical encounter (diagnostic tests, assessment and treatment) must be completed along a 
single outpatient visit. To that end, differentiated points of care would be specifically 
equipped with the technical and human resources necessary to carry out each of the clinical 
encounters concerned. In this way, instead of making successive reservations at a non-
earmarked ophthalmologist's office, disease-specific workspaces would be allocated, for 
some hours a day, to manage the complete workflow. 
The integration of all these proposals into the process of monitoring the treatment of patients 
diagnosed with wet AMD should accelerate the flow of patients through the clinical process, and 
hence alleviate the waiting lists in that service. It is estimated that whereas an ordinary consultation of 
ophthalmology in the SNS-O attends approximately 24 encounters per day including patients 
presenting different eye diseases, the high resolution consultation proposed would alleviate a patient 
every 10 minutes exclusively from the waiting lists of wet AMD (about 30 patients dispatched in 5 
hours of operation). 
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4.2.2 DESIGN OF THE CLINICAL PROCESS 
B.1 Definition of the Clinical Process  
The high resolution consultation designed by the work team manages patients from different clinical 
processes which, after specific diagnostic tests and assessments, have been diagnosed with wet AMD. 
Therefore, the clinical process actually begins when, based on clinical information gathered during 
diagnosis, a retinologist determines whether the therapy of anti-VEGF intravitreal injections is suitable 
or not for a patient being assessed.  
If so, the patients selected receive the first cycle of treatments directly on the ophthalmologist's office, 
which entails one monthly intravitreal injection for three months. Thereafter, the progression of AMD 
must be monitored periodically, so patients are convened once a month and the corresponding 
diagnostic tests are performed and electronically registered.  
Finally, a retinologist from a remote workstation examines the results of those clinical tests, and 
determines, depending on the response of the patient to the last treatment, whether to repeat or not 
the anti-VEGF intravitreal injections. The treatment takes place directly in the office of the 
ophthalmologist expert in retina, and whether treated or not, a patient's review is scheduled for next 
month.   
Therefore, as shown in Figure 19, the management of the treatment for wet AMD was defined into 
four clinical stages, plus an additional stage to contextualize new patients diagnosed with wet AMD. 
Each one of these stages is analysed in detail along this section: 
− BACKGROUND (Diagnosis of wet AMD): Patients, who during routine clinical encounters 
such as primary care services, eye emergency services, or general ophthalmology presented 
signs of possible AMD, are immediately referred for further examination to specialized 
consultation of a retinologist. During that consultation, the diagnostic tests of VA, eye fundus 
examination using slit lamp biomicroscopy and a non-contact fundus lens, OCT and 
angiography are undertaken. Besides, depending on each case, the retinologist can consider 
appropriate carrying out additional tests, such as direct eye fundus examination. Then, the 
retinologist examines those tests as a whole, and determines a diagnosis for the clinical 
findings that initially raised the suspicion of AMD. Once diagnosed, only patients presenting 
wet/exudative AMD are included in the healthcare process proposed, and thus receive 
treatment of intravitreal anti-VEGF injections. Nevertheless, patients with dry AMD could 
develop wet AMD in the future. Therefore, their condition is periodically reviewed (within 
periods of 1-2 years) to detect any sign of disease's progression leading to wet AMD. Finally, 
some of the patients examined could be affected any other condition beyond AMD, so an 
appropriate therapeutic strategy should be determined according to each case. This last 
scenario is out of the scope of the model proposed.  
Actually, the high resolution consultation does not begin until next stage, in which patients 
are enrolled for the treatment of wet AMD. For this reason, the process to establish the 
diagnosis of wet AMD was not included from the electronic model. Nevertheless, to avoid 
duplication of diagnostic tests, the decision on admission for the first cycle of treatments is 
mainly based on retrospective information from this stage. Therefore, the diagnostic tests 
resulting from the diagnosis of wet AMD are analysed in the admission stage, to provide a 
context to each candidate for the intravitreal anti-VEGF therapy (Figure 19).  
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Figure 19: Activity diagram describing the workflow proposed for a high resolution consultation 
to monitor the treatment for wet AMD. 
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− STAGE 1 (Patient admission): The same ophthalmologist expert in retina entrusted of 
determining the diagnosis of AMD, evaluates each patient to decide whether will be or not 
enrolled into the long-term treatment for wet AMD. To that end, the retinologist must address 
two decisions before admit a patient within the cycle of treatments proposed for wet AMD:  
 Diagnosis of wet AMD: As seen above, only patients assessed with wet/exudative 
AMD are included into the first cycle of treatments of intravitreal anti-VEGF 
injections. Thus, evaluation of new candidates for such treatment is triggered 
whenever the retinologist confirms the diagnosis of wet AMD during the review of a 
patient.  
 No contraindications for anti-VEGF therapy: Then, the ophthalmologist must 
determine the best therapy for each case, thus verifies whether patients fulfil the 
minimum requirements to receive the anti-VEGF injections. Thereby, patients 
presenting contraindications such as very low VA (values below 0.1 in decimal scale) 
or healed lesions resulting from previous treatments are excluded from the treatment.  
Those patients chosen in accordance with those conditions are enrolled into the high 
resolution consultation service, and thus scheduled to receive the first cycle of intravitreal anti-
VEGF injections described below. 
 
− STAGE 2 (AMD treatment): The first cycle of treatments consists of monthly administration of 
an intravitreal antiangiogenic injection for three months. Once those treatments have been 
completed, an ophthalmologist must evaluate the response of patients to previous treatments 
right before determining each new retreatment. In this way, ophthalmologists are able to 
adjust the frequency of injections administered, or even interrupt the treatment according to 
the needs of each patient. 
Whenever an ophthalmologist, as a result of the therapeutic assessment described along the 
last stage, determines the retreatment for a patient with wet AMD, the patient is called 
urgently to his office. There, the patient is informed about the procedure, then the 
ophthalmologist examines its eye fundus to prepare the intervention, and finally the 
intravitreal anti-VEGF injections are administered in-situ. However, there is an ongoing 
debate on the safest procedure for administering the intravitreal injections [78, 184]. In that 
respect, the following guidelines were established for the healthcare scenario of the SNS-O 
so as to ensure the safety of the intervention: 
 Clinical setting for injection: Intravitreal injections may be safely performed in an 
office setting, with the added advantages of greater agility and flexibility compared 
to booking an operating room. Hence, most patients will receive by default, the 
injections directly at the same office used by the ophthalmologist for assessment.  
 Prevention of infection: Both the clinicians responsible for the injection and the 
patient himself must wear surgical masks to avoid the microbe spread coming from 
their upper respiratory tract. The clinical personnel involved in the procedure must 
wear sterile gloves before any patient contact. The use of topical antibiotics is not 
considered necessary due to insufficient evidence in literature supporting this routine. 
To prevent contact between the needle/injection site and the eyelashes and eyelids, 
a speculum is used, or alternately, a nurse conducts a manual eyelid retraction while 
the ophthalmologist administers the injection. 
 Topical anesthetics: Topical anesthetic drops are applied to reduce patient 
discomfort during the intervention. 
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 Antiseptic usage: Povidone-iodine (5-10%) is applied to the conjunctival surface at 
the intended injection site, avoiding eyelid contact on this area. This must be the last 
agent applied before injection so as to reduce the incidence of endophthalmitis. In 
addition, according to the guidelines in force at the ophthalmology department of 
the SNS-O, the application of povidone-iodine is also contemplated on eyelids, 
including the eyelashes and eyelid margins. In that respect, eyelid scrubbing or 
eyelid pressure should be avoided since, this routine increases the risk of liberating 
bacteria from the meibomian glands. 
 Anti-VEGF agents administered: Ranibizumab, aflibercept and bevacizumab are 
injected indistinctly, as they present equivalent outcomes in the treatment of wet 
AMD (see section 2.1.2).  
 
− STAGE 3 (Follow-up schedule): The diagnostic tests aimed at the assessment of the response 
of patients to the treatment are then scheduled for the month following the last injection from 
the current treatment cycle. In this way, the ophthalmologists will have at their disposal the 
results of these tests just before proceeding with next treatment. 
 
− STAGE 4 (Diagnostic tests): As seen in section 2.1.2, the ophthalmologist must combine the 
assessment of patient's latest measurements of VA, eye fundus photographies, and OCT 
studies so as to review the treatment of wet AMD. The measurement of VA must be conducted 
in the first place, in order to subsequently administer mydriatic agents to the patient. This is 
because, although mydriasis is recommended to conduct the OCT test, and it is beneficial for 
the acquisition of eye fundus images, it is contraindicated for the measurement of VA. Then, 
once the mydriatic effect is active, NMR and OCT tests could be carried out.  
Based on these guidelines, three differentiated workspaces were proposed to distribute the 
patient flow due to the diagnostic tests involved on the high resolution consultation (see 
Figure 19): 
 The first workspace: Point of care managed by a nurse specialized on VA testing and 
acquisition of non-mydriatic retinal photographs. It is worth mentioning that, at this 
workspace, the eye fundus evaluation using slit lamp biomicroscopy undertaken in 
traditional consultation of ophthalmology has been substituted by digital 
retinography. In this way, the eye fundus photographs will be ubiquitously available 
for their remote assessment. Therefore, the workspace must be equipped with a non-
mydriatic fundus camera, and a Snellen chart for VA testing. Likewise, the 
illumination and dimensions of the room must be appropriate for such diagnostic 
tests. First of all, the nurse obtains the VA test in decimal scale. Then converts the 
results into a logarithm of the Minimum Angle of Resolution (logMAR) for easier 
comparison of values along subsequent consultations. Next, the nurse induces 
mydriasis to the eye or eyes affected by AMD so as to prepare the patient for the 
clinical imaging tests. Once pupils are dilated, the nurse acquires in-situ the non-
mydriatic retinographies corresponding to the study of AMD, and orders a study of 
the macula for the OCT situated in the second workspace (described below).  
Regarding the fundus photography, the same guidelines used for DR screening were 
considered adequate for the study of AMD. Thus, two funduscopic images are 
obtained, one centred from the papilla and the other from on the macula. Thereby, 
although the assessment of AMD is focused on the examination of the macula, the 
additional picture of papilla will be available for future studies, e.g. concerning DR. 
Finally, those images are uploaded to the PACS, whereas the results of VA are 
registered into the EHR. In this way, diagnostic tests will remain remotely accessible 
for the ophthalmologist responsible for their assessment. 
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 The second workspace: This point of care is equipped by an OCT device. Therefore, 
a nurse or imaging technician specifically trained on the use of the OCT is in 
charge. The studies of AMD scheduled in the OCT consist of cross-sectional images 
of the retina nearby to the macula. Thus, in terms of the protocol used in the 
healthcare service of the SNS-O in that respect, a scan containing ten OCT sections 
in parallel which covers the whole macula, plus an extra scan comprised of a high-
resolution section centred on the macula are acquired. For the same reason as in 
the case of fundus photographs, all resulting OCT sections are uploaded to the 
PACS. 
 The third workspace: It corresponds to the office of the retinologist in which the AMD 
monitoring was managed along with other eye diseases. Nevertheless, it is also the 
office from which the high resolution consultation is coordinated and monitored. 
Therefore, during the time slots reserved for the high resolution consultation, this 
workspace is dedicated exclusively to manage patients diagnosed with wet AMD. To 
that end, the office has been equipped with a workstation from which, the 
retinologist requests and assesses the diagnostic tests necessary for monitoring the 
progression of wet AMD. Those tests are acquired in the other two workspaces 
mentioned above, whereas the retinologist uses this office to evaluate the 
acquisitions remotely as it is described in next stage. Nonetheless, besides the 
treatment and the remote assessment, this workspace was prepared as well to host 
diagnostic examinations whenever required. Thus, patients presenting any adverse 
drug reaction such as the mydriatic agent, or other problems that require the specific 
expertise of a retinologist are called to this office for further examination. Likewise, if 
the retinologist, having assessed the results of all diagnostic tests available remotely, 
still requires additional information to make the adequate therapeutic decision, the 
corresponding patients are referred to his office for a face-to-face consultation. In 
light of this, the office was equipped with a slit-lamp with a non-contact lens given 
that the retinologist could consider necessary the direct examination of eye fundus. 
 
− STAGE 5 (AMD assessment): Once the diagnostic tests contemplated in the high resolution 
consultation are completed, the ophthalmologist in charge of AMD assessment has remote 
access to all clinical information it requires to determine the most suitable therapeutic 
decision for the patient. First of all, the ophthalmologist must determine whether the condition 
is progressive, or on the contrary it has been stabilized due to previous treatments. In that 
respect, the progression of AMD is identified by the occurrence of at least one of the 
following criteria: 
 Loss of at least one line of VA, in comparison to the previous revision, associated 
with the presence of macular fluid indicative of activity on AMD. The macular fluid 
indicative of activity or progression on AMD is detected using the OCT, and can be 
either intraretinal or subretinal. 
 Persistence of macular fluid indicative of activity identified through the OCT. 
 Emerging new macular haemorrhage detected by digital retinography or fundus 
examination of the patient. 
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If the condition turns out to be stable, the retreatment is postponed and the next review of the 
patient is scheduled within a month. Nevertheless, if AMD is unstable, the effectiveness of 
anti-VEGF therapy must be guaranteed prior to decide the retreatment. In fact, patients not 
responding to the treatment may require a different therapy, hence the anti-VEGF treatment is 
permanently discontinued for the following cases: 
 There is established or suspicion of hypersensitivity to the anti-VEGF agents used on 
the therapy (Ranibizumab, Aflibercept and Bevacizumab). 
 VA decreased for three consecutive reviews below 0.1 in decimal scale. 
 Progressive deterioration of the morphology of the lesion, detected either by fundus 
examination or by OCT. 
Finally, those patients with signs of progression but responding to previous treatments receive 
immediately a new intravitreal injection and next review is scheduled within a month. 
B.2 Study of Clinical Concepts 
At this point, the stages of the clinical process defined above were reviewed so as to identify the 
clinical concepts to be included in the electronic model. Nevertheless, the high resolution consultation 
proposed for monitoring patients receiving treatment for wet AMD is still in a pilot stage. This means 
that this healthcare approach will coexist with the traditional face-to-face consultation whilst the high 
resolution consultation is validated for the healthcare scenario of ophthalmology in the SNS-O. 
Hence, the EHR system must be prepared to handle indistinctly the information resulting from both 
strategies of consultation. In this sense, given that the high resolution consultation must cover the 
same procedures comprehended in traditional consultations held in an office of specialized care, the 
clinical concepts considered at this point should be valid for both models (Table 8). Nonetheless, the 
implementation of the new model has to be supported by objective parameters of efficiency and 
reliability with respect to the face-to-face consultation which to date is regarded as gold standard.  
In consequence, besides the clinical concepts identified in the clinical process above, administrative 
and sociodemographic concepts for benchmarking both approaches were also considered. The 
inclusion of those non-clinical concepts in the modelling would enable the analysis of 
sociodemographic information (current age, sex, age at diagnosis, VA when the study began), the 
study of comparative administrative variables (time spent during each consultation, compliance with 
established time limits between revisions, need to repeat treatment, record of problems such 
endophthalmitis stemming from the treatment), and the consequent data mining of the studies from 
each of the two approaches (number of treatments received along the year of monitoring, patients 
with VA below 0.1, cases with no treatable damage). The outcomes of these parameters would be 
useful to take further steps toward validation of the high resolution consultation. 
With consideration of all the above, the concepts listed in Table 8 were chosen to model a service that 
would gradually integrate in the SNS-O a high resolution consultation, into the current service 
monitoring the treatment of wet AMD. As seen in Table 8, the concepts identified at this point were 
reused, whenever possible, from those available either in the CKM or described in the preceding 
model presented for DR screening. 
B.3 Hierarchical Organization of Knowledge Artefacts 
As in the modelling of the DR screening service, the clinical concepts identified in previous step were 
structured according to their occurrences into the clinical stages described along step B.1. Although 
this time, most concepts were reused from the archetypes modelled for the DR screening service. Thus, 
the organization of the concepts gained relevance with respect to the effort put into modelling.  
In that respect, the work team designed the diagram shown in Figure 20 according to the 
specifications for establishing the hierarchy between knowledge artefacts proposed in Figure 9. 
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Table 8: Clinical concepts identified as a result of studying each stage in the service proposed to 
monitor the treatment of AMD. 
 Identified concept name Equivalent archetype 
Archetype 
class 
Process stages in 
which it is applicable 
1.  Reason for encounter 
- Found on CKM 
- Usable as is 
Evaluation Stage 1 
2.  Story/history 
- Found on CKM 
- Usable as is 
Observation Stage 1 
3.  Symptom/Sign 
- Found on CKM 
- Usable as is 
Cluster Stage 1 
4.  Visual acuity 
- Found on CKM 
- It has to be adapted 
Observation 
Stage 1 
Stage 4 
5.  
Funduscopic 
examination of eyes 
- Concept reused from DR 
screening service 
Observation 
Stage 1 
Stage 4 
Stage 5 
6.  
Ophthalmic tomography 
examination 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Observation 
Stage 1 
Stage 4 
Stage 5 
7.  Clinical synopsis 
- Found on CKM 
- Usable as is 
Evaluation 
Stage 1 
Stage 5 
8.  Problem/diagnosis 
- Found on CKM 
- Usable as is 
Evaluation 
Stage 1 
Stage 5 
9.  
Classification of age-
related macular 
degeneration 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Cluster 
Stage 1 
Stage 5 
10.  Contraindication 
- Found on CKM 
- Usable as is 
Evaluation 
Stage 1 
Stage 5 
11.  Recommendation 
- Found on CKM 
- Usable as is 
Evaluation 
Stage 1 
Stage 5 
12.  
Enrolment in a long-
term healthcare process 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Evaluation 
Stage 1 
Stage 5 
13.  Medication order 
- Found on CKM 
- Usable as is 
Instruction Stage 2 
14.  Medication action 
- Found on CKM 
- Usable as is 
Action Stage 2 
15.  
Intravitreal injection 
details 
- Concept reused from DR 
screening service 
Cluster Stage 2 
16.  Adverse reaction 
- Found on CKM 
- Usable as is 
Evaluation Stage 2 
17.  Care plan (request) 
- Found on CKM 
- Usable as is 
Instruction Stage 3 
18.  Care plan 
- Found on CKM 
- Usable as is 
Action Stage 3 
19.  Referral request 
- Found on CKM 
- Usable as is 
Instruction Stage 3 
20.  
Imaging examination 
request 
- Found on CKM 
- Usable as is 
Instruction Stage 3 
21.  
Acquisition details on 
eye fundus images 
- Concept reused from DR 
screening service 
 
Cluster 
 
Stage 3 
Stage 4 
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 Identified concept name Equivalent archetype 
Archetype 
class 
Process stages in 
which it is applicable 
22.  
Acquisition details on 
ophthalmic tomography 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Cluster 
Stage 3 
Stage 4 
23.  Procedure 
- Found on CKM 
- Usable as is 
Action Stage 4 
24.  Medical device 
- Found on CKM 
- Usable as is 
Cluster Stage 4 
25.  Medical device details 
- Found on CKM 
- Usable as is 
Cluster Stage 4 
26.  Imaging examination 
- Found on CKM 
- Usable as is 
Action Stage 4 
27.  Anatomic location 
- Found on CKM 
- Usable as is 
Cluster Stage 4 
28.  Mydriasis application 
- Concept reused from DR 
screening service 
Cluster Stage 4 
29.  Medication amount 
- Found on CKM 
- Usable as is 
Cluster Stage 4 
30.  
Diagnostic report 
request 
- Concept reused from DR 
screening service 
Instruction 
Stage 4 
Stage 5 
31.  Service request 
- Found on CKM 
- Usable as is 
Instruction 
Stage 4 
Stage 5 
32.  
Healthcare procedure 
efficiency 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Admin entry Stage 5 
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Figure 20: Hierarchy among the knowledge artefacts involved in the treatment of wet AMD.
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4.2.3 BUILDING THE ELECTRONIC MODEL 
C.1 Creation and Update of Archetypes 
The high resolution consultation proposed to monitor the treatment for wet AMD consists of 32 
different archetypes (excluding organizational section and composition type archetypes). 
From those, 21 were obtained from the openEHR CKM and directly used on the model. Besides, the 
“Visual acuity” archetype was also included, in whose development we were actively engaged so as to 
meet the requirements of our electronic models. With regard to the remaining 10 archetypes not 
provided by CKM, only half were completely new, whereas the rest were reused from those previously 
modelled for the DR screening service (see Table 8). 
From the new archetypes proposed, “Healthcare procedure efficiency” is noteworthy. It introduces the 
admin entry class into the electronic model: a new type of entry-type archetype besides the care entry 
archetypes (observation, evaluation, instruction and action) seen up to now. This new type of 
archetype is used to capture administrative information in parallel to the clinical activity recorded by 
care entry archetypes. 
In this regard, the “Healthcare procedure efficiency” archetype was designed to register objective 
parameters regarding the evaluation of efficiency for a specific healthcare activity, namely the 
encounter type, duration, healthcare resources expended, success of the encounter and so on.  
Thereby, it constitutes a powerful tool to evaluate the efficiency for a specific healthcare activity, and 
hence a means of improving the management of healthcare resources. As proof of concept, this 
archetype proved to be useful regarding the treatment of wet AMD, in terms of comparing the high 
resolution consultation with the traditional face-to-face approach. 
C.2 Definition of Semantic links to Clinical Terminologies 
A total of 10 different termsets were used to extend the terminology of archetypes involved in the 
electronic model. Nevertheless, according to reusability of the knowledge artefacts, eight of the 
termsets initially designed for the DR screening service proved to be applicable too in the clinical 
process monitoring the treatment for wet AMD. Furthermore, some of the termsets were reused along 
the clinical process corresponding to wet AMD (see Figure 20). 
Consequently, only two new termsets had to be specifically created to adjust the electronic model to 
the new healthcare scenario proposed. Those new termsets were built on the basis of tables 
normalized in the DICOM standard, so as to increase their use in future healthcare scenarios.  
All the aforementioned termsets and their use along the stages in the clinical process are described in 
Table 9. 
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Table 9: Termsets modelled to support the archetypes in the service proposed to monitor the treatment of AMD. 
 
Termset name Description of termset Availability 
Process stages in 
which it is applicable 
1.  Findings on posterior pole of eye Clinical findings identifiable in posterior pole of eye. Reused from DR screening 
Stage 1 
Stage 5 
2.  Anatomic structures of eye 
List of regions of interest in the study of eye (based on 
DICOM Tables: CID 4209, CID 4211 and CID 4266). 
Newly created 
Stage 1 
Stage 3 
Stage 4 
Stage 5 
3.  Compounds for intravitreal injection 
Compounds administered in ophthalmology in the form 
of intraocular injection. 
Reused from DR screening Stage 2 
4.  Compounds for local anaesthesia Compounds available to apply local anaesthesia. Reused from DR screening Stage 2 
5.  Anti-infective agents List of anti-infective agents available. Reused from DR screening Stage 2 
6.  Subdivision of retina 
List of zones in eye retina for ophthalmic image 
positioning. 
Reused from DR screening 
Stage 3 
Stage 4 
7.  Mydriatic agents 
List of mydriatic agents and their corresponding doses 
validated for ophthalmologic use. 
Reused from DR screening Stage 4 
8.  
Complications on ophthalmic image 
acquisition 
List of possible complications during ophthalmic imaging 
studies that may affect the quality of acquisitions (based 
on Table CID 4222 of DICOM standard). 
Reused from DR screening Stage 4 
9.  Ophthalmic photography devices 
Lists the ophthalmic photography acquisition devices 
(based on Table CID 4202 of DICOM standard). 
Reused from DR screening Stage 4 
10.  Ophthalmic tomography devices 
List of acquisition devices (based on Table CID 4210 of 
DICOM standard). 
Newly created Stage 4 
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C.3 Building Templates 
The archetypes modelled in previous steps were structured into templates in the same way as 
described for the remote screening service for DR. As a result of that modelling, 16 different templates 
were built: among those, 11 corresponded to templates designed to adapt the archetypes contained 
in each section identified in Figure 20 to the requirements of the service for monitoring the treatment 
of AMD. The remaining 5 templates were designed to manage the information corresponding to each 
one of the stages in which the healthcare was divided along the clinical process seen in Figure 20. 
Among those templates corresponding to sections, 3 were reused along the clinical process: 
considering that there is some common ground between the first encounter for patient admission and 
the subsequent AMD assessments, the templates “Classification and treatment of AMD” and “Patient’s 
enrolment in anti-VEGF therapy” were reused along the first and last stage. Likewise, the archetype 
“Next step in AMD monitoring service” was devised to manage the pathway among stages, so it was 
first used at the fourth stage to refer patients toward the office assessment once all diagnostic tests 
were acquired, but besides, turned out to be useful at the fifth stage to schedule the next review in a 
month, and then, arrange or postpone the anti-VEGF treatment. 
In addition, the DR screening service modelled beforehand provided interesting patterns with regard to 
the current proposal for AMD. In this sense, 2 templates initially modelled for the DR screening were 
reused with the consequent time saving for modellers: 
− Intraocular injection: Although originally used by the DR screening service, its template had to 
be enhanced since the intraocular injection is a critical activity on the treatment of wet AMD. 
Therefore, the corresponding template was redesigned in light of the service monitoring the 
treatment of AMD, and then, the model that describes the DR screening was retrospectively 
updated. Thus, at this point both models share the same template “Intraocular injection”. 
− Funduscopic test: This diagnostic test is required on both clinical processes, so its 
corresponding template “Acquisition and validation of NMR” resulted equally applicable in 
both models. 
Many other templates used in the AMD monitoring service were slightly adapted from those originally 
built for the DR screening. For example, the templates “Patient's background leading to the diagnosis 
of AMD” and “Classification and treatment of AMD” enclose practically the same archetypes used in 
“Patient's background leading to suspicion of DR”, but including some additional archetypes specific 
to the diagnosis of wet AMD.  
Finally, the “Diagnostic tests in the DR screening service” and “Diagnostic tests for monitoring the 
treatment of wet AMD” share the same structure although the archetypes included must cover different 
diagnostic tests (see Figure 21).  
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Figure 21: The structure of templates envisaged to register clinical encounters resulting from 
the high resolution consultation devised to monitor the treatment of wet AMD.
SYMBOL LEGEND
Follow-up schedule for the 
treatment of wet AMD
Patient admission into the long-
term treatment for wet AMD
Encounter
Intraocular injection (anti-VEGF)
Patient's background
Clinical decision
Visual acuity study
Clinical image acquisition 
and validation
Clinical image acquisition 
and validation
Image test analysis
Clinical decision
Patient‟s admittance 
Intraocular injectionProgress note
Patient's background leading to the 
diagnosis of AMD
Classification and treatment of 
AMD
Progress note Visual acuity study
Acquisition and validation of NMR
Acquisition and validation of OCT
Diagnostic tests for monitoring 
the treatment of wet AMD
AMD assessment
Result report Image test analysis for AMD
Classification and treatment of 
AMD
Patient‟s enrolment in anti-VEGF 
therapy
AMD treatment
Templates
Reused templates
Entry class archetypesComposition-type archetypes
Section-type archetypes Cluster-type archetypes
Patient‟s admittance
Next step planning
Next step in AMD monitoring 
service
Analysis of clinical encounter
Evaluation of the remote 
assessment model for wet AMD
Patient‟s enrolment in anti-VEGF 
therapy
Diagnostic test planningRequest for service
Planning the diagnostic tests to 
monitor AMD progression
Next step planning
Next step in AMD monitoring 
service
- 103 - 
 
C.4 Modelling Guideline Rules and Workflow 
Six rules were designed to govern patients‟ flow through the clinical process. The archetypes 
participating in these rules can be found in Appendix A:  
− Anti-VEGF therapy convenient: From every patient diagnosed with wet AMD, only those which 
comply with this rule will access to the long-term treatment of wet AMD by intravitreal 
injections. Thus, this rule is activated when, after a consultation on specialized care, a 
retinologist determines whether the anti-VEGF therapy is convenient or not for the current 
patient. The archetype named “Enrolment in a long-term healthcare process” is used to 
register such decision.  
This rule checks the value chosen in the data element “admittance” of that archetype, and if 
the patient is inscribed in the therapy, activates the medication order to initiate the first cycle 
of anti-VEGF treatments comprised of three monthly intraocular injections.  
− Treatment cycle completed: This rule verifies if every anti-VEGF injection ordered for a 
specific patient have been carried out, and, if true, automatically schedules the next 
consultation for patient review. Basically, it checks for every new contribution submitted to the 
EHR, if the pathway of the archetype “Medication action” has been registered as completed. 
If so, the rule queries the CPOE manager for all open orders for intravitreal injections related 
to a specific patient, and then tags as closed the corresponding one. At this point, in case of 
treatment discontinuation for whatever reason, the retinologist must intervene in consequence 
either by ordering again the missing interventions or by suspending definitively the treatment. 
Once all medication orders for intravitreal injection have been closed, this rule determines 
that the cycle of treatments is completed. As a result, the archetype “Care plan (request)” is 
instantiated, in which the diagnostic tests involved on reviewing the outcomes of the treatment 
for wet AMD are specified.  
− Diagnostic tests completed: Similarly to the preceding one, this rule must guarantee the 
completion of every diagnostic test ordered for a specific patient before proceeding with the 
remote assessment. Except instead of medication orders for intravitreal injection, this rule 
must coordinate the lifecycle of every diagnostic test scheduled to review the effectiveness of 
the treatment of wet AMD (i.e. VA, NMR and OCT). 
To that end, every new contribution of the archetype “Care plan” submitted to the EHR that 
corresponds to the “Service for monitoring the treatment of wet AMD” is reviewed. When the 
pathway of this archetype is set to “Care plan completed”, it means that every diagnostic tests 
scheduled within the follow-up have been acquired. Consequently, the rule uses the 
archetype “Diagnostic report request” to request the remote assessment for the set of 
diagnostic tests acquired. 
− AMD stable: Provided that the retinologist does not identifies signs of activity or progression 
on AMD since the last review (neither new haemorrhages nor worsening of VA), a new anti-
VEGF injection would not be effective to treat such disease. In light of the above, this rule 
checks the therapeutic decision in the archetype “Recommendation”, and if the therapeutic 
recommendation corresponds to “Do not treat”, the rule will schedule the respective 
diagnostic tests to review the patient in a month. In this way, the progression of the disease is 
periodically monitored, whereas the treatment is postponed until applying the injections is 
really effective. At this point, the archetype “Service request” is instantiated to schedule the 
follow-up service for the treatment of wet AMD, where the diagnostic tests included in the 
monthly revision of wet AMD are planned (VA, NMR and OCT). 
− Repeat anti-VEGF treatment: This rule orders a new intravitreal injection if the retinologist, as 
a result of the assessment of diagnostic tests, determines that the patient presents signs 
activity or progression on AMD. The criteria to repeat the treatment is the worsening of VA 
associated to macular fluid, identifying macular fluid, and emerging new haemorrhages 
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within the macula. If any of these criteria are identified during the remote assessment of a 
patient, the retinologist would set the “Intravitreal anti-VEGF injection” as therapeutic 
recommendation for the archetype “Recommendation”. Likewise, the rationale of the same 
archetype would be used to register the criteria used to reach that therapeutic decision. 
Finally, the retinologist must reconsider patient's enrolment in the intravitreal anti-VEGF 
therapy. Thus, the positive value of admittance registered in the archetype “Enrolment in a 
long-term healthcare process” for the healthcare process “Long-term therapy of anti-VEGF 
intravitreal injections” will trigger this rule. And whenever this rule is triggered, it will 
instantiate the “Medication order” archetype so as to schedule the anti-VEGF injection 
corresponding to the current month. 
− Discontinuation of anti-VEGF therapy: Finally, if the minimum conditions of “Admittance” for 
the long-term therapy of anti-VEGF intravitreal injections are not fulfilled, directly the patient 
would not be included into the cycle of treatments (stage 1: anti-VEGF therapy not indicated). 
Moreover, if the patient is already included in the cycle of anti-VEGF injections, but the 
retinologist identifies contraindications to continue with the therapy during any of the periodic 
assessments, the patient's enrolment in the long-term treatment for wet AMD will be revoked 
(stage 4: patient not responding to treatment). Both scenarios above will trigger this rule, 
which in consequence excludes the patient from the treatment and then schedules the next 
consultation for AMD review at the retinologist's office. Thereby, these patients fall beyond the 
scope of our model, given that they have been excluded from the long-term therapy of anti-
VEGF injections. 
With consideration of the above, first of all, the rule verifies the latest contribution in the EHR 
of the archetype “Classification of age-related macular degeneration”. In fact, only patients 
with the classification of “Exudative or wet AMD” are covered by the long-term therapy 
proposed, so other diagnoses will trigger this rule. 
Conversely, if the diagnosis of AMD corresponds to the abovementioned classification, then 
the rule must verify if there is any contraindication that could jeopardize effectiveness of 
intravitreal injections: 
 Exclusion criteria for new patients: During the admission stage of the anti-VEGF 
therapy, those patients who show very low VA (below 0.1), healed lesions due to 
previous treatments (PDT, laser photocoagulation scars, or any vitreoretinal 
operative procedure), multimorbidity (coexistence of AMD with other alterations on 
the retina causative of visual impairment), or any known adverse reaction to anti-
VEGF agents used in intravitreal injections will definitely trigger this rule. 
 Exclusion criteria for permanent discontinuation of therapy: From the patients 
already receiving intravitreal anti-VEGF injections, those who at some point have 
presented hypersensitivity to the anti-VEGF agents used in the injections, those not 
responding to treatment (VA decreased for three consecutive reviews below 0.1 in 
decimal scale), and cases affected by a progressive deterioration of the morphology 
of the lesion will definitely trigger this rule. 
In this regard, any contribution to the archetype “Contraindication” referring to intravitreal 
anti-VEGF injections will lead to withdraw the patient from therapy. 
Thus, if any of the conditions above triggers the rule, it would be necessary to place on 
record the exclusion of the patient from the “Long-term therapy of anti-VEGF intravitreal 
injections”. So that, the value of “Admittance” in the archetype “Enrolment in a long-term 
healthcare process” is set to false, and “Criteria” is established according to the value of 
“Evidence/Rationale” registered within the archetype “Contraindication”. Finally, the “Service 
request” archetype is instantiated so as to schedule next patient's review at the retinologist's 
office. 
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Table 10: Description of the guideline rules designed for the high resolution consultation proposed to monitor the treatment for wet AMD. 
 Rule name Conditions Actions 
1.  
Anti-VEGF therapy 
convenient 
The precondition for this rule is the therapeutic 
recommendation of “Intravitreal anti-VEGF injection” for 
the archetype “Recommendation”. 
Archetype “Enrolment in a long-term healthcare process”: 
 Healthcare process: “Long-term therapy of anti-VEGF 
intravitreal injections” 
 Admittance: “True”  
Archetype instantiated  “Medication order”: 
 Dose directions description: “Intravitreal anti-VEGF injections for wet 
AMD” 
 Dose timing description: “Three monthly intraocular injections” 
Other details about the intravitreal injection will depend on each clinical 
setting. 
2.  
Treatment cycle 
completed 
Archetype “Medication action”: 
 Reason: “Treatment of wet AMD” 
 Pathway: “Complete medication” 
All orders active in the CPOE for a specific patient, which 
belong to the treatment of wet AMD must be completed. 
Archetype instantiated “Care plan (request)”: 
 Care plan name: “Service for monitoring the treatment of wet AMD” 
Archetype instantiated  “Referral request”: 
 Service requested: VA test 
Archetype instantiated “Imaging examination request”: 
 Service requested: NMR 
 Service requested: OCT study 
3.  
Diagnostic tests 
completed 
Archetype “Care plan”: 
 Care plan name: “Service for monitoring the 
treatment of wet AMD” 
 Pathway: “Care plan completed” 
Archetype instantiated “Diagnostic report request”: 
 Service requested: “Remote assessment of wet AMD” 
 Reason for request: “Completed the diagnostic tests necessary for 
assessment” 
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 Rule name Conditions Actions 
4.  AMD stable 
Archetype “Recommendation”: 
 Therapeutic recommendation: “Do not treat” 
Archetype instantiated: “Service request”  
 Service name: “Follow-up schedule for the treatment of wet AMD” 
 Description: “Follow-up comprised by VA, NMR, OCT tests” 
 Service due: 1 month 
5.  
Repeat anti-VEGF 
treatment 
Similarly to the first rule, the precondition for this rule is 
the therapeutic recommendation of “Intravitreal anti-VEGF 
injection” for the archetype “Recommendation”. Then, 
patient's enrolment in the intravitreal anti-VEGF therapy is 
reviewed. 
Archetype “Enrolment in a long-term healthcare process”: 
 Healthcare process: “Long-term therapy of anti-VEGF 
intravitreal injections” 
 Admittance: “True” 
Archetype instantiated: “Service request”  
 Service name: “Repeat anti-VEGF injection to treat wet AMD” 
Archetype instantiated  “Medication order”: 
 Dose directions description: “Intravitreal anti-VEGF injections for wet 
AMD” 
 Dose timing description: “A monthly intraocular injection” 
Other details about the intravitreal injection will depend on each clinical 
setting. 
6.  
Discontinuation of 
anti-VEGF therapy 
Archetype “Classification of age-related macular 
degeneration”: 
 AMD classification != “Exudative or wet AMD” 
In addition, any new contribution of the archetype 
“Contraindication” referring to intravitreal anti-VEGF 
injections will definitely trigger this rule. 
Archetype instantiated  “Enrolment in a long-term healthcare process”: 
 Healthcare process: “Long-term therapy of anti-VEGF intravitreal 
injections” 
 Admittance: “False” 
 Criteria = Evidence/Rationale (in archetype “Contraindication”) 
Archetype instantiated  “Diagnostic report request”: 
 Service name: “Review of AMD state at the retinologist's office” 
 Reason for request: “Patient not responding to treatment” 
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C.5 Modelling UI Forms 
Following the same guidelines described for the DR screening service, 5 UI forms were created using 
the Marand EhrExplorer. These UI forms represent each one of the stages that comprise the AMD 
monitoring service proposed. This will enable to automatically generate the UI views to be displayed 
on front-end applications, based on the UI specifications detailed on the form-description files 
resulting from the UI modelling. However, given the lack of consensus on the definition of UI form 
specifications, the parsers available which transform the form specifications resulting from the Marand 
EhrExplorer into HTML views, will only work for front-end applications devised for the Marand 
EhrScape server. Therefore, specific UI generators must be implemented in order to reuse our UI form 
definitions into front-end applications compliant to other openEHR-compliant EHR implementations. 
For example, in the case of the open source applications proposed by Cabolabs, the UI generator 
from the openEHR-OPT project can be adapted to parse the UI form-description files instead of the 
OPTs used to define these UI forms. In this way, anyone could build their own HTML front-end 
applications based on the UI form definitions modelled in this Thesis. 
4.2.4 IMPLEMENTATION OF THE SERVICE 
Currently, both the high resolution consultation and traditional approach coexist in the SNS-O toward 
monitoring patients receiving anti-VEGF therapy for wet AMD. This stems from the fact that the high 
resolution consultation proposed is still in a pilot stage. As such, before proceeding with an extensive 
implementation, it must prove its efficiency and reliability against traditional consultation.  
As regards the traditional consultation model, except for the OCT acquisitions provided in printed 
form, the diagnostic tests involved in the study of AMD require the presence of the patient at the 
ophthalmologist's office (measurement of VA and eye fundus examination using slit lamp 
biomicroscopy). This facilitates the face-to-face assessment, in contrast to the high resolution 
consultation approach, which redistributes those diagnostic tests among specialized workspaces. Thus, 
in case of the latter approach, the evaluation of the acquisitions resulting of all those workspaces must 
be managed remotely. At this point, the need arises to share through the corporate network of the 
SNS-O, the studies acquired concerning the diagnosis and follow-up of AMD. Therefore, the proposal 
of a remote assessment service entails reconsidering the technical requirements of the current 
healthcare service, initially designed to accommodate the traditional consultation. 
In that respect, the ICT infrastructure arranged in the SNS-O for the DR screening service described 
along section 4.1 was reused to cover some of the technical requirements of the high resolution 
consultation. On the one hand, the workspace allocated for diagnostic test acquisition in DR 
screening was adapted to receive also patients affected by wet AMD. As seen in section 4.1.4, this 
workspace already included tonometry and pachymetry devices for IOP measurement, a non-
mydriatic retinal camera, and a PC workstation to register findings identified during acquisitions. Thus, 
by installing a Snellen chart for VA measurement, this space covered every diagnostic test specified for 
the first workspace of the high resolution consultation.  
On the other hand, given that in principle, the OCT test is not considered for the DR screening, a new 
workspace was allocated in the SNS-O to host that test according to the specifications of the high 
resolution consultation. There, to connect such diagnostic device to the PACS server available in the 
healthcare service, the workstation and the server side were configured in compliance with DICOM 
specifications for both ends. 
Moreover, the workspace allocated for remote assessment whether in the case of DR or AMD, it was 
established into the office of an ophthalmologist expert in retina. In that office, the ophthalmologist 
uses a PC workstation, connected to the PACS and EHR servers, to evaluate remotely the diagnostic 
tests and then register the diagnostic reports. Furthermore, given that some diagnostic tests are 
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overlapped in the study of both DR and AMD, the whole set of tests contained in the PACS would be 
accessible regardless the process for which they were originally intended. 
As proof of concept for the healthcare scenario modelled along this chapter, the archetypes and 
templates built were loaded into an openEHR-compliant EHR. The same information systems used in 
the DR screening service were chosen to that end, namely the EHRServer and the EHRCommitter, both 
developed by Cabolabs [181, 182]. In this way, clinicians involved in both clinical processes can use 
the same EHR system to register clinical information specific to each healthcare scenario.  
For the time being, the openEHR-compliant EHR is only used for research purposes, hence medical 
records must be recorded into the main EHR in the SNS-O as well. And once it is proved that the 
openEHR-compliant EHR is reliable enough to be connected to the main EHR, both information 
systems will be able to exchange EHR extracts. Consequently, the information among systems will be 
coordinated automatically.  
 
Figure 22: Flux of information through the service monitoring the treatment of wet AMD. 
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Building on the electronic model described for the service monitoring the treatment of wet AMD, a 
solution was considered in order to standardize the information recorded through the web platform 
launched at the SNS-O to evaluate the telemedicine model for wet AMD follow-up [38]. Originally 
this platform was not compliant to the openEHR specifications, but given the clinical domain in 
common, it could be easily standardized using the knowledge artefacts modelled along this section.  
Standardization of the platform would enable to exchange medical records with other systems 
compliant to openEHR, hence extending the applicability of the information registered beyond the 
walls of an institution. Likewise, fine-grained data-mining functionalities would be enabled thanks to 
the semantically computable EHR data. This could be a proof of concept toward integration of many 
software tools and information systems found in health services, which being designed for very specific 
healthcare scenarios, usually end up being an information silo. 
The challenge on this approach was to model, ex post, the use case scenario presented in the web 
platform. Therefore, instead of generating the UI views from the knowledge models, the modelling 
was reversed to avoid having to modify the UI views defined on the non-standardized web platform. In 
this case, an OPT was specifically designed to conform to the clinical concepts originally registered 
through the web platform as described in Appendix B. Most of the clinical concepts defined in the 
OPT have direct correspondence with the data fields represented on the UI forms. Conversely, other 
concepts defined in the OPT are not shown on the view. These must be inferred from the context, 
since the clinical practice is well-known for this healthcare scenario. 
The aforementioned template was modelled in compliance with the ADL 1.4 specifications, using the 
template designer developed by Ocean Informatics. Once finished, it was uploaded to the CKM 
under the name of “Consultation for AMD assessment”, thus allowing the OPT to be available for 
everyone to download (steps 1 and 2 in Figure 23).  
Next, the methods provided by the project openEHR-OPT of Cabolabs were used to extract the paths 
pointing to every data element specified within the OPT [185](step 3 in Figure 23). Each one of those 
paths was then assigned to equivalent data fields identified in the HTML file that depicts the UI form at 
the web platform. The data types (according to the openEHR reference model), default values, and 
other data constraints were also included into the HTML elements where necessary (step 4 in Figure 
23).  
Furthermore, the resulting HTML view was integrated with a controller as explained in the openEHR-
skeleton example of how to create e-health apps [186]. This controller is responsible for validating the 
data entered in the form, creating EHR instances from these data, and committing them to the EHR. In 
this regard, the openEHR-OPT was used to validate the clinical data, and compose new EHR 
instances in conformance with the openEHR EHR information model [185]. Indeed, the openEHR 
compositions generated whenever the HTML form is submitted, may be considered equivalent to a 
signed clinical document. In this way, although the resulting HTML form apparently presents no 
changes for end users, it would be prepared to exchange medical records with openEHR-compliant 
EHR systems (step 5 in Figure 23). To that end, the project EHRCommitter developed by Cabolabs 
was adapted to send the resulting versioned compositions to the EHRServer [182] (last step in Figure 
23). 
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Figure 23: Adaptation of data registered through the non-standardized web platform into openEHR-compliant medical records.
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4.3 MODELLING AN E-HEALTH BASED FOLLOW-UP PROCEDURE FOR CG 
As seen in section 2.1, individuals affected with CG are asymptomatic until late in the disease 
process, while even mild VF loss decreases health-related quality of life. Furthermore, once patients 
with CG have been diagnosed, they would require lifelong ophthalmic care. Consequently, although 
the clinical course of CG is usually slow, periodic examinations are necessary to detect the slightest 
hint of disease progression. 
In this regard, a follow-up service for patients undergoing therapy of CG would make it possible for 
ophthalmologists to adapt the treatment whenever considered necessary to slow or prevent the VF loss 
before it becomes significant. This section of the PhD dissertation defines a proposal to that effect that 
leverages ICTs and model-driven information systems in healthcare to manage efficiently the follow up 
of any sign of progression in patients diagnosed with CG. 
4.3.1 DEFINITION OF THE PROJECT 
Considering the complexity of the overall health management in glaucoma, the modelling proposed 
was focused on the follow-up of patients already diagnosed with CG who are medically stable. 
Regarding those patients, with the treatments available nowadays, many of them do not exhibit signs 
of progression or worsening over the long term. Therefore, the healthcare process concerned comes 
down to check periodically if the disease shows signs of progression. And, if so, to adapt the treatment 
accordingly. 
As seen in section 2.1.3, the follow-up of patients receiving treatment for CG relies on observation of 
the optic disc, examination of the VF, measurement of IOP and the VA. Thus, the traditional model to 
monitor the progression of the disease requires numerous consultations with ophthalmologists to 
address the clinical tests and decide accordingly the suitable treatment. However, after analysing 
individually the diagnostic tests concerned in the follow-up of glaucoma, none of them require the 
presence of an ophthalmologist during acquisition.  
The use of a tonometer and a pachymeter for IOP measurement as well as the VA test are reasonable 
processes for specifically trained personnel. Additionally, digital retinography can reliably substitute 
the direct examination, hence specifically trained nurses and imaging technicians can reliably 
photograph the optic disc with sufficient quality for diagnosis [170]. Finally, the OCT to observe the 
thickness of fiber layers surrounding the optic disc, and the perimetry to register the VFs are usually 
carried out by auxiliary personnel.  
Consequently, it is feasible to establish an e-ophthalmology-based model that distinguishes the stage 
of acquisition for the diagnostic tests, from the later examination and assessment of clinical data. In 
this way, the clinical encounters aimed to diagnostic acquisitions are handled in parallel in 
workspaces assigned for that purpose. Meanwhile, ophthalmologists expert in glaucoma can access 
to the results of the whole set of tests concerned in the follow-up and hence decide if the current 
treatment is the most suitable for each case. 
Unlike the model proposed for DR screening, due to the complexity of identifying the progression of 
the glaucoma, ophthalmologists are the only ones responsible of the examination and assessment of 
diagnostic tests. However, improving the patient flow on clinical encounters aimed to acquisition and 
validation of diagnostic tests brings key advantages to the management of CG: 
− A more agile workflow: Patients affected with CG require periodic examinations to assess the 
progression of the disease. However, none of the diagnostic tests involved in those 
examinations requires the presence of an ophthalmologist. Therefore, an e-health approach 
would enable a redistribution of the workload into differentiated workspaces managed by 
specifically trained personnel. Consequently, the waiting lists would be alleviated compared 
to standard clinical procedure which present a bottleneck in the office of ophthalmology [33]. 
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− Broader diagnostic perspective: All measurements and diagnostic images implied in the 
follow-up are accessible ubiquitously. Thus, once those have been acquired in distributed 
workspaces, the ophthalmologists would examine remotely the resulting diagnostic tests using 
a single workstation. Thereby, all diagnostic information required to determine an accurate 
diagnosis is displayed in a single screenshot, whereas the traditional approach requires 
numerous consultations. As a result, the therapeutic decisions made using the e-health 
approach are supported by a comprehensive study of the disease. 
− Less time-consuming for specialists: From a clinical standpoint, e-health models are less time-
consuming for specialists than standard clinical evaluations. Furthermore, as the assessment 
is not limited to the timing of patients during clinical encounters, ophthalmologists can 
multitask, and thereby organize more efficiently their work time. Thus, in view of the fact that 
the scarcity of ophthalmologists with expertise in glaucoma limits the capacity of the service, 
an efficient use of the time of specialists would foster the assistance of a greater number of 
patients. 
− Comparison of studies retrospectively: The comparison of clinical information corresponding 
to the same patient, but registered along different consultations successive in time provide 
interesting information about disease progression. In that respect, the follow-up service 
proposed has a clear advantage with regard to the medical records in paper. Indeed, in case 
of the e-health model, a single workstation provides ubiquitous access to all clinical 
information registered longitudinally along the healthcare process of each patient.  
− Clinical data mining: The digitized diagnostic tests, and normalized clinical records enable 
the development of powerful tools for data mining. These tools, in turn, foster the design of 
clinical and epidemiological studies based on the clinical information registered during the 
follow-up of CG. The outcomes of these studies will provide objective and real-time 
information to support on decisions made toward improving the management of the follow-
up service. 
Considering these premises, a multidisciplinary work team including ophthalmologists and nurses 
from the SNS-O, and engineers with expertise in implementation of ICTs in healthcare were convened 
to redesign the follow-up service in the SNS-O for CG.  
4.3.2 DESIGN OF THE CLINICAL PROCESS 
B.1 Definition of the Clinical Process  
With consideration of the signs of evolution in CG such as morphologic changes on parapapillary 
region or VF loss can be very subtle but still progressive over the long term, the work team devised a 
follow-up service to review patients undergoing treatment of CG in the SNS-O. 
As seen in Figure 24, first and foremost patients have to go through three consultations on specialized 
care to determine the diagnosis and a stable treatment for CG: suspicion of glaucoma, diagnosis of 
glaucoma and establishment of long-term therapy. Originally, these consultations fall outside the 
scope of the follow-up service. Nevertheless, the information registered up to this point will provide a 
baseline to identify the slightest sign of glaucomatous progression with regard to the disease trajectory 
envisioned for every new patient enrolled in the follow-up service. 
Once patients are medically stable, they are included in the circuit monitoring the evolution of CG. 
Then, as seen in Figure 25, the specialist arranges the next review specifying the diagnostic tests 
necessary for the follow-up of each case of CG. That review begins with the acquisition and 
digitization of the diagnostic tests requested by the specialist. Specialised workspaces managed by 
nurses and imaging technicians are allocated to that end. Once all scheduled diagnostic tests have 
been completed, their results are recorded into the respective information systems (EHR and PACS).  
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Figure 24: Activity diagram describing the overall management of CG in the SNS-O.
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Thereafter, the specialist would assess from a remote workstation all acquisitions comprised on the 
follow-up of a patient, so as to identify any sign of glaucomatous progression. Stable patients are 
therefore scheduled for next review, whereas patients presenting progressive glaucoma are called for 
further examination at the office of specialised care. During the office examination, the glaucoma 
specialist would conduct the additional examinations considered necessary to determine the 
appropriate therapy that would curb the progression of glaucoma into a medically stable state. 
At this point, the follow-up service proposed for CG was organized into the background described in 
Figure 24, which consists of the consultations in specialised care preceding the diagnosis of 
glaucoma, plus the subsequent four clinical stages identified in Figure 25. Each one of these stages is 
analysed in detail along this section: 
− BACKGROUND (Diagnosis and treatment of CG): Patients who presented potential signs of 
glaucoma during routine eye consultations, or on the review of a specific eye condition, and 
patients with family history of glaucoma are referred to the office of an ophthalmologist 
specialized on glaucoma for further examination. For example, the IOP measurement 
included in the DR screening service, inter alia, could be useful to identify asymptomatic 
patients presenting early stages of glaucoma.  
Along the first consultation on specialized care, first of all, tonometry and pachimetry tests are 
scheduled to obtain patient's corrected IOP measurement. Then, the ophthalmologist 
examines the papilla through direct ophthalmoscopy and confirms (or not) the suspicion of 
glaucoma.  
Accordingly, patients presenting elevated IOP or suspicious papilla are therefore scheduled to 
perform perimetry. With the results of VF test, the patient is convened at the ophthalmologist's 
office for a thorough analysis that would help to confirm the diagnosis of glaucoma. Once 
there, a new measurement of corrected IOP is carried out to reveal any progression with 
regard to the last encounter. This second consultation on specialized care entails the joint 
analysis of patient's visual field, the progression of IOP since the previous encounter, and the 
clinical findings reported as a result of the examination of the papilla conducted in the first 
consultation (see Figure 24). In consequence, the ophthalmologist confirms (or not) the 
diagnosis of glaucoma and classifies the type and severity for such condition.  
The IOP can be lowered by medical treatment, laser therapy, or incisional glaucoma surgery. 
Thus, the ophthalmologist must determine, according to the state of the disease they present, 
the appropriate treatment for each one of patients on which glaucoma has been confirmed. 
In that regard, the objective of the third consultation on specialized care is to adjust the 
treatment toward stabilizing the disease evolution. To that end, regardless the treatment 
chosen, a target IOP is estimated for each patient. Below this value, further optic nerve 
damage is unlikely to occur or the worsening of glaucoma will be slow enough that the risk of 
additional intervention is not justified.  
For that reason, the following clinical encounters include patient's corrected IOP 
measurement. Indeed the ophthalmologist use that value to adapt the treatment by successive 
approximations until patient's IOP is stabilized below the aforementioned target value. 
Therefore, the third consultation comprises as many encounters as the ophthalmologist 
considers necessary so as to find the adequate treatment for a specific patient.  
Finally, the third consultation on specialized care is closed once the ophthalmologist 
determines that a patient has been stabilized. At which point such patient should be included 
into the follow-up service of CG as it is described in next stage (Figure 25). 
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Figure 25: Activity diagram detailing the follow-up service proposed for CG.
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− STAGE 1 (Patient admission): The patient admission stage would correspond to the encounter 
on specialized care on which the adaptation of treatment for a specific patient concludes. As 
such, patients affected with CG are included into the follow-up service when the IOP is 
stabilized under a target value, and hereby the ophthalmologist considers the therapy chosen 
as appropriate for a long-term treatment. 
To make such a decision, the ophthalmologist must review the set of diagnostic tests 
registered during the background stage so as to determine whether the disease trajectory has 
stabilized. The first examination of papilla, the VF test that confirmed the diagnosis of 
glaucoma and the progression of IOP values obtained so far are available in this regard (see 
Figure 24). 
At the end of this stage, the responsible ophthalmologist establishes the long-term treatment 
and schedules the next consultation for patient's review. 
 
− STAGE 2 (Follow-up schedule):  Once the long-term therapy has been established, next 
appointment is requested through a referral note in which the period for patient's review and 
the diagnostic tests indicated on that review are specified. 
 
− STAGE 3 (Diagnostic tests): The advance of CG may be manifested in different ways, and the 
slightest sign of progression could lead to reconsider the therapeutic strategy. Consequently, 
toward the completeness of the review, the study of CG in the SNS-O covers the examination 
of various fronts simultaneously: the evolution of IOP, observation of the optic disc, and 
examination of the VF. 
In that respect, the patient goes through different workspaces managed by specifically trained 
nurses and imaging technicians, where the corresponding diagnostic tests are carried out. 
Those workspaces were devised in the spirit of maximizing the infrastructure sharing with the 
other e-health developments described along this chapter. Specifically, the diagnostic tests 
involved in the follow-up of CG were distributed into three differentiated workspaces (see 
Figure 25): 
 The first workspace: This workspace is equipped with a non-mydriatic fundus 
camera, a non-contact tonometer, a pachymeter and a Snellen chart. First of all, the 
nurse in charge of the workspace conducts the VA test to patients as they arrive to 
this point of care. As well as in monitoring of patients with wet AMD, VA is obtained 
in decimal scale and then converted into logMAR. This way, the overall visual loss 
caused by the current stage of glaucoma is appreciated before proceeding with the 
following tests. 
Next, the nurse obtains patient's IOP measurements using a non-contact tonometer. 
Since this procedure does not requires direct contact with the eye, there is no need of 
topical anesthesia either. Then, pachymetry is used to adjust the IOP values obtained 
by tonometry according to the corneal thickness measured for each patient. In this 
way, the resulting corrected IOP provides key information about the disease 
trajectory, especially concerning the fulfillment of target IOP value. 
Then, the corresponding nurse uses a non-mydriatic fundus camera to acquire 
photographs of patient's optic disc, as an alternative to the direct examination of the 
optic disc carried out by ophthalmologists in face-to-face consultations. The resulting 
acquisitions are uploaded to the PACS server of the health service. Likewise, the VA 
and IOP values are registered into the EHR system. In this way, all diagnostic 
information is accessible for remote assessment. 
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 The second workspace: This workspace is specialized on acquisition of OCT studies. 
Concerning the follow-up of CG, the OCT test provides the analysis of three 
parameter groups for classification and detection of disease progression: optic nerve 
head, RNFL and ganglion cell complex. From those, trend analyses of the RNFL 
thickness measurements around the optic disc are especially useful to quantify the 
glaucomatous progression in terms of the loss of visual fibers. 
Therefore, a nurse or imaging technician conducts a study of the thickness of the 
RNFL to every patient with CG, as they arrive to the OCT workstation.  
That OCT study consists of a radial scan acquired around the optic disc of the eye 
or eyes affected by glaucoma. As such, this scan will provide the current thickness of 
the RNFL, so once the study is sent to the PACS server, it could be compared with 
previous studies. Thereby, the aforementioned OCT study will be crucial in next 
stage for identifying signs of thickness reduction over time. 
 The third workspace: Whereas the workspaces above were adapted from other 
clinical processes presented along this Thesis, the third workspace is exclusive of the 
CG follow-up service. 
This workspace was set in an office reserved to host the VF test. Consequently, the 
office is managed by a nurse especially assigned to operate with the Humphrey 
perimeter available in the service. 
As patients scheduled arrive to the office, first of all, the nurse in charge evaluates 
the refraction parameters obtained during the VA test conducted in the “first 
workspace” seen above. That result is then applied in the calculation of the offset 
needed to correct the refractive error given during the VF test. 
Thereafter, the nurse configures the perimetry test in view of studying the progression 
of CG: given that threshold perimetry is the recommended standard in glaucoma, 
SITA-Standard or SITA-Fast test strategies are used indistinctly in the SNS-O. These 
strategies are governed by the Swedish Interactive Thresholding Algorithm (SITA), 
which optimizes the sequence of the stimuli presented and estimates the expected 
threshold values for each point measured all over the VF. Those are continuously 
estimated based on the patient's age and the thresholds established in neighbouring 
points. Although the ophthalmologist who requested the review can specify other test 
patterns whenever considers necessary, the Humphrey 24-2 testing algorithm is 
chosen by default in the SNS-O. In fact, the 54 individual points tested all over 
patient's VF, save in exceptional cases, provide a sufficient resolution for studying 
progression in CG [89, 187]. 
Traditionally the report resulting from the VF testing is printed and then examined by 
an expert ophthalmologist. Thus, despite the fact that most of the information 
provided by perimetry is comprised of numeric and statistical data, at this stage of 
the proceeding, the report is uploaded to the PACS server as an image. 
 
− STAGE 4 (CG assessment): Once all the diagnostic tests necessary for the assessment of a 
specific patient have been completed, the ophthalmologist who requested those tests must 
assess the resulting clinical data and diagnostic images. In that respect, a workstation 
equipped with a DICOM image viewer and an EMR front-end connected to the EHR system is 
provided to make the remote assessment possible at the office of specialized care. 
There, the ophthalmologist begins the revision by loading into the DICOM viewer all 
diagnostic images considered relevant, including those from previous consultations, and 
related to the patient under study. This should provide an overall view of glaucoma on which 
to base the assessment. 
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At this point, the ophthalmologist analyzes the VA measurements and especially the IOP 
values recorded in the EHR to date. In fact, an upward trend, or values exceeding the target 
IOP can lead into irreversible glaucomatous damage still not identifiable by the rest of 
diagnostic tests. Given that perimetry depicts pretty graphic representation of glaucomatous 
functional deterioration, the VFs resulting from consecutive studies of a specific patient are 
then compared so as to determine whether there are signs of progressive visual loss. 
Nevertheless, it should be noted that, although in some cases progression may be detected 
before, the analysis of CG requires a long enough time span (two years approximately), and 
at least five consecutive tests before presenting evident signs of progression [89]. 
Next, the ophthalmologist focuses the assessment on reviewing the funduscopic and OCT 
studies archived. Whereas perimetry provided information about functional deterioration of 
the optic nerve, these tests are analyzed for structural findings that could reveal glaucomatous 
activity. Regarding the assessment of funduscopic photographs, the ophthalmologist pays 
special attention to the enlargement of the optic disc cupping, changes in RNFL appearance, 
evolution of parapapillary atrophy, positional changes of the vessels at the optic disc, and 
emerging new haemorrhages on or bordering the optic disc. Whilst the OCT studies provide 
excellent tools for identifying signs of thickness reduction in the RNFL. 
Provided that perimetry reveals progressive visual loss, the assessment of funduscopic and 
OCT acquisitions could explain the cause of such deterioration on the VF. Conversely, if 
perimetry does not indicate a clear disease progression, the aforementioned tests are 
reviewed anyway so as to identify any glaucomatous activity that could lead to visual loss in 
the future. 
As a result of the overall analysis of the aforementioned test results, at this point, the 
ophthalmologist must determine whether the CG remains stable, or on the contrary there is 
any sign of disease progression. Regardless of the diagnostic decision, how to proceed in 
each case is described in the next stage. 
 
− STAGE 5 (Modify CG treatment): Provided that after consulting the examination results, the 
ophthalmologist determined that a specific patient is well controlled, a new examination is 
scheduled within a given period, and the necessary tests are ordered accordingly. 
If, conversely, the specialist considers that treatment modification is warranted but the change 
is simple, the patient will be kept informed about any adjustment on medication by telephone 
or e-mail. 
However, whenever the problem is more complex or if surgery is required, the patient is 
temporally excluded from the follow-up service, and a new hospital visit is scheduled. That 
visit would correspond to the third encounter on specialized care intended to adjust the 
treatment and stabilize the disease evolution, which indeed is further described along the 
“background stage” above. Thus, in light of the above, the clinical process would continue 
from that point on. 
B.2 Study of Clinical Concepts 
As a result of the analysis of the clinical process described in the previous step, the clinical concepts 
listed in Table 11 were chosen to register the clinical information generated during the follow-up 
service for CG. Every concept was then associated with the clinical stages they belonged to. 
Excluding the concepts inherent to the assessment of glaucoma, or those related to the VF test, most 
of the clinical concepts identified on this healthcare scenario were reused, either from the electronic 
models presented along this Thesis, or the CKM. On the basis of the modelling work carried out 
beforehand, defining the follow-up service for CG turned out to be more agile than the previous use 
cases presented along this Thesis.  
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Table 11: Clinical concepts identified as a result of studying each stage in the follow-up service 
proposed for CG. 
 
Identified concept name Equivalent archetype 
Archetype 
class 
Process stages in 
which it is applicable 
1.  Reason for encounter 
- Found on CKM 
- Usable as is 
Evaluation Stage 1 
2.  Story/history 
- Found on CKM 
- Usable as is 
Observation Stage 1 
3.  Risk factors in glaucoma 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Cluster Stage 1 
4.  
Intraocular pressure 
measurement 
- Concept reused from DR 
screening service 
Observation 
Stage 1 
Stage 3 
 
5.  Visual acuity 
- Concept reused from 
AMD monitoring service 
Observation 
Stage 1 
Stage 3 
6.  
Funduscopic 
examination of eyes 
- Concept reused from the 
two preceding models 
Observation 
Stage 1 
Stage 3 
Stage 4 
7.  
Ophthalmic tomography 
examination 
- Concept reused from 
AMD monitoring service 
Observation 
Stage 1 
Stage 3 
Stage 4 
8.  
Visual field 
measurement 
- Found on CKM 
- It has to be adapted 
Observation 
Stage 1 
Stage 3 
Stage 4 
9.  Problem/diagnosis 
- Found on CKM 
- Usable as is 
Evaluation 
Stage 1 
Stage 4 
10.  
Classification of 
glaucoma 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Cluster 
Stage 1 
Stage 4 
11.  Findings in glaucoma 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Cluster 
Stage 1 
Stage 4 
12.  Clinical synopsis 
- Found on CKM 
- Usable as is 
Evaluation 
Stage 1 
Stage 4 
13.  Contraindication 
- Found on CKM 
- Usable as is 
Evaluation 
Stage 1 
Stage 4 
14.  Recommendation 
- Found on CKM 
- Usable as is 
Evaluation 
Stage 1 
Stage 4 
15.  
Enrolment in a long-
term healthcare process 
- Concept reused from 
AMD monitoring service 
Evaluation Stage 1 
16.  Care plan (request) 
- Found on CKM 
- Usable as is 
Instruction 
 
Stage 2 
 
17.  Care plan 
- Found on CKM 
- Usable as is 
Action Stage 2 
18.  Referral request 
- Found on CKM 
- Usable as is 
Instruction Stage 2 
19.  
Imaging examination 
request 
- Found on CKM 
- Usable as is 
Instruction Stage 2 
20.  
Acquisition details on 
eye fundus images 
- Concept reused from the 
two preceding models 
Cluster 
Stage 2 
Stage 3 
21.  
Acquisition details on 
ophthalmic tomography 
- Concept reused from 
AMD monitoring service 
Cluster 
Stage 2 
Stage 3 
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 Identified concept name Equivalent archetype 
Archetype 
class 
Process stages in 
which it is applicable 
22.  
Acquisition details on 
visual field test 
- No equivalences found 
- Archetype has to be 
modelled from scratch 
Cluster 
Stage 2 
Stage 3 
23.  Procedure 
- Found on CKM 
- Usable as is 
Action 
Stage 3 
Stage 5 
24.  Medical device 
- Found on CKM 
- Usable as is 
Cluster Stage 3 
25.  Medical device details 
- Found on CKM 
- Usable as is 
Cluster Stage 3 
26.  
Central corneal 
thickness details 
- Concept reused from DR 
screening service 
Cluster Stage 3 
27.  Imaging examination 
- Found on CKM 
- Usable as is 
Action Stage 3 
28.  Anatomic location 
- Found on CKM 
- Usable as is 
Cluster Stage 3 
29.  Mydriasis application 
- Concept reused from the 
two preceding models 
Cluster Stage 3 
30.  Medication amount 
- Found on CKM 
- Usable as is 
Cluster Stage 3 
31.  
Diagnostic report 
request 
- Concept reused from the 
two preceding models 
Instruction 
Stage 3 
Stage 4 
32.  Service request 
- Found on CKM 
- Usable as is 
Instruction 
Stage 3 
Stage 4 
33.  Medication order 
- Found on CKM 
- Usable as is 
Instruction Stage 5 
34.  Medication action 
- Found on CKM 
- Usable as is 
Action Stage 5 
35.  Adverse reaction 
- Found on CKM 
- Usable as is 
Evaluation Stage 5 
36.  Procedure request 
- Found on CKM 
- Usable as is 
Instruction Stage 5 
37.  
Ophthalmic laser 
procedure details 
- Concept reused from DR 
screening service 
Cluster Stage 5 
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B.3 Hierarchical Organization of Knowledge Artefacts 
The clinical concepts identified in the previous step were structured according to their appearance in 
the follow-up service detailed for CG. During the organization of that service, many similarities were 
found with regard to the models proposed in previous sections. 
For example, patient admission and follow-up schedule are essentially the same for the study of CG 
and the service monitoring wet AMD, except for the additional diagnostic tests involved on the former. 
However, both services differ in the way the treatment is managed: when monitoring wet AMD, the 
treatment is applied immediately after a patient is enrolled on the therapy. And thereafter, the 
retreatment must be confirmed after each assessment. Conversely, every patient admitted for the CG 
follow-up service should remain stable due to the medical treatment they are receiving. In fact, the 
office examination and therapeutic decision is reserved for exceptional cases in which the specialist 
considers that treatment modification is warranted. Thus, the stage for modifying the treatment of 
glaucoma was mainly based on the stage defined for the treatment in the DR screening service. 
Regarding the acquisition and validation of diagnostic tests, they were configured as a combination of 
the analogous clinical stages provided within the DR screening and wet AMD monitoring services. 
That was possible because the follow-up of CG covers all diagnostic tests used in the preceding 
models, and besides, introduces the VF test. Finally, the clinical stage for the remote assessment of 
these tests was designed in line with the AMD assessment seen in Figure 20.   
Considering all the above, the work team captured the hierarchy among knowledge artefacts involved 
within the follow-up of CG into the Figure 26. As in the other healthcare scenarios modelled so far, 
the resulting diagram was built according to the hierarchy among knowledge artefacts described in 
Figure 9. 
4.3.3 BUILDING THE ELECTRONIC MODEL 
C.1 Creation and Update of Archetypes 
The model proposed to follow-up patients diagnosed with CG consists of 37 entry-type archetypes. Of 
these, 22 archetypes were obtained from the openEHR CKM: 21 were directly used on the model, 
and a new version of the “Visual field measurement” was provided to fulfil the requirements of our 
model. For further information, a list of all the archetypes modelled along this Thesis can be found in 
Appendix A.  
Then, the work team was engaged in the creation of the other 15 archetypes not available in the 
CKM. Given the clinical processes modelled along this Thesis, the follow-up of CG is the one that 
presents the greatest complexity in terms of diversity of archetypes. However, given the high rate of 
archetypes that were reused from previous electronic models, only 4 archetypes were specifically built 
for this use case: “Risk factors in glaucoma”, ”Classification of glaucoma”, “Findings in glaucoma”, 
and “Acquisition details on visual field test”. 
Therefore, excluding the aforementioned, the 11 ones left were obtained from previous models: 
3 archetypes were reused from the DR screening service, another 4 from the service monitoring the 
treatment of wet AMD, and the remaining 4 were common in all three models described along this 
Thesis (see Table 11). 
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Figure 26: Hierarchy among the knowledge artefacts involved in the follow-up of CG.
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C.2 Definition of Semantic links to Clinical Terminologies 
A total of 14 termsets were used to model the follow-up of patients diagnosed with CG. Of these, 5 
were specifically created for this use case, 7 were reused from the DR screening service modelled 
beforehand, whereas the remaining two were initially created for the monitoring of wet AMD. All the 
aforementioned termsets and their use along the stages in the clinical process are described in Table 
12. 
C.3 Building Templates 
The model comprises 19 different templates: 14 of those organize the archetypes contained inside 
sections, whereas the remaining templates compose each one of the 5 stages of the clinical process 
that contain the aforementioned sections (Figure 26).  
From the aforementioned, 2 templates were reused along the clinical process: on the one hand, the 
treatment established before patient's admittance, must be periodically reviewed along the CG follow-
up service. For this reason, the template “Classification and treatment of CG” was replicated for the 
first and third stages (admission and assessment). On the other hand, the template “Next step in CG 
follow-up service” was first used at third stage, to refer patients toward the CG assessment once all 
diagnostic tests were acquired, but also at the fourth stage, either to schedule next review or to ask for 
modifying the treatment. 
Furthermore, taking advantage of the common clinical domain among the models proposed along 
this Thesis, some templates used on this healthcare scenario were directly reused from our previous 
modelling experiences. Of the total number of templates used, 2 came from the DR screening service, 
and another 2 were obtained from the service proposed to monitor the treatment of AMD. This is 
because some of diagnostic tests required to follow-up CG were also contemplated in the 
aforementioned services. In this way, templates that describe the “Intraocular pressure study” and the 
“Acquisition and validation of NMR” proposed in the DR screening clinical process were used with no 
need of modifications to follow-up CG. Likewise, the “Visual acuity study” and the “Acquisition and 
validation of OCT” were obtained, as is, from the model proposed to monitor the treatment of wet 
AMD. 
Therefore, 15 templates were specifically created for this healthcare model, and yet most of them 
share similarities to analogous templates used in the healthcare services modelled beforehand. For 
instance, the template corresponding to the section “Patient's admittance”, originally built for the 
service monitoring the treatment of AMD was adapted to enrol patients in the follow-up for CG. 
Furthermore, the template “Laser procedures to treat CG” is practically the same as “Laser 
procedures to treat DR” used in the DR screening service. It only differs on the use of a different 
termset adapted to each healthcare scenario, since the choice of laser surgery differs depending on 
the condition to be treated (Figure 27). This is because most of knowledge artefacts required to 
model the follow-up of CG were already available, hence more than modelling a new healthcare 
process, the templates available were reorganized and adapted to conform this use case. 
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Table 12: Termsets that support the archetypes within the follow-up service proposed for CG. 
 
Termset name Description of termset Availability 
Process stages in which 
it is applicable 
1.  Findings of visual field List of findings distinguishable on the visual field test. Newly created 
Stage 1  
Stage 4 
2.  Findings on posterior pole of eye Clinical findings identifiable in posterior pole of eye. Reused from DR screening 
Stage 1  
Stage 4 
3.  Anatomic structures of eye 
List of regions of interest in the study of eye (based on 
DICOM Tables: CID 4209, CID 4211 and CID 4266). 
Reused from the AMD 
monitoring 
Stage 1, Stage 2 
Stage 3, Stage 4 
4.  Classification of glaucoma 
List of disorders distinguishable on the diagnosis of 
glaucoma. 
Newly created 
Stage 1 
Stage 4 
5.  Glaucoma treatments 
List of therapeutic options to treat different types and stages 
of glaucoma. 
Newly created 
Stage 1  
Stage 4  
Stage 5 
6.  Subdivision of retina List of zones in eye retina for ophthalmic image positioning. Reused from DR screening 
Stage 2 
Stage 3 
7.  
Corneal thickness measurement 
devices 
List of methods to obtain the corneal thickness 
measurement. 
Reused from DR screening Stage 3 
8.  Mydriatic agents 
List of mydriatic agents and their corresponding doses 
validated for ophthalmologic use. 
Reused from DR screening Stage 3 
9.  
Complications on ophthalmic 
image acquisition 
List of possible complications during ophthalmic imaging 
studies that may affect the quality of acquisitions (based on 
Table CID 4222 of DICOM standard). 
Reused from DR screening Stage 3 
10.  Ophthalmic photography devices 
Lists the ophthalmic photography acquisition devices 
(based on Table CID 4202 of DICOM standard). 
Reused from DR screening Stage 3 
11.  Ophthalmic tomography devices 
List of acquisition devices (based on Table CID 4210 of 
DICOM standard). 
Reused from the AMD 
monitoring 
Stage 3 
12.  Visual field illumination colours 
List of illumination colours used as visual stimuli on visual 
field test (based on Table CID 4255 of DICOM standard). 
Newly created Stage 3 
13.  IOP lowering agents List of agents used in ophthalmology for IOP lowering. Newly created Stage 5 
14.  Ophthalmic laser devices List of laser devices for ophthalmic use. Reused from DR screening Stage 5 
- 125 - 
 
 
Figure 27: The structure of templates envisaged to register clinical encounters resulting from 
the follow-up of CG.
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C.4 Modelling Guideline Rules and Workflow 
A total of 6 rules were designed to govern patients‟ flow through the clinical stages defined for the 
clinical process. The archetypes participating in these rules can be found in Appendix A: 
− Glaucoma follow-up convenient: Patients diagnosed with CG would be enrolled into the 
follow-up service, when the ophthalmologist responsible of their therapy establishes a 
medical treatment that achieves the target IOP and curbs the progression of the disease into 
a medically stable state. 
Consequently, the follow-up begins the instant that the ophthalmologist registers a patient 
into the medical treatment for CG by submitting the archetype “Enrolment in a long-term 
healthcare process” to the EHR. 
In light of this, this rule checks all contributions for that archetype, so as to detect the 
admittance of every new patient to the glaucoma follow-up service. Thus, if the healthcare 
process corresponds to the “Follow-up service for chronic glaucoma” and patient's 
admittance is set to “true”, this rule automatically will define a care plan where the diagnostic 
tests necessary for monitoring the progression of chronic glaucoma would be scheduled.  
At this point, the “Referral request” and “Imaging examination request” archetypes are used 
to manage the reservation of the diagnostic tests of VA, IOP, NMR, OCT, and VF 
measurement. Besides the aforementioned, if necessary, the ophthalmologist can also 
include additional tests into the care plan, according to the severity presented by each 
patient. 
− Diagnostic tests completed: Similarly to the homonymous rule defined for the monitoring of 
wet AMD, this rule must guarantee the completion of every diagnostic test ordered for a 
specific patient before proceeding with the remote assessment. Except in this case, the 
diagnostic tests to be managed include VA, IOP, NMR, OCT, and VF measurement, plus the 
complementary tests considered necessary by the ophthalmologist. 
In the same way as in the case of monitoring wet AMD, as diagnostic tests are carried out, 
every new contribution for the archetype “Care plan” submitted to the EHR would be checked 
until the pathway is set to “Care plan completed”. This would mean that all diagnostic tests 
defined in the care plan are available for assessment. 
Finally, when all diagnostic tests required for the follow-up of CG are completed, the rule 
instantiates the archetype “Diagnostic report request” to schedule a consultation for remote 
assessment of chronic glaucoma. 
− Glaucoma stable: If, as a result of an overall assessment of glaucoma, the ophthalmologist 
does not identify clear signs of disease progression, it means that the patient is well 
controlled, so the treatment applied so far is appropriate. Thus, with the aim of identify which 
patients present a medically stable state of glaucoma, this rule verifies every contribution 
upon the archetype “Classification of glaucoma” submitted as a result of the assessment of 
progression in CG. Hence, this rule only considers patients with a confirmed diagnosis of 
glaucoma (glaucoma suspects are excluded), in which the data element about disease 
progression has been set to false. If so, provided that patients presenting a stable state of 
glaucoma should maintain the medical treatment they are receiving, the rule is triggered 
whenever the therapeutic recommendation registered within the archetype 
“Recommendation” is set to “Maintain medical therapy”. 
Then, as there is no need of therapeutic adjustments, the next consultation for glaucoma 
review is automatically scheduled using the “Service request” archetype. At this point, the 
follow-up scheduled for chronic glaucoma will specify the same diagnostic tests considered in 
the first rule, to wit, VA, IOP, NMR, OCT, and VF measurement. 
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− Glaucoma progressive: In contrast to the previous rule, this one identifies patients diagnosed 
with glaucoma that present any sign of disease progression that could lead to visual loss in 
the future. Thus, the rule is triggered whenever the ophthalmologist responsible of the remote 
assessment of CG records as true the parameter “Progressive disease” from the archetype 
“Classification of glaucoma”. 
For such cases, the follow-up service envisages an office examination where the same 
ophthalmologist responsible of the remote assessment would determine the appropriate 
therapeutic decision for each patient. Therefore, this guideline rule organizes such encounter 
by instantiating the archetype “Diagnostic report request” similarly to the request made for the 
remote assessment, except this time the service is scheduled at the ophthalmologist's office. 
− Modify the medical treatment: This rule covers the scenario in which, as a result of the office 
assessment, the ophthalmologist considers that treatment modification is warranted, but the 
disease could be easily stabilized by adjusting the medication regimen. 
Thus, the rule is triggered whenever the ophthalmologist records the therapeutic 
recommendation of “Medical treatment” into the archetype “Recommendation”. Hereby, this 
rule creates an instance of “Medication order”, in which the ophthalmologist must establish 
the details of the new medical treatment. Subsequently, the archetype “Service request” is 
used to plan the follow-up for chronic glaucoma in order to review if the condition returns to 
a medically stable state after the new treatment.  
Therefore, the patient is informed about the new instructions for the administration of the 
medication, and then, the diagnostic tests corresponding to the next consultation for 
glaucoma review are scheduled (VA, IOP, NMR, OCT, and VF measurement). 
− Surgery required: When clear signs of CG progression are identified in the office assessment, 
and the target IOP is not reached through medical treatment, the ophthalmologist must 
consider surgical procedures for lowering IOP. In this regard, the archetype 
“Recommendation” predefines the therapeutic procedures involving surgery on the treatment 
of progressive glaucoma. Therefore, from all therapeutic recommendations that the 
ophthalmologist recorded on that archetype, this rule is activated when one of the following 
are chosen: “Laser therapy”, “Incisional glaucoma surgery”, “Cyclodestructive surgery” or 
“Other glaucoma surgeries”. If it is the case, this rule will automatically instantiate the 
“Procedure request” archetype, and request the surgical procedure specified as therapeutic 
recommendation. Likewise, the “Indication description” for that procedure will be determined 
by the rationale submitted to support the therapeutic recommendation. 
Finally, given that the surgical procedures fall outside the scope of the follow-up service, the 
patient must be temporally excluded from glaucoma monitoring. Indeed, before resume the 
follow-up, the ophthalmologist must reassess the validity of the medical treatment and must 
readjust the target pressure in accordance with the outcomes of the surgery. Thus, in light of 
the above, the archetype “Enrolment in a long-term healthcare process” is instantiated to 
temporally deregister the patient from the “Follow-up service for chronic glaucoma”. 
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Table 13: Description of the guideline rules designed for the follow-up service proposed for CG. 
 
Rule name Conditions Actions 
1.  
Glaucoma follow-up 
convenient 
Archetype “Enrolment in a long-term healthcare process”: 
 Healthcare process: “Follow-up service for chronic 
glaucoma” 
 Admittance: “True”  
Archetype instantiated “Care plan (request)”: 
 Care plan name: “Follow-up service for chronic 
glaucoma” 
Archetype instantiated  “Referral request”: 
 Service requested: VA test 
 Service requested: IOP measurement 
Archetype instantiated “Imaging examination request”: 
 Service requested: NMR 
 Service requested: OCT study 
 Service requested: VF measurement 
2.  Diagnostic tests completed 
Archetype “Care plan”: 
 Care plan name: “Follow-up service for chronic glaucoma” 
 Pathway: “Care plan completed” 
Archetype instantiated “Diagnostic report request”: 
 Service requested: “Remote assessment of chronic 
glaucoma” 
 Reason for request: “Completed the diagnostic tests 
necessary for assessment” 
3.  Glaucoma stable 
The preconditions for this rule, are the “Classification of 
glaucoma” to be different to “No glaucoma” (Concept ID in 
SNOMED-CT: 310596004) and “Glaucoma suspect” 
(Concept ID in SNOMED-CT: 232079008), and besides, the 
parameter "Progressive disease" to be set as false. 
Archetype “Recommendation”: 
 Therapeutic recommendation: “Maintain medical 
therapy” 
 Rationale: “Glaucoma stable” 
Archetype instantiated “Service request”: 
 Service name: “Follow-up schedule for chronic 
glaucoma” 
 Description: “Follow-up comprised by IOP 
measurement, VA, NMR, OCT and VF tests” 
- 129 - 
 
 
Rule name Conditions Actions 
4.  Glaucoma progressive 
Archetype “Classification of glaucoma”: 
 Classification: Exists and it is different to “No glaucoma” 
and “Glaucoma suspect” 
 Progressive disease: “True” 
Archetype instantiated “Diagnostic report request”: 
 Service requested: “Office assessment of glaucoma” 
 Reason for request: “Determine therapy for 
progressive glaucoma” 
5.  Modify the medical treatment 
The conditions established within the rule “Glaucoma 
progressive” comprise the precondition for this rule. 
Archetype “Recommendation”: 
 Therapeutic recommendation: “Medical treatment” 
Archetype instantiated “Medication order” (modify the 
medical regimen). Then, the follow-up service for chronic 
glaucoma is requested to review if the condition returns to 
a medically stable state after the new treatment. 
Archetype instantiated “Service request”: 
 Service name: “Follow-up schedule for chronic 
glaucoma” 
 Description: “Follow-up comprised by IOP 
measurement, VA, NMR, OCT and VF tests” 
6.  Surgery required 
The conditions established within the rule “Glaucoma 
progressive” comprise the precondition for this rule. 
Archetype “Recommendation”: 
 Therapeutic recommendation: “Laser therapy”, “Incisional 
glaucoma surgery”, “Cyclodestructive surgery” or “Other 
glaucoma surgeries” 
 
Archetype instantiated “Procedure request” 
 Procedure name = Therapeutic recommendation (in 
“Recommended treatment for glaucoma”) 
 Objective: “Curb the progression of glaucoma into a 
medically stable state” 
 Indication description = Rationale (in “Recommended 
treatment for glaucoma”)  
Archetype instantiated “Enrolment in a long-term 
healthcare process”: 
 Admittance: “False” 
 Healthcare process: “Follow-up service for chronic 
glaucoma” 
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C.5 Modelling UI Forms 
As in previous electronic models, the Marand EhrExplorer was used to model UI forms for each of the 
5 stages that comprise the CG follow-up service. Given that the final users must interact with the 
resulting UI views, their modelling was closely supervised by ophthalmologists. Because the framework 
chosen for modelling the UI forms is restricted to test purposes, the resulting form-description files 
were downloaded for further study. Consequently, we can deploy the UI forms defined in our own 
servers.  
4.3.4 IMPLEMENTATION OF THE SERVICE 
Given the background on management of clinical information in the SNS-O and the common ground 
of the CG follow-up service with regard to the previous implementations presented along this Thesis, 
this service would be built upon the ICT infrastructure and information systems deployed so far. 
Returning to the workspaces established for this clinical process, the electronic devices allocated to 
each of them must be interconnected so as to exchange data with the corresponding information 
systems. In this regard, the first workspace includes tonometry and pachymetry devices for IOP 
measurement, a non-mydriatic retinal camera, and a PC workstation in compliance with the DR 
screening service. In addition, a Snellen chart for VA measurement was incorporated afterwards, as 
stated in the technical requirements of the wet AMD monitoring. The second workspace corresponds 
to the office originally set up for acquisition of the OCT studies carried out in the service monitoring 
the treatment of wet AMD. Because of previous implementations, no action was necessary on these 
workspaces. 
In fact, the main contribution of the follow-up service for CG was the establishment of the third 
workspace. This one was specifically conceived for VF measurement, as this test was not covered by 
the previous implementations. Therefore, a Humphrey perimeter was installed in the healthcare 
service, and then, it was connected into the DICOM network of the SNS-O. In this way, the nurse 
responsible of operating with the perimeter can consult the worklist of patients scheduled into the 
device, and upload the resulting VF measurements to the PACS server. 
Finally, the workspace dedicated to the assessment, was established in the office of the 
ophthalmologist specialized on glaucoma. There, besides complementary diagnostic tests available 
for further examination of patients, in line with analogous workspaces in the preceding models, a PC 
workstation was included to ensure access for the ophthalmologist to PACS and EHR servers. This will 
enable the ophthalmologist to evaluate patients presenting CG remotely. 
At this point, similarly to the previous implementations proposed along this Thesis, the archetypes and 
templates modelled for the CG follow-up service were loaded into an openEHR-compliant EHR. On 
the one hand, the EHRServer originally launched for DR screening service (and reused on the AMD 
monitoring service) was chosen to register the medical records. On the other hand, the openEHR-OPT 
developed by Cabolabs would be used to generate UI forms from the OPT files. And then, the 
EHRCommitter would be used as front-end to send toward the EHR the clinical reports produced at 
the different workspaces. In this way, clinicians would be able to register clinical information specific 
to the follow-up of CG, using the UI forms dedicated to each stage of the clinical process, and with 
no need of introducing changes on the main EHR system of specialized care in the SNS-O. 
Meanwhile, the main EHR system would be used to coordinate the services provided by the 
complementary information systems involved in the clinical process: medical imaging management 
through PACS, arrange appointments on specialized care on the HIS, handle the electronic referrals 
using the CPOE management system, or keep track of electronic prescriptions on the pharmacy 
information management system. 
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Figure 28: Flux of information through the service monitoring the treatment of CG.
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Chapter 5: 
Discussion 
This Chapter discusses the topics covered along the Thesis. First of all, the implications of applying 
the methodology proposed for modelling healthcare into model-driven information systems are 
outlined. Then, how the health computing platform proposed could change the strategy for 
management of clinical information is discussed. Finally, the conclusions reached after modelling 
three clinical processes in ophthalmology are described.  
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5.1 DISCUSSION ABOUT THE METHODOLOGY PROPOSED TO FORMALIZE CLINICAL PRACTICE  
As seen in Chapter 2.3, the advent of model-driven information systems enabled clinicians to 
participate actively in building their own electronic models. However, building such models is an 
intricate, laborious process. Moreover, it requires tight collaboration among multidisciplinary 
professionals (domain experts, physicians, technical developers, terminologists, etc.). This is a complex 
situation which requires high levels of coordination for harmonizing the different schedules. But 
nevertheless, to make the most of this technology, we need to attract experts in the clinical domain to 
contribute to the knowledge base available today. To that end, as a result of a thorough study of the 
different approaches for modelling clinical knowledge found in scientific literature, a comprehensive 
methodology was proposed in Chapter 3.1, to formalize the clinical practice into model-driven 
information systems. 
One of the limitations of this methodology is that it should be adapted to the extent that model-driven 
information systems evolve and integrate new knowledge artefacts. Additionally, open modelling tools 
must be provided so that any workgroup can contribute to the knowledge base without restrictions. 
However, the software tools found, especially open-access ones, still have to improve their user-
friendliness to encourage domain experts and terminologists to develop electronic models with no 
need of additional training. Many of these tools are technified, i.e. require advanced understanding of 
e-health standards, present bugs or they are still in development due to the ongoing discussion on the 
specifications of the e-health standards involved.  
For example, there is a modelling tool for building archetypes and templates in compliance with 
openEHR ADL 2 specifications [179]. However, given the recent development of ADL 2, although such 
application is going to be essential for modellers in the near future, it would not be widely used until 
the modelling tools and information systems necessary to implement the model-driven approach 
incorporate these specifications. Until then, applications based on ADL 1.4 specifications will prevail 
with regards to building electronic models using openEHR archetypes and templates. In the case of 
modelling UI forms, there is no even a consensus on their specifications. Hence each company must 
create its own proprietary solutions. It would be therefore interesting to work toward filling this gap by 
providing open specifications and modelling tools for UI form building.  
Another issue which may discourage modellers is the difficulty of setting up the workspace to start on 
the modelling. In this regard, diverse software tools must be configured, besides organizing local and 
remote knowledge repositories depending on the knowledge artefacts handled. In this sense, there are 
initiatives such as the CKM platform, or the aforementioned ADL-designer that provide open-access to 
a web platform in which the modelling tools have been configured beforehand. In this way, once 
registered on the platform, modellers can immediately start modelling healthcare without worrying 
about technical matters. In addition, as virtual workspaces are used to model knowledge artefacts 
located into remote repositories, this approach would foster collaborative, peer-reviewed modelling 
strategies, thus facilitating coordination among multidisciplinary modellers. It is therefore expected 
that the trend in modelling tools should follow these examples and be integrated into open-access 
web platforms. 
In any case, all the limitations described above, such as the need of user-friendlier software tools, are 
common among the other proposals of methodologies cited in the literature. However, the approach 
proposed in this Thesis solves some of the limitations that discourage clinicians to engage in 
modelling the clinical practice. For example, the guidelines found in literature do not cover all aspects 
of clinical processes pursued by this work. Conversely, the methodology proposed covers the whole 
process to build electronic models from the clinical concept to the presentation layer. Moreover, 
within this methodology, the guidelines covering specific stages of the overall modelling were unified 
following a common thread: the layers of interoperability presented in section 2.2. This is a two-fold 
advantage. First, the modellers would be able to use only part of the methodology proposed, which 
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will depend on the scope of their projects, with the certainty that the rest of the layers could be added 
in a straightforward manner in the future. Second, the methodology proposed has been defined to 
guide domain experts in building high-quality electronic models, independently of their knowledge on 
technologies and e-health standards, which have little to do with their expertise.  
5.2 DISCUSSION ABOUT THE ARCHITECTURE PROPOSAL FOR AN OPEN HEALTH COMPUTING 
PLATFORM 
Given the state of the art on the different open health computing platform, described in section 2.4, 
and together with the current management of clinical information in the SNS-O, described in section 
2.5, an overall architecture for implementation of a model-driven e-health platform was proposed in 
section 3.2.  
As regard to the limitations, this proposal includes the most commonly used modules in the health 
care environment. However, being as comprehensive as it is, additional modules could be considered 
depending on the requirements of each specific implementation of the platform. This may imply a 
slight modification of the architecture proposed. Moreover, the proposal provides some examples of 
architectures and technologies that could be used for implementing the platform (such as SOA, REST, 
JSON, etc.). However, these are mere recommendations in order to facilitate the practical 
implementation of the platform. Obviously, a software architect is free to choose other technologies 
for specific implementations. Also, the selected technologies could be changed in the future. 
Nevertheless, although the specific implementations could differ one from another, the general 
architecture proposal would be still valid, as long as all the components that comprise the platform 
share the same reference model. 
Additionally, with the advent of connectable e-health devices in healthcare, today, diverse diagnostic 
tests can be combined to reach a valid diagnosis. Therefore, the clinical guidelines applied in each 
healthcare scenario should be adapted depending on the diagnostic equipment available, even if they 
respond to the same care plan. This would lead to a patient-centered health environment in which 
clinicians must choose between different clinical procedures, all valid to solve a specific healthcare 
problem. On top of this, each health service must deal with an installed base of legacy information 
systems developed by different manufacturers which probably use proprietary formats to register 
clinical information. In this regard, unlike other existing proposals in the literature, the modular and 
standards-based architecture described in section 3.2 would enable to progressively structure the 
clinical information of such legacy systems into a semantically computable format. The advantages of 
the normalization of clinical information are two-fold. First, since the content of the medical records is 
arranged depending on the archetype model, clinicians could use the paths pointing to specific 
clinical concepts of the archetype model to build queries for precise exploitation of data without the 
need of programming skills. Second, the normalization of data could lead to establishing 
conformance points among manufacturers toward a platform-based economic ecosystem. In other 
words, unifying all clinical information into a vendor-independent health computing platform would 
enable scalable and tailor-made solutions for health services. 
Rather than building applications from scratch to cover the needs of specific healthcare scenarios, the 
proposed platform approach aims at building customized plugins with the interfaces necessary to 
interact with the health computing platform. Moreover, as in the example shown in section 4.2.4, by 
adding the appropriate data mapping and communication interfaces, even the existing legacy 
applications could be integrated into the platform of the health service. Alternatively, as Marco-Ruiz et 
al. proposed [136], relevant clinical information contained in databases of non-standardized 
information systems could be directly mapped to archetype-based EHR standards.  
To sum up, in this new scenario, in which all the modules integrated in this platform are normalized 
with respect to the same reference model, the control and ownership of the data at the health 
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computing platform are guaranteed. This prevents the technical lock-in when incorporating 
departmental software tools and information systems to support clinical practices ongoing into the 
health service. Consequently, on the basis of the architecture proposed in section 3.2, the health 
computing platforms implemented would be unique for each health service, as they would 
progressively integrate heterogeneous modules and applications developed by diverse manufacturers 
according to the local needs of the service at the time of procurement. 
5.3 DISCUSSION ABOUT THE ELECTRONIC MODELS BUILT FOR OPHTHALMOLOGY  
The advent of model-driven information systems plus the methodology for modelling clinical 
knowledge proposed in Chapter 3.1 provided a direct way for clinical experts to be involved in the 
specification of their own clinical models. 
Nevertheless, the novelty of this approach still requires modelling different healthcare scenarios to 
compete with specialised software tools used so far in healthcare. This is because the knowledge 
artefacts available for download are scarce, and there are even fewer peer-reviewed artefacts. In fact, 
healthcare modellers worldwide tend to define clinical concepts widely used in medicine, whereas 
more specific concepts are also necessary with regards to building electronic models for real 
healthcare scenarios. It is assumed that the more specific the clinical concepts are to a clinical 
specialty, the higher the likeliness that the corresponding knowledge artefacts either have not been 
modelled yet, or, at best, they are only available as draft proposals, i.e. they have not yet overcome 
the peer review procedure. This limits the use of the open-access clinical knowledge base available so 
far to very specific use cases, such as the case of ophthalmology. 
Consequently, seeing no short-term prospects for leveraging the effort made in modelling healthcare, 
many clinicians will get discouraged from contributing with their expertise to open-access clinical 
knowledge repositories. In order to address this issue, the electronic models proposed along Chapter 
4 of this Thesis covered three real healthcare scenarios in ophthalmology. However, the task of 
modelling every possibility into each archetype involved in a complex clinical process (constraints, 
translations, terminology bindings, and maintenance regarding updates in the model) turned out to be 
a huge workload for a single research group. Therefore, each knowledge artefact proposed can be 
further improved if we analyse them separately. Nonetheless, the resulting electronic models were 
intended to provide comprehensive turn-key solutions for the three healthcare scenarios, i.e. any user 
interested in implementing our models can download and directly start using them. This should 
encourage clinicians interested in these specific implementations to contribute toward improving the 
specific components of these models. Therefore, it is expected the critical mass of clinicians involved 
in modelling the clinical knowledge to increase, and thus the quality of knowledge artefacts defined 
for ophthalmology. In subsequent revisions, the clinical processes proposed can be modelled even in 
more detail. For example, the electronic models proposed in this Thesis were focused on assessment 
more than therapy. Thus, the stages corresponding to treatment can be extended in the future. 
Finally, although in principle these models were built for the SNS-O, this Thesis pursues the reusability 
of electronic resources that comprise these models, so they have been made available in the CKM. 
Consequently, any healthcare institution managing DR screening services, AMD monitoring services, 
or CG follow-up services can download these resources (archetypes, templates, termsets, and CDS 
rules) and adapt them to meet the needs of specific healthcare scenarios. 
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Chapter 6: 
Conclusions and future lines 
This last Chapter highlights the final conclusions and the main outcomes of the work 
presented up to this point, based on the hypotheses and objectives established at the outset 
of this Thesis. To conclude, this chapter envisions lines of prospective further research that 
could be strategic to move forward based on the contributions made along this work. 
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6.1 OVERALL CONCLUSIONS 
Seven overall objectives were raised in the first chapter of this Thesis. Below is an overview of how 
these have been addressed along the different chapters of this PhD dissertation: 
First objective: “To deeply study the ecosystem of standards and specifications pervasive in e-health, 
remarking initiatives focused on interoperability among EHR systems, e.g. openEHR, EN/ISO 13606, DICOM, 
Health Level 7 (HL7v2, HL7v3, HL7 Clinical Document Architecture or CDA, and more recently HL7 FHIR), and 
standard medical terminologies (Logical Observation Identifiers Names and Codes – LOINC, Systematic 
Nomenclature of Medicine - Clinical Terms – SNOMED-CT, International Statistical Classification of Diseases 
and Related Health Problems – ICD-x or International Classification of Primary Care – ICPC).” 
According to the first of those objectives, main standards and specifications involved in the electronic 
management of information in healthcare were studied. Such study provided the background 
presented in Chapter 2 with regard to the different layers of interoperability considered along the 
Thesis.  
Further on, along Chapter 3, second and third overall objectives were approached in sections 3.1 
and 3.2 respectively:  
Second objective: “To design a methodology that would guide domain experts to actively engage in modelling 
their own electronic models compliant to model-driven e-health standards.”  
On the one hand, section 3.1 guides domain experts in creating high-quality electronic models for 
specific clinical processes. Given that health computing platforms involve multitudinous e-health 
standards and entail different layers of interoperability, modelling healthcare domain must be carefully 
planned to facilitate an active participation of domain experts. Otherwise, the information systems not 
receiving continuous contributions from domain experts would be likely to fall into obsolescence. In 
consequence, a methodology was proposed to model patient-centred clinical processes with the goals 
of interoperability and reusability of all knowledge components necessary to ensure continuity of 
patient care. This methodology enables experts of the clinical domain to actively engage in content 
definition of EHRs, without recourse to software developers. Additionally, the information registered 
through the health information standards entailed in the methodology fosters the exchange of 
knowledge artefacts with information systems worldwide, the scalability and extensibility of the 
resulting models, and the data mining – with no need of programming skills – of the information 
registered during clinical encounters.  
Third objective: “To propose an open architecture for building health computing platforms based on the e-
health standards mentioned above, so as to coordinate heterogeneous information systems toward a 
comprehensive management of patient-centred clinical processes and guaranteeing the continuity of care of 
patients.”  
On the other hand, in section 3.2, a health computing platform was proposed toward integration and 
harmonization of e-health standards into patient-centred clinical processes. Although other proposals 
equally valid can be found in literature, it is projected that computerized management of healthcare 
will progress in the direction of a health computing ecosystem based on the open platform 
architecture in which different e-health standards coexist. Thus, software developers would build 
applications for multiple competing platforms, whereas health services retain control and ownership of 
the data regardless of manufacturers. 
All remaining overall objectives were approached throughout Chapter 4, where a DR screening 
service, a high resolution consultation to monitor the treatment of wet AMD, and a follow-up service 
for CG were considered strategic to alleviate the main bottlenecks in waiting lists for the chronic 
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conditions with greatest burden in ophthalmology. Thus, each section from Chapter 4 (4.1, 4.2 and 
4.3) was focused on modelling each of the aforementioned services, considering the specific 
requirements of the healthcare scenario found in the SNS-O:  
Fourth objective: “To contribute to the design of new e-health services in the SNS-O that would optimize 
clinical practice in chronic diseases threatening to overload the waiting lists of the ophthalmology department 
(DR, wet AMD, and CG).” 
First of all, the design and development of efficient e-health services was addressed as proposed in 
the fourth objective. To that end, the clinical practices applied to manage the above mentioned 
ophthalmic conditions were studied within the SNS-O, and new clinical processes were proposed 
accordingly to address the shortcomings found in the health service. In this regard, pervasive clinical 
guidelines were adapted to the resources available in the health service. As a result, the consequent e-
health services were depicted using diagrams and tables, which were made available to health 
domain modellers interested on reproducing such services into other health services. 
Fifth objective: “To formalize into electronic models the clinical processes devised in the previous point, i.e. a 
DR screening service, a service monitoring the intravitreal antivascular endothelial growth factor (anti-VEGF) 
therapy used to treat wet AMD, and a follow-up service for CG.” 
Secondly, once the e-health services were well defined, the knowledge artefacts required to build the 
corresponding electronic models were modelled as proposed in the fifth objective. During the 
definition of the domain knowledge for the electronic models provided along this Thesis, a total of 
103 archetypes were used, excluding organizational classes (section and composition). Of these, 46 
were different from the others, which means that the reusability accounted for more than half of the 
archetypes used among the three models. Regarding non-repeated archetypes, 23 were used as is 
from the openEHR CKM, 4 were adapted to the needs of the healthcare scenario, and the remaining 
19 were specially created from scratch for this Thesis. These archetypes conformed to structure-
specific clinical encounters within 47 different templates, of which 31 were devised to structure the 
aforementioned archetypes inside the sections in order to ease clinician readability. The remaining 16 
templates were created to manage the compositions containing these section-type templates. Among 
all the clinical processes modelled, 19 guideline rules were designed to manage the navigation of 
patients through the healthcare service. Furthermore, 23 termsets were created to bind selectable data 
elements from the archetypes and templates to standard terminology services. Once modelled, these 
standardized representations for clinical knowledge were published in open-access repositories so that 
any healthcare service interested on implementing the same e-health services could download and 
adapt these resources to meet the needs of specific health services. In this way, although the clinical 
processes proposed were initially modelled for the SNS-O, these can be reproduced in a variety of 
healthcare scenarios, facilitating collaboration among healthcare facilities. Consequently, clinical 
information resulting from these e-health services would be managed electronically using model-
driven health computing platforms. All these knowledge artefacts have been listed in Appendix A.  
Besides the aforementioned elements, 16 UI forms were also defined; one for each composition-type 
template built. Nevertheless, these UI forms were not published given that their applicability was 
limited to the specific healthcare scenarios proposed for the SNS-O.  
Sixth overall objective: “To collaborate closely with standard-setting institutions and to use open platforms to 
share the experience gained during this Thesis.” 
Thirdly, and according to the sixth overall objective, modelling of clinical domain was carried out in 
close collaboration with standard-setting institutions, especially with the openEHR community 
members. In fact, the electronic models designed along this work were devised with a view to 
endeavour to maximise their usability in miscellaneous healthcare scenarios worldwide. 
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Seventh objective: “To prepare the ophthalmology department to implement e-health proposals: 
standardization of the diagnostic tests and information systems involved in the clinical processes proposed 
above.” 
Fourthly, as proposed in the last overall objective, specialised workspaces were set up in the 
ophthalmology department of the SNS-O, equipped with the technical and human resources 
necessary to implement the aforementioned e-health services. In the case of the high resolution 
consultation to monitor the treatment of wet AMD, additionally, a web platform was launched in 
compliance with openEHR specifications, to validate the therapeutic decisions made in the e-health 
service proposed.  
As a general conclusion, this Thesis proves that a definition of a comprehensive methodology for 
formalizing clinical practice into information systems, the design of a model-driven, standard-based, 
open e-health platform and the creation semantically enabled electronic models improves the 
management of electronic information in healthcare, the interoperability as well as the reutilization of 
the resources. 
6.2 FUTURE LINES 
The normalization of clinical knowledge in electronic information systems, in the way it has been 
proposed in this Thesis, provides interesting opportunities for objective evaluation of the parameters 
regarding the quality and efficiency of clinical practice:  
- The day-to-day functioning of services can be monitored, to identify bottlenecks and points 
for improvement on the current clinical practice. 
- The working services can be compared to new healthcare strategies resulting from research, 
before their widespread implementation. 
- New possibilities arise in medical research, such as objective assessment and comparison 
between therapies or drugs available.  
Therefore, besides facilitating the worldwide spread of more efficient care models, the model-driven e-
health approach should facilitate research toward modelling new clinical services.  
Furthermore, building electronic models is an intricate, laborious process which requires tight 
collaboration among multidisciplinary professionals (domain experts, physicians, technical developers, 
terminologists, etc.). For instance, the task of modelling every possibility into each archetype involved 
within a complex clinical process (constraints, translations, terminology bindings, and maintenance 
regarding updates in the model) represents a huge workload for just one research group. 
Consequently, most knowledge artefacts proposed so far were published as drafts. Nevertheless, it is 
envisaged that the peer-review process in openEHR's CKM repository would fill the gaps of that first 
version of the electronic models proposed: 
- Considering that the electronic models proposed in this Thesis were focused on assessment 
more than therapy, the stages corresponding to treatment could be extended in subsequent 
revisions. 
- The electronic models presented should be adapted to the extent that clinical practice evolves 
and integrates new concepts and healthcare strategies. 
- Future versions of the knowledge artefacts should adhere to the openEHR ADL 2 
specifications. 
- The methodology proposed for modelling healthcare into model-driven information systems 
could be applied to new healthcare scenarios. 
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Moreover, the applications available to build standardised electronic models still have to become 
user-friendly to encourage domain experts and terminologists to develop their own knowledge 
artefacts with no need of additional training: 
- There is work to be done in development of stable releases of modelling tools, and integrate 
them into fully-functional, open-access web platforms.  
- In the case of UI forms, there is not even a consensus on how to build them. It would be 
therefore interesting to provide open specifications and modelling tools to normalize the UI 
form building. 
Provided that open source knowledge modelling tools are along these lines, the expectation is that the 
electronic models will evolve over time as the number of users interested in adopting and testing them 
in real healthcare scenarios increases. And accordingly, the more healthcare scenarios these 
archetypes are used in, the more healthcare facilities will be able to share semantically enabled 
clinical information.  
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Appendix A: 
Knowledge artefacts proposed along this Thesis 
This appendix lists all archetypes, templates, termsets and guideline rules defined for the 
different electronic models presented along this Thesis. 
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Table 14: List of archetypes used on the proposed electronic models. 
 Archetype name Archetype source Archetype class Process stages in which it is applicable 
1.  Reason for encounter 
- Found on CKM 
- Usable as is 
Evaluation 
DR screening service: stage 1 
AMD monitoring service: stage 1 
CG follow-up service: stage 1 
2.  Clinical synopsis 
- Found on CKM 
- Usable as is 
Evaluation 
DR screening service: stage 1, stage 4, and stage 5 
AMD monitoring service: stage 1 and stage 5 
CG follow-up service: stage 1 and stage 4 
3.  Problem/diagnosis 
- Found on CKM 
- Usable as is 
Evaluation 
DR screening service: stage 1, stage 4, and stage 5 
AMD monitoring service: stage 1 and stage 5 
CG follow-up service: stage 1 and stage 4 
4.  Diagnostic criteria DR 
- No equivalences found 
- Archetype has to be modelled from scratch 
Cluster DR screening service: stage 1, stage 4, and stage 5 
5.  Story/history 
- Found on CKM 
- Usable as is 
Observation 
DR screening service: stage 1 
AMD monitoring service: stage 1 
CG follow-up service: stage 1 
6.  Symptom/Sign 
- Found on CKM 
- Usable as is 
Cluster 
DR screening service: stage 1 
AMD monitoring service: stage 1 
7.  DR screening convenient 
- No equivalences found 
- Archetype has to be modelled from scratch 
Evaluation DR screening service: stage 1 
8.  Care plan (request) 
- Found on CKM 
- Usable as is 
Instruction 
DR screening service: stage 2 
AMD monitoring service: stage 3 
CG follow-up service: stage 2 
9.  Care plan 
- Found on CKM 
- Usable as is 
Action 
DR screening service: stage 2 
AMD monitoring service: stage 3 
CG follow-up service: stage 2 
10.  Referral request 
- Found on CKM 
- Usable as is 
Instruction 
DR screening service: stage 2 
AMD monitoring service: stage 3 
CG follow-up service: stage 2 
11.  
Imaging examination 
request 
- Found on CKM 
- Usable as is 
Instruction 
DR screening service: stage 2 
AMD monitoring service: stage 3 
CG follow-up service: stage 2 
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 Archetype name Archetype source Archetype class Process stages in which it is applicable 
12.  
Acquisition details on 
eye fundus images 
- No equivalences found 
- Archetype has to be modelled from scratch 
Cluster 
DR screening service: stage 2 and stage 3 
AMD monitoring service: stage 3 and stage 4 
CG follow-up service: stage 2 and stage 3 
13.  Procedure 
- Found on CKM 
- Usable as is 
Action 
DR screening service: stage 3 and stage 6 
AMD monitoring service: stage 4 
CG follow-up service: stage 3 and stage 5 
14.  
Intraocular pressure 
measurement 
- Found on CKM 
- It has to be adapted 
Observation 
DR screening service: stage 3 
CG follow-up service: stage 1 and stage 3 
15.  
Central corneal 
thickness details 
- No equivalences found 
- Archetype has to be modelled from scratch 
Cluster 
DR screening service: stage 3 
CG follow-up service: stage 3 
16.  Medical device 
- Found on CKM 
- Usable as is 
Cluster 
DR screening service: stage 3 
AMD monitoring service: stage 4 
CG follow-up service: stage 3 
17.  Medical device details 
- Found on CKM 
- Usable as is 
Cluster 
DR screening service: stage 3 
AMD monitoring service: stage 4 
CG follow-up service: stage 3 
18.  Imaging examination 
- Found on CKM 
- Usable as is 
Action 
DR screening service: stage 3 
AMD monitoring service: stage 4 
CG follow-up service: stage 3 
19.  Anatomic location 
- Found on CKM 
- Usable as is 
Cluster 
DR screening service: stage 3 
AMD monitoring service: stage 4 
CG follow-up service: stage 3 
20.  Mydriasis application 
- No equivalences found 
- Archetype has to be modelled from scratch 
Cluster 
DR screening service: stage 3 
AMD monitoring service: stage 4 
CG follow-up service: stage 3 
21.  Medication amount 
- Found on CKM 
- Usable as is 
Cluster 
DR screening service: stage 3 
AMD monitoring service: stage 4 
CG follow-up service: stage 3 
22.  
Funduscopic 
examination of eyes 
- Found on CKM 
- It has to be adapted 
Observation 
DR screening service: stage 3, stage 4, and stage 5 
AMD monitoring service: stage 1, stage 4, and stage 5 
CG follow-up service: stage 1, stage 3, and stage 4 
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 Archetype name Archetype source Archetype class Process stages in which it is applicable 
23.  
Diagnostic report 
request 
- No equivalences found 
- Archetype has to be modelled from scratch 
Instruction 
DR screening service: stage 3 and stage 4 
AMD monitoring service: stage 4 and stage 5 
CG follow-up service: stage 3 and stage 4 
24.  
Classification of 
Diabetic Retinopathy 
- No equivalences found 
- Archetype has to be modelled from scratch 
Cluster DR screening service: stage 4 and stage 5 
25.  
Exclusion of a 
problem/diagnosis 
- Found on CKM 
- Usable as is 
Evaluation DR screening service: stage 4 and stage 5 
26.  Service request 
- Found on CKM 
- Usable as is 
Instruction 
DR screening service: stage 4, stage 5 
AMD monitoring service: stage 4 and stage 5 
CG follow-up service: stage 3 and stage 4 
27.  Recommendation 
- Found on CKM 
- Usable as is 
Evaluation 
DR screening service: stage 5 
AMD monitoring service: stage 1 and stage 5 
CG follow-up service: stage 1 and stage 4 
28.  Medication order 
- Found on CKM 
- Usable as is 
Instruction 
DR screening service: stage 6 
AMD monitoring service: stage 2 
CG follow-up service: stage 5 
29.  Medication action 
- Found on CKM 
- Usable as is 
Action 
DR screening service: stage 6 
AMD monitoring service: stage 2 
CG follow-up service: stage 5 
30.  
Intravitreal injection 
details 
- No equivalences found 
- Archetype has to be modelled from scratch 
Cluster 
DR screening service: stage 6 
AMD monitoring service: stage 2 
31.  Adverse reaction 
- Found on CKM 
- Usable as is 
Evaluation 
DR screening service: stage 6 
AMD monitoring service: stage 2 
CG follow-up service: stage 5 
32.  Procedure request 
- Found on CKM 
- Usable as is 
Instruction 
DR screening service: stage 6 
CG follow-up service: stage 5 
33.  
Ophthalmic laser 
procedure details 
- No equivalences found 
- Archetype has to be modelled from scratch 
Cluster 
DR screening service: stage 6 
CG follow-up service: stage 5 
34.  
Ophthalmic surgery 
details for posterior 
segment of eye 
- No equivalences found 
- Archetype has to be modelled from scratch 
Cluster DR screening service: stage 6 
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 Archetype name Archetype source Archetype class Process stages in which it is applicable 
35.  Visual acuity 
- Found on CKM 
- It has to be adapted 
Observation AMD monitoring service: stage 1, and stage 4 
CG follow-up service: stage 1 and stage 3 
36.  
Ophthalmic tomography 
examination 
- No equivalences found 
- Archetype has to be modelled from scratch 
Observation AMD monitoring service: stage 1, stage 4, and stage 5 
CG follow-up service: stage 1, stage 3, and stage 4 
37.  
Classification of age-
related macular 
degeneration 
- No equivalences found 
- Archetype has to be modelled from scratch 
Cluster 
AMD monitoring service: stage 1 and stage 5 
38.  Contraindication 
- Found on CKM 
- Usable as is 
Evaluation AMD monitoring service: stage 1 and stage 5 
CG follow-up service: stage 1 and stage 4 
39.  
Enrolment in a long-
term healthcare process 
- No equivalences found 
- Archetype has to be modelled from scratch 
Evaluation AMD monitoring service: stage 1 and stage 5 
CG follow-up service: stage 1 
40.  
Acquisition details on 
ophthalmic tomography 
- No equivalences found 
- Archetype has to be modelled from scratch 
Cluster AMD monitoring service: stage 3 and stage 4 
CG follow-up service: stage 2 and stage 3 
41.  
Healthcare procedure 
efficiency 
- No equivalences found 
- Archetype has to be modelled from scratch 
Admin entry 
AMD monitoring service: stage 5 
42.  Risk factors in glaucoma 
- No equivalences found 
- Archetype has to be modelled from scratch 
Cluster 
CG follow-up service: stage 1 
43.  
Visual field 
measurement 
- Found on CKM 
- It has to be adapted 
Observation 
CG follow-up service: stage 1, stage 3, and stage 4 
44.  
Classification of 
glaucoma 
- No equivalences found 
- Archetype has to be modelled from scratch 
Cluster 
CG follow-up service: stage 1 and stage 4 
45.  Findings in glaucoma 
- No equivalences found 
- Archetype has to be modelled from scratch 
Cluster 
CG follow-up service: stage 1 and stage 4 
46.  
Acquisition details on 
visual field test 
- No equivalences found 
- Archetype has to be modelled from scratch 
Cluster 
CG follow-up service: stage 2 and stage 3 
 
Total of different archetypes used:  46  
Archetypes in DR screening service: 34   Archetypes in AMD monitoring service: 32    Archetypes in CG follow-up service: 37 
Archetypes built from scratch:  19   Archetypes directly used from the CKM: 23   Archetypes adapted from CKM: 4    
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Table 15: List of templates designed for the proposed electronic models. 
 Template name Template class Process stages in which it is applicable 
1.  Patient admission into the DR screening service Composition DR screening service: stage 1 
2.  Patient's background leading to suspicion of DR Section DR screening service: stage 1 
3.  Patient‟s enrolment in DR screening Section DR screening service: stage 1 
4.  Follow-up schedule for patients with suspected DR Composition DR screening service: stage 2 
5.  Planning the diagnostic tests to detect and classify DR Section DR screening service: stage 2 
6.  Diagnostic tests in the DR screening service Composition DR screening service: stage 3 
7.  Intraocular pressure study Section 
DR screening service: stage 3 
CG follow-up service: stage 3 
8.  Acquisition and validation of NMR Section 
DR screening service: stage 3 
AMD monitoring service: stage 4 
CG follow-up service: stage 3 
9.  Next step in DR screening service Section DR screening service: stage 3, stage 4 and stage 5 
10.  DR screening Composition DR screening service: stage 4 
11.  Image test analysis for DR Section DR screening service: stage 4 and stage 5 
12.  Identification of patients with DR Section DR screening service: stage 4 
13.  DR assessment Composition DR screening service: stage 5 
14.  Classification and treatment of DR and DME Section DR screening service: stage 5 
15.  DR treatment Composition DR screening service: stage 6 
16.  Intraocular injection (anti-VEGF or corticoids) Section 
DR screening service: stage 6 
AMD monitoring service: stage 2 
17.  Laser procedures to treat DR Section DR screening service: stage 6 
18.  Surgical procedures to treat DR Section DR screening service: stage 6 
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 Template name Template class Process stages in which it is applicable 
19.  Patient admission into the long-term treatment for wet AMD Composition AMD monitoring service: stage 1 
20.  Patient's background leading to the diagnosis of AMD Section AMD monitoring service: stage 1 
21.  Classification and treatment of AMD Section AMD monitoring service: stage 1 and stage 5 
22.  Patient‟s enrolment in anti-VEGF therapy Section AMD monitoring service: stage 1 and stage 5 
23.  AMD treatment Composition AMD monitoring service: stage 2 
24.  Follow-up schedule for the treatment of wet AMD Composition AMD monitoring service: stage 3 
25.  Planning the diagnostic tests to monitor AMD progression Section AMD monitoring service: stage 3 
26.  Diagnostic tests for monitoring the treatment of wet AMD Composition AMD monitoring service: stage 4 
27.  Visual acuity study Section 
AMD monitoring service: stage 4 
CG follow-up service: stage 3 
28.  Acquisition and validation of OCT Section 
AMD monitoring service: stage 4 
CG follow-up service: stage 3 
29.  Next step in AMD monitoring service Section AMD monitoring service: stage 4 and stage 5 
30.  AMD assessment Composition AMD monitoring service: stage 5 
31.  Image test analysis for AMD Section AMD monitoring service: stage 5 
32.  Evaluation of the remote assessment model for wet AMD Section AMD monitoring service: stage 5 
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 Template name Template class Process stages in which it is applicable 
33.  Patient admission into the follow-up service for CG Composition CG follow-up service: stage 1 
34.  Patient's background and diagnosis of glaucoma Section CG follow-up service: stage 1 
35.  Classification and treatment of glaucoma Section CG follow-up service: stage 1 and stage 4 
36.  Patient‟s enrolment in CG follow-up Section CG follow-up service: stage 1 
37.  Follow-up schedule for CG Composition CG follow-up service: stage 2 
38.  Planning the diagnostic tests to follow-up the progression of CG Section CG follow-up service: stage 2 
39.  Diagnostic tests in the follow-up of CG Composition CG follow-up service: stage 3 
40.  Acquisition and validation of VF test Section CG follow-up service: stage 3 
41.  Next step in CG follow-up service Section CG follow-up service: stage 3 and stage 4 
42.  CG assessment Composition CG follow-up service: stage 4 
43.  Image test analysis for CG Section CG follow-up service: stage 4 
44.  Modify CG treatment Composition CG follow-up service: stage 5 
45.  Administration of antiglaucoma drugs Section CG follow-up service: stage 5 
46.  Laser procedures to treat CG Section CG follow-up service: stage 5 
47.  Incisional glaucoma surgery Section CG follow-up service: stage 5 
 
Total of different templates used:  47  
Templates used in DR screening service: 18 Templates used in AMD monitoring service: 16  Templates used in CG follow-up service: 19  
Total of templates reused: 12   Templates reused in different processes:  5  Templates reused within a process: 7 
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Table 16: List of termsets built for the proposed electronic models.  
 Termset name Description of termset Process stages in which it is applicable 
1.  Findings on posterior pole of eye Clinical findings identifiable in posterior pole of eye. 
DR screening service: stage 1, stage 4, and stage 5 
AMD monitoring service: stage 1 and stage 5 
CG follow-up service: stage 1 and stage 4 
2.  Subdivision of retina List of zones in eye retina for ophthalmic image positioning. 
DR screening service: stage 2 and stage 3 
AMD monitoring service: stage 3 and stage 4 
CG follow-up service: stage 2 and stage 3 
3.  
Corneal thickness measurement 
devices 
List of methods to obtain the corneal thickness measurement. 
DR screening service: stage 3 
CG follow-up service: stage 3 
4.  Mydriatic agents 
List of mydriatic agents and their corresponding doses 
validated for ophthalmologic use. 
DR screening service: stage 3 
AMD monitoring service: stage 4 
CG follow-up service: stage 3 
5.  
Complications on ophthalmic image 
acquisition 
List of possible complications during ophthalmic imaging 
studies that may affect the quality of acquisitions (based on 
Table CID 4222 of DICOM standard). 
DR screening service: stage 3 
AMD monitoring service: stage 4 
CG follow-up service: stage 3 
6.  Ophthalmic photography devices 
Lists the ophthalmic photography acquisition devices (based on 
Table CID 4202 of DICOM standard). 
DR screening service: stage 3 
AMD monitoring service: stage 4 
CG follow-up service: stage 3 
7.  Identification of diabetic retinopathy 
Identification of presence or absence of DR for screening 
purposes. 
DR screening service: stage 4 
8.  
Clinical grading for diabetic 
retinopathy 
International Clinical Diabetic Retinopathy Disease Severity 
Scale. 
DR screening service: stage 5 
9.  
Classification for diabetic macular 
edema 
Classification levels for the presence of ME as defined by the 
international scale for DR grading. 
DR screening service: stage 5 
10.  
Therapeutic procedures for diabetic 
retinopathy 
List of therapies available to treat different stages of DR. DR screening service: stage 5 
11.  Compounds for intravitreal injection 
Compounds administered in ophthalmology in the form of 
intraocular injection. 
DR screening service: stage 6 
AMD monitoring service: stage 2 
12.  Compounds for local anaesthesia Compounds available to apply local anaesthesia. 
DR screening service: stage 6 
AMD monitoring service: stage 2 
13.  Anti-infective agents List of anti-infective agents available. 
DR screening service: stage 6 
AMD monitoring service: stage 2 
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 Termset name Description of termset Process stages in which it is applicable 
14.  Laser procedures in ophthalmology List of laser procedures available for ophthalmic purposes. DR screening service: stage 6 
15.  Ophthalmic laser devices List of laser devices for ophthalmic use. 
DR screening service: stage 6 
CG follow-up service: stage 5 
16.  
Operative procedures on posterior 
segment of eye 
List of operative procedures on the posterior segment of eye. DR screening service: stage 6 
17.  Anatomic structures of eye 
List of regions of interest in the study of eye (based on DICOM 
Tables: CID 4209, CID 4211 and CID 4266). 
AMD monitoring service: stage 1, stage 3, stage 4, 
and stage 5 
CG follow-up service: stage 1, stage 2, stage 3 
and stage 4 
18.  Ophthalmic tomography devices 
List of acquisition devices (based on Table CID 4210 of 
DICOM standard). 
AMD monitoring service: stage 4 
CG follow-up service: stage 3 
19.  Finding of visual field List of findings distinguishable on the visual field test. CG follow-up service: stage 1 and stage 4 
20.  Classification of glaucoma List of disorders distinguishable on the diagnosis of glaucoma. CG follow-up service: stage 1 and stage 4 
21.  Glaucoma treatments 
List of therapeutic options to treat different types and stages of 
glaucoma. 
CG follow-up service: stage 4 and stage 5 
22.  Visual field illumination colours 
List of illumination colours used as visual stimuli on visual field 
test (based on Table CID 4255 of DICOM standard). 
CG follow-up service: stage 3 
23.  IOP lowering agents List of agents used in ophthalmology for IOP lowering. CG follow-up service: stage 5 
 
Total of different termsets built:  23    
Termsets in DR screening service: 16   Termsets in AMD monitoring service: 10  (2 new)  Termsets in CG follow-up service: 14 (5 new) 
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Table 17: List of guideline rules designed to direct the patients through the proposed clinical processes. 
 Rule name Description of the rule Process stages in which it is applicable 
1.  DR screening convenient 
This rule checks if the patient meets the criteria for 
inclusion in the screening process, and, if so, schedules 
the corresponding diagnostic tests. 
DR screening service: transition from stage 1 to stage 3 
2.  Diagnostic tests valid for screening 
This rule validates the diagnostic tests once acquired, 
and discards any unusual value before proceeding with 
the screening stage. 
DR screening service: transition from stage 3 to stage 4 
3.  Office examination required 
This rule identifies patients with dangerously high IOP 
values (≥22 mmHg) or low-quality fundus images (<4 
of 5 levels of quality), and therefore arranges directly 
the patient's assessment at the ophthalmologist's office. 
DR screening service: transition from stage 3 to stage 4 
4.  Altered retina 
This rule requests an assessment report to an 
ophthalmologist, if any alteration on the retina is 
identified during the screening. 
DR screening service: transition from stage 4 to stage 5 
5.  Apparently not altered retina 
Provided that the patient does not present signs of DR, 
this rule must schedule the diagnostic tests to conduct 
the next review defined by the follow-up process. 
DR screening service: transition from stage 4 to stage 2 
6.  DR treatment required 
This rule schedules the corresponding procedure or 
administration of medication to carry out treatment of 
DR. 
DR screening service: transition from stage 5 to stage 6 
7.  DR treatment not required 
If the ophthalmologist does not consider necessary to 
treat the patient on this point, this rule refers the patient 
to the next review defined by the follow-up process. 
DR screening service: transition from stage 5 to stage 2 
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 Rule name Description of the rule Process stages in which it is applicable 
8.  Anti-VEGF therapy convenient 
After a consultation on specialized care, this rule 
determines whether the patient will access or not to the 
long-term treatment of wet AMD by intravitreal 
injections. 
AMD monitoring service: transition from stage 1 to stage 2 
9.  Treatment cycle completed 
This rule verifies if every anti-VEGF injection ordered 
for a specific patient have been carried out, and, if 
true, automatically schedules the next consultation for 
patient review. 
AMD monitoring service: transition from stage 2 to stage 4 
10.  Diagnostic tests completed (AMD) 
This rule must guarantee the completion of every 
diagnostic test ordered for a specific patient before 
proceeding with the remote assessment. 
AMD monitoring service: transition from stage 4 to stage 5 
11.  AMD stable 
This rule postpones the treatment provided that the 
retinologist does not identifies signs of activity or 
progression on AMD, and therefore a new anti-VEGF 
injection would not be effective to treat such disease. 
AMD monitoring service: transition from stage 5 to stage 3 
12.  Repeat anti-VEGF treatment 
This rule orders a new intravitreal injection if the 
retinologist, as a result of the assessment of diagnostic 
tests, determines that the patient presents signs activity 
or progression on AMD. 
AMD monitoring service: transition from stage 5 to stage 2 
13.  Discontinuation of anti-VEGF therapy 
This rule revokes the patient's enrolment in the long-
term treatment for wet AMD, if the retinologist identifies 
contraindications to continue with the therapy during 
any of the periodic assessments. 
AMD monitoring service: terminate the clinical process from 
stage 1 or stage 5 
14.  Glaucoma follow-up convenient 
This rule checks if the patient meets the criteria for 
admittance to the glaucoma follow-up service, and, if 
so, schedules the corresponding diagnostic tests. 
CG follow-up service: transition from stage 1 to stage 3 
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 Rule name Description of the rule Process stages in which it is applicable 
15.  Diagnostic tests completed (CG) 
This rule must guarantee the completion of every 
diagnostic test ordered for a specific patient before 
proceeding with the remote assessment. What 
differentiates this one from the homonymous rule 
defined for the monitoring of wet AMD are the 
diagnostic tests to be completed in each case. 
CG follow-up service: transition from stage 3 to stage 4 
16.  Glaucoma stable 
This rule schedules the diagnostic tests involved in the 
follow-up process, whenever as a result of an overall 
assessment of glaucoma, the ophthalmologist does not 
identifies clear signs of disease progression, and 
hence, the patient is well controlled. 
CG follow-up service: transition from stage 4 to stage 2 
17.  Glaucoma progressive 
This rule is triggered by patients diagnosed with 
glaucoma that present any sign of disease progression 
that could lead to visual loss in the future. For such 
cases, the rule arranges an office examination where 
the same ophthalmologist responsible of the remote 
assessment would determine the appropriate 
therapeutic decision for each patient. 
CG follow-up service: transition from stage 4 to stage 5 
18.  Modify the medical treatment 
This rule covers the scenario in which, as a result of the 
office assessment, the ophthalmologist considers that 
treatment modification is warranted, but the disease 
could be easily stabilized by adjusting the medication 
regimen. 
CG follow-up service: terminate the clinical process from 
stage 5 
19.  Surgery required 
This rule arranges a surgical procedure for lowering 
IOP, when an ophthalmologists identifies clear signs of 
glaucoma progression, and the target IOP is not 
reached through medical treatment. 
CG follow-up service: terminate the clinical process from 
stage 5 
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Appendix B: 
Web platform for evaluation of the high resolution consultation 
to manage the treatment of wet AMD 
This appendix presents the web platform used at the SNS-O for validating the high resolution 
consultation approach in comparison to the traditional strategy for the treatment of wet 
AMD. To that end, first, the procedure used for the validation is presented. Second, an OPT 
was modelled to enable objective comparisons between traditional and high resolution 
consultations in compliance with openEHR specifications. Third, the preliminary results of the 
study that established the validity of therapeutic decisions made in a remote setting are 
presented. 
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B.1 EVALUATION OF THE HIGH RESOLUTION CONSULTATION 
The high resolution consultation is still in pilot stage. Therefore, it would not be sensible to implement 
the whole model built for monitoring of the treatment of patients diagnosed with wet AMD before 
proving the feasibility of the new consultation with regard to the traditional approach. 
In that respect, firstly, a web platform was launched to facilitate the integration of the high resolution 
consultation into the SNS-O. Considering the traditional consultation as the gold standard, this 
website would validate the therapeutic decisions made in remote workstations as suggested in the 
high resolution consultation approach. To that end, patients with exudative AMD treated with at least 
three intravitreal injections were evaluated through the office examination, and the corresponding 
diagnostic reports were registered into the web platform. At this point, a waiting period of four weeks 
was considered sufficient for the specialists not to recognize test acquisitions already assessed. Then, 
the same patients were reassessed but this time the evaluation was addressed remotely, i.e. based on 
diagnostic tests examined through an electronic workstation. Therefore, the web platform compared 
the records corresponding to both models of consultation to determine the agreement at the time of 
deciding for each patient whether an additional intravitreal treatment was necessary. Other 
parameters such as sociodemographic variables, or information concerning the efficiency of each 
consultation approach were analyzed by the platform.  
Originally, the web platform was launched to manage a study on the local scenario of the SNS-O, 
without regard for the interoperability and reusability of information. Nevertheless, eventually different 
healthcare facilities joined the platform, and new parameters were considered for analysis. In 
consequence, the exploitation of the information became more complex to the extent that the study 
evolved toward more ambitious projects. Thus, to avoid the ungovernability of information, the 
medical forms defined in the web platform were modelled in compliance with openEHR specifications. 
The resulting electronic models should provide backward compatible medical records, even if different 
users work with custom-made medical forms, or the study incorporates new concepts on the future.  
B.2 MODELLING AN OPENEHR OPT TO EVALUATE THE HIGH RESOLUTION CONSULTATION 
APPROACH 
In light of the entire clinical process modelled for monitoring patients receiving anti-VEGF therapy for 
wet AMD, this study would cover the fifth clinical stage established in the AMD monitoring service (see 
Figure 20). Therefore, some of the clinical concepts identified for that clinical stage were combined to 
build a template analogous to the medical forms provided by the web platform. It is possible to review 
this template since it was uploaded to the CKM under the name of “Consultation for AMD 
assessment”. 
On the one hand, the template proposed consists of some sociodemographic variables considered 
useful for later epidemiologic purposes (patient‟s identifier, age, and sex). Information about the 
reporting healthcare professional is also included to facilitate the development of interobserver and 
intraobserver studies. The “Individual’s personal demographics” and “Healthcare professional” 
archetypes from CKM were included in the template to that end. 
On the other hand, as seen along the design of the clinical process, the office examination includes 
VA, fundus exam and OCT. Considering that eye fundus evaluation can be reliably substituted by 
digital retinography, a non-mydriatic fundus camera is used during office examination in addition to 
the direct ophthalmoscopy. Therefore, the resulting retinographies are converted to DICOM and then 
submitted to the PACS server along with the OCT acquisitions, so that they can be remotely reviewed 
in the high resolution consultation. However, the clinical findings identified from the examination of 
these tests must be registered using the web platform. Thus, the template includes the archetypes 
“Funduscopic examination of eyes” and “Ophthalmic tomography examination” to that end. In case of 
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the VA measurement, the archetype “Visual acuity” is provided twice into the template: one to register 
the VA value at the study onset, and one for the latest measurement obtained. In this way, it is 
possible to identify any progression on visual loss.  
The template also comprises the “Healthcare procedure efficiency” archetype. It was included to 
record the time spent to complete the remote assessment, and thus compare the measured value with 
the duration of an office examination which is estimated at 10 minutes per patient. 
Finally, the archetype “Recommendation” was added toward the end of the template. This stems from 
the need of registering into the web platform, the therapeutic decision of whether treat or not the 
patient with anti-VEGF injections as well as the criteria used to arrive at this conclusion whatever the 
type of consultation. 
Therefore, based on the same sociodemographic variables and VA measurements, the imaging 
studies were first examined directly in the ophthalmologist's office and later reviewed remotely by 
means of a DICOM visualizer. Accordingly, a study of agreement was carried out, by comparing the 
therapeutic decisions, and criteria registered in the web platform for both models of consultation. 
Likewise, the time spent by retina specialists was compared for the office and remote models of 
assessment (see Figure 29).  
B.3 STATISTICS RESULTING FROM THE STUDY 
According to the last analysis of results carried out on the web platform, 201 patients were included in 
the study at 31th August 2016. 88 were male (44%) and 113 female (56%). Mean age was 81 years. 
During office examination in 87 cases (43%) the decision was to repeat the injection while in 114 
cases (57%) it was decided not to repeat treatment. With respect to the comparison among office and 
remote evaluation, in 181 (90%) cases the results were the same. Among the 20 remaining patients 
and considering office examination as the gold standard, 17 correspond to false positives (office 
examination indicates not to repeat treatment but remote examination indicates to repeat treatment) 
and 3 to false negatives (office examination indicates to repeat treatment but remote examination 
indicates not to repeat treatment). With these data the sensitivity and specificity of remote evaluation 
are 96 and 87% respectively. The average amount of time spent in remote evaluation is 1 minute 22 
seconds compared with 10 minutes spent in office examination. 
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Figure 29: Comparative study between office examination and remote evaluation with regard to determine the treatment of exudative AMD.
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